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EXECUTIVE SUMMARY
The focus of this research was to explore the capabilities of stereolithography
(SL) to photocrosslink a well-known biopolymer, poly(ethylene glycol) (PEG), and create
three-dimensional scaffolds with applications in tissue engineering. The specific aim
was to produce a scaffold for use in peripheral nerve regeneration. This research was
divided into three parts: 1) stereolithography of photocrosslinkable PEG, 2) fabrication
of peripheral nerve guidance conduits using stereolithography, and 3) cell viability of
human dermal fibroblasts in response to stereolithography parameters.
The use of SL to fabricate PEG-based hydrogels, both complex structures and
multi-material
demonstrated.

structures

with

specified

spatially-controlled

characteristics

was

Photopolymerization experiments were performed to characterize

different PEG-based photopolymer solutions for use in SL, where the crosslinked depth
(or gel thickness) was measured at different laser energies. The different photopolymer
solutions characterized consisted of two different types of photocrosslinkable PEG:
(poly(ethylene glycol) dimethacrylate MW 1K, and poly(ethylene glycol) diacrylate MW
3.4K) at two different concentrations (20 and 30%), and a fixed concentration (0.5%) of
the photoinitiator Irgacure 2959. Gel thickness was a strong function of energy dosage,
PEG type and concentration. Results of mechanical testing showed that mechanical
properties are also a strong function of energy dosage, PEG type and concentration:
PEG-da 3.4K gels are stronger (have a higher ultimate stress value) than PEG-dma 1K
gels, gels prepared with a photopolymer concentration of 30% are stronger than the
ones prepared at a 20% concentration, and as more energy is used to crosslink the
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gels, the stronger the gels. Equilibrium swelling behavior data of different PEG gels
crosslinked

at

different

energies

showed

that
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polymer type and concentration, but not on energy dosage for the two energies
investigated. Hydrogels fabricated with the PEG-da 3.4K photopolymer had a lower sol
fraction and a higher swelling ratio than the ones fabricated with PEG-dma 1K, and
hydrogels fabricated with a 20% concentration had a higher swelling ratio and a higher
sol fraction than the ones fabricated with the 30% concentration.

The equilibrium

swelling behavior in terms of dimensional changes of simple constructs was
investigated. The determined dimensional swelling factor exhibited a dependence on
energy dosage, PEG type, and concentration.

Overall, PEG-dma 1K gels at the

equilibrium swollen state (placed in distilled water after fabrication for more than 48
hours) decreased in size, while PEG-da 3.4K gels increased in size, and as the polymer
concentration in solution prior to crosslinking decreased (from 30 to 20% (w/v)), the size
of the gels decreased. In summary, the first part of this research investigated what was
necessary to fabricate complex structures in a layer-by-layer fashion, using SL and
photopolymerizable PEG with sufficient mechanical robustness and with specified final
swollen feature sizes.
In the second part of this research, the fabrication of a 3D nerve guidance
conduit (NGC) design with SL was demonstrated using high-molecular weight
photocrosslinkable PEG. The design of the NGC has two important characteristics: a
vii

capped portion at each end that allows effective suturing of the proximal and distal
stumps of the damaged nerve to the NGC, and a multi-lumen middle portion that
provides a greater surface area for support cells and sprouting axons. The dimensions
of the design were the smallest permitted by the SL system used for the fabrication:
2.94mm OD, 1.72mm ID, with seven 400-μm diameter lumens. Due to swelling of the
material the dimensions in the final swollen state were approximately: 3.38mm OD,
2.43mm ID with lumen diameters of 585μm. The complete manufacturing process of
NGCs consisted of four different stages: 1) photocrosslinking using SL, which permits a
rapid fabrication strategy for complex 3D scaffolds; 2) swelling to equilibrium in a
phosphate buffered saline (PBS) solution, to allow the scaffold to reach the final
dimensions while removing unreacted photopolymer; 3) lyophilization, that preserves
the scaffold, making it an off-the-shelf product with improved suturability; and, 4)
sterilization with hydrogen peroxide, to be able to implant in vivo.

The fabricated

conduits were characterized at each stage of the manufacturing process. Optical and
scanning electron microscopy showed that the conduits had a rough topography, with
bumps and dimples in the free-surface and that a micro-porous, sheet-like microstructure of the material was created by the lyophilization process. The weight degree
of swelling and dimensional swelling factors, showed that the final dimensions of the
conduits were significantly larger than the original dimensions, and that the samples
returned easily and rapidly to a swollen state when placed in an aqueous solution.
Furthermore, resistance to deformation under compressive force, and static coefficient
of friction of the fabricated conduits with and without post-processing (lyophilization)
viii

were evaluated. As implantable NGCs should resist compression from surrounding
tissue, it was determined that a multi-lumen design (with and without post-processing)
has a better resistance to compression than a single-lumen design with an equivalent
surface area. The calculated coefficient of friction of the conduits on glass was 1.10
and 0.56 for conduits with and without post-processing (lyophilization) respectively,
indicating that the post-processed conduits at the swollen state were less slippery and
therefore easier to handle, which represents a desirable characteristic of the ideal NGC.
The suturability of the conduits was also demonstrated.
In the third part of this research, SL parameters related to unfavorable cell growth
and survival, including photoinitiator (PI) exposure, ultraviolet (UV) exposure, and
radical formation of the PI upon exposure to UV energy were assessed in vitro using
human dermal fibroblast (HDFs) cells to explore the capabilities of SL to create
scaffolds with encapsulated cells.

Cell viability of HDFs exposed to increasing

concentrations of two types of PIs, and to a fixed concentration of PI for different
exposure times was investigated.

Cytotoxicity increased with increasing PI

concentration, and increased exposure time, as expected. For a given PI concentration
(0.5%), the detrimental effect of the PIs on cell survival is evident after 4 hours of
exposure. For prolonged exposures (24 hours), cell viability was similar to the nonDMSO control (complete media) for HDFs treated with the PI Irgacure 2959 (I-2959)
only at concentrations up to 0.05%. These results agree with previous studies on the
effect of I-2959 on cytotoxicity of cells. It should be noted, however, that the longer
exposure times used here are greater than any exposure the cells would actually
ix

experience during the SL process. Once constructs are made (30-40 minutes, even for
complex 3D structures), the constructs would be placed in media and excess PI would
begin leaching out. Thus, 0.5% I-2959 could realistically be used in conjunction with SL
without severe cytotoxicity. The toxic effect of UV irradiation, and the combined effect
of PI (at a given concentration of 0.5%) under UV irradiation on cultured HDFs was
examined. HDFs cultured on tissue culture plates at two different cell concentrations
(5,000 and 50,000 cells/cm2) were exposed to a range of UV irradiation from 0 – 20,000
mJ/cm2 from the 325 nm laser of the SL system. Cell viability was determined using
fluorescence readings and image analysis. No detrimental effect of UV irradiation, nor
of photoinitiator under UV irradiation, was observed in the experiment using a high
concentration of cells (50,000 cells/cm2).

For a low concentration of cells (5,000

cells/cm2), cell viability decreased with increasing UV energy dosage. Cell viability of
cells exposed to a concentration of 0.5% (w/v) of the photoinitiator I-2959 and irradiated
with different dosages of UV also decreased with increasing energy dosages. Results
from image analysis were comparable to fluorescence readings, but for the experiment
using a low cell concentration exposed to the photoinitiator under UV irradiation, image
analysis was better able to detect the significant differences in cell viability.

In

summary, results showed that SL threshold levels for unfavorable cell survival were well
above the levels used to create PEG-based scaffolds in SL. Furthermore, HDFs were
encapsulated in photocrosslinkable PEG hydrogels using SL and the viability of the cells
was evaluated at 2 and 24 hours following encapsulation. Two different types of PEG
were used to encapsulate the cells: PEG-dma 1K, and PEG-da 3.4K.
x

Hydrogel

scaffolds with encapsulated cells showed a uniform distribution of cells throughout the
scaffolds, and a high percentage of viable cells at both 2 and 24 hours (at least 87%),
with no significant difference in the viability of cells at the two time points, nor with PEG
type. The results indicate that the use of SL and photocrosslinkable biomaterials, such
as photocrosslinkable PEG, appears feasible for fabricating scaffolds with living cells for
a variety of important tissue engineering applications.

xi

TABLE OF CONTENTS
ACKNOWLEDGMENTS ........................................................................................................ IV
EXECUTIVE SUMMARY ....................................................................................................... VI
TABLE OF CONTENTS ........................................................................................................XII
LIST OF TABLES ...............................................................................................................XVI
LIST OF FIGURES ............................................................................................................ XVII
CHAPTER 1
INTRODUCTION................................................................................................... 1
1.1. RESEARCH MOTIVATION .............................................................................................. 1
1.1.1. THE PERIPHERAL NERVOUS SYSTEM ......................................................... 2
1.1.2. REGENERATION CAPACITY OF THE PERIPHERAL NERVOUS SYSTEM ............. 5
1.1.3. CLINICAL TREATMENT FOR PERIPHERAL NERVE INJURIES ............................ 6
1.2. SCAFFOLD FABRICATION STRATEGIES IN TISSUE ENGINEERING ...................................... 9
1.3. STEREOLITHOGRAPHY ............................................................................................... 12
1.4. MATERIALS USED...................................................................................................... 15
1.4.1. POLY(ETHYLENE GLYCOL) ....................................................................... 15
1.4.2. IRGACURE 2959 .................................................................................... 18
1.5. PROPOSED NERVE REGENERATION SCAFFOLD ........................................................... 19
1.6. REFERENCES ........................................................................................................... 21
CHAPTER 2
OBJECTIVES .................................................................................................... 30
CHAPTER 3
STEREOLITHOGRAPHY OF POLY(ETHYLENE GLYCOL) ......................................... 33
3.1. INTRODUCTION ......................................................................................................... 34
xii

3.2. MATERIALS AND METHODS ........................................................................................ 39
3.2.1. PHOTOPOLYMER SOLUTION .................................................................... 39
3.2.1.1. SYNTHESIS OF BIOACTIVE PEG (PEG-RGDS) ................................ 40
3.2.1.2. SYNTHESIS OF FLUORESCENTLY LABELED BIOACTIVE PEG (PEGRGDS-FITC) ............................................................................... 40
3.2.2. APPARATUS AND SOFTWARE................................................................... 40
3.2.3. CURE DEPTH / GEL THICKNESS ASSESSMENT .......................................... 47
3.2.4. MECHANICAL TESTING ............................................................................ 51
3.2.5. GEL CHARACTERIZATION ........................................................................ 53
3.2.6. FABRICATION OF 3D STRUCTURES .......................................................... 54
3.2.7. CELL MAINTENANCE ............................................................................... 60
3.2.8. STATISTICAL ANALYSIS ........................................................................... 61
3.3. RESULTS AND DISCUSSION ........................................................................................ 61
3.3.1. GEL THICKNESS ..................................................................................... 62
3.3.2. MECHANICAL TESTING ............................................................................ 71
3.2.3. GEL CHARACTERIZATION ........................................................................ 83
3.2.4. FABRICATION OF 3D STRUCTURES .......................................................... 90
3.4. CONCLUSIONS ........................................................................................................ 101
3.5. REFERENCES ......................................................................................................... 106
CHAPTER 4
FABRICATION OF MULTI-LUMEN PEG-BASED NERVE GUIDANCE CONDUITS USING
STEREOLITHOGRAPHY ............................................................................... 113
4.1. INTRODUCTION ....................................................................................................... 114
4.2. MATERIALS AND METHODS ...................................................................................... 120
4.2.1. PHOTOPOLYMER SOLUTION .................................................................. 120
xiii

4.2.2. APPARATUS ......................................................................................... 121
4.2.3. SCAFFOLD FABRICATION ...................................................................... 121
4.2.3.1. STEREOLITHOGRAPHY.................................................................. 121
4.3.2.2. SWELLING ................................................................................... 124
4.3.2.3. LYOPHILIZATION .......................................................................... 124
4.3.2.4. STERILIZATION ............................................................................ 125
4.3.2.5. SUTURE ...................................................................................... 125
4.2.4. CHARACTERIZATION ............................................................................. 125
4.2.5. STATISTICAL ANALYSIS ......................................................................... 129
4.3. RESULTS AND DISCUSSION ...................................................................................... 129
4.3.1. SCAFFOLD FABRICATION ...................................................................... 129
4.3.2. CHARACTERIZATION ............................................................................. 135
4.3.2.1. WEIGHT CHANGES ....................................................................... 135
4.3.2.2. DIMENSIONAL CHANGES ............................................................... 137
4.3.2.3. OPTICAL MICROSCOPY................................................................. 141
4.3.2.4. SCANNING ELECTRON MICROSCOPY ............................................. 143
4.3.2.5. MECHANICAL TESTING ................................................................. 154
4.3.2.6. COEFFICIENT OF FRICTION ........................................................... 159
4.4. CONCLUSIONS ........................................................................................................ 159
4.5. REFERENCES ......................................................................................................... 161
CHAPTER 5
CELL VIABILITY OF HUMAN DERMAL FIBROBLASTS TO STEREOLITHOGRAPHY
PARAMETERS AND CELL ENCAPSULATION USING STEREOLITHOGRAPHY ........ 168
5.1. INTRODUCTION ....................................................................................................... 169
xiv

5.2. MATERIALS AND METHODS ...................................................................................... 172
5.2.1. CELL MAINTENANCE ............................................................................. 172
5.2.2. PHOTOINITIATOR TOXICITY .................................................................... 173
5.2.3. UV IRRADIATION TOXICITY..................................................................... 174
5.2.4. UV IRRADIATION + PHOTOINITIATOR TOXICITY ........................................ 175
5.2.5. CELL ENCAPSULATION.......................................................................... 176
5.2.6. CELL VIABILITY AND TOXICITY EVALUATION ............................................. 177
5.2.7. STATISTICAL ANALYSIS ......................................................................... 181
5.3. RESULTS AND DISCUSSION ...................................................................................... 181
5.3.1. PHOTOINITIATOR TOXICITY .................................................................... 181
5.3.2. CYTOTOXICITY OF UV IRRADIATION AND
PHOTOTINITIATOR-UV IRRADIATION ...................................................... 183
5.3.3. CELL ENCAPSULATION.......................................................................... 191
5.4. CONCLUSIONS ........................................................................................................ 194
5.5. REFERENCES ......................................................................................................... 196
CHAPTER 6
CONCLUSIONS AND RECOMMENDATIONS .......................................................... 200
CURRICULUM VITAE ....................................................................................................... 207

xv

LIST OF TABLES

Table 3.1. Build style overcure parameters and the effect on vector speed. The 3rd and
4th columns show the vector file generated by 3DLightyearTM and the vector file
drawn on laser paper, respectively. # No hatch is drawn because the hatch vector
speed is too fast and does not mark the laser paper. * No hatch is drawn as there
is no hatch vector in the vector file. ........................................................................ 44
Table 3.2. Measured weights (in grams) of hydrogel samples fabricated using SL at two
different energy dosages for the four different PEG solutions investigated (n = 6).
o: original weight, weight of the sample immediately after fabrication. d: weight of
the sample dried following fabrication, dried at room temperature for > 48 hrs. s:
swollen weight, after allowed to reach equilibrium in distilled water. rd: weight of
the sample dried following swelling, dried at room temperature for > 48 hrs.......... 86
Table 3.3. Swelling ratio and sol fraction of hydrogels fabricated at two different energy
dosages, for the four different PEG-based solutions investigated (n = 6). ............. 86
Table 3.4. Dimensional swelling factor (DSF) of hydrogels fabricated at two different
energy dosages, for the four different PEG-based solutions investigated (n = 6). . 88

xvi

LIST OF FIGURES

Figure 1.1. The nervous system: central nervous system (CNS) in light blue and
peripheral nervous system (PNS) in dark blue.18 ..................................................... 3
Figure 1.2. Schematic of a peripheral neuron.21 ............................................................. 5
Figure 1.3. Hierarchical schematic of the anatomy of a peripheral nerve. Axons
surrounded by sheaths of myelinating Schwann cells are enclosed by
endoneurium. Next, the perineurium joins individual axons to form nerve fascicles.
Finally the support tissue called epineurium groups the nerve fascicles forming the
nerve.13 .................................................................................................................... 5
Figure 1.4. Responses to nerve transection in the PNS (adapted from [13]). Following
axotomy the distal nerve stump degenerates leaving cellular debris. Proliferating
Schwann cells, along with macrophages and monocytes work together to clean the
cellular debris and generate a microenvironment supportive of regeneration.
Schwann cells align forming a column called band of Bunger to guide axonal
growth. Reinnervation is achieved when the axonal outgrowths reach their distal
target. ....................................................................................................................... 7
Figure 1.5. Peripheral nerve regeneration process through a guidance channel.17........ 9
Figure 1.6. Commercial SL system (3D Systems 250/50) (left) and schematic of the SL
process (right). ....................................................................................................... 14
Figure 1.7. Working curve for SL 5149.55 ..................................................................... 15
Figure 1.8. Chemical structures of A) poly(ethylene glycol) (PEG), B) and C)
photocrosslinkable PEG, and D) Irgacure 2959 (I-2959). ....................................... 16
Figure 1.9. Schematic of crosslinked PEG. .................................................................. 18
Figure 1.10. Dissociation reaction of Irgacure 2959 into free radicals. ......................... 19
Figure 1.11. Cartoon of the proposed multi-lumen and multi-material bioactive PEG
nerve guidance conduit (NGC). The red spheres represent the gradient of NGF
and the blue cubes represent the tetrapeptide RGDS that has a uniform
concentration throughout the multi-lumen section of the conduit. .......................... 21
Figure 3.1. Stereolithography system. A: Commercial SL apparatus 250/50. B:
Building envelope of the commercial SL apparatus. C: Building envelop in the
modified setup (insert shows the sssembly of the self-aligning mini-vat setup. ...... 41
xvii

Figure 3.2. Top view of the patterns crosslinked used two different software conditions.
A, C, and E: default 3DLightyearTM parameters (extra border and different border
and hatch speeds. B, D, and F: modified parameters (no extra border and same
border and hatch speeds. C and D: inner openings. E and F: outer openings.
Patterns crosslinked using a PEG-dma 1K 30% solution. Marker in A and B
represents 1mm. Marker in C – F represents 0.5 mm. .......................................... 46
Figure 3.3. Gel thickness experimental setup. A: schematic of SL apparatus, B: filling
the container with the PEG-based solution, C: drawing the vector pattern through
the glass slide, D: measuring the gel thickness with calipers, E: enlargement
showing the gel attached to the glass slide and illustrating the gel thickness. ....... 48
Figure 3.4. Different vector files used in the cure depth experiment (left: vector file
according to 3DLightyearTM, right: vector file etched in laser paper). A: single (x)
hatch with hatch spacing of 0.010 in, B: double x-y hatch with hatch spacing of
0.010 in, and C: default hatch, double x-y hatch with hatch spacing of 0.004 in. ... 50
Figure 3.5. Compressioon testing of cure depth assessment samples. A: Prior to
testing, the sample is placed on compression base and the thickness is measured
at a pre-load force of 0.01N. B: Prior to testing, the sample is wetted with distilled
water. C: Start of test, notice tht the whole sample is covered in water to avoid
drying of the sample during testing. D: End of test, notice that the upper
compression disk is in contact with the compression base. ................................... 52
Figure 3.6. Stress-Strain curve from compression testing of cure depth assessment
samples indicating the ultimate stress, ultimate strain, and compressive modulus.53
Figure 3.7. Schematic of the self-aligning mini-vat setup. ............................................ 55
Figure 3.8. Multi-material scaffold design. A and B: computer-aid design. C and D:
vector file of the regions patterned using the photopolymer solution containing
fluorescently-labeled dextran or bioactive PEG. E and F: vector file of the regions
patterned using the primary photopolymer solution. Units are in mm.................... 58
Figure 3.9. Effect of photoinitiator type and concentration on gel thickness. Solid
markers correspond to HMPP and hollow markers correspond to I-2959: ■ 20%
PEG-dma; ♦ 30% PEG-dma. The energy dosage to obtain the gels was ~650
mJ/cm2 (power dosage ~65 mW/cm2). ................................................................... 63
Figure 3.10. Effect of energy dosage on gel thickness for a PEG-dma 1K solution with
0.5% (w/v) of I-2959. Solid markers correspond to 20% (w/v), and hollow markers
correspond to 30% (w/v). ....................................................................................... 64
Figure 3.11. Effect of energy dosage on gel thickness for a PEG-da 3.4K solution with
0.5% (w/v) of I-2959. Solid markers correspond to 20% (w/v), and hollow markers
correspond to 30% (w/v). ....................................................................................... 65
xviii

Figure 3.12. Effect of energy dosage on gel thickness for PEG-dma 1K (square marker)
and PEG-da 3.4K (diamond markers) solutions with 0.5% (w/v) of I-2959. Solid
markers correspond to 20% (w/v), and hollow markers correspond to 30% (w/v). . 68
Figure 3.13. Gel thickness versus laser speed for a 20% (v/w) PEG-da 3.4K solution
with 0.5% (w/v) of I-2959 using three different vector files. Diamond markers
correspond to a single hatch vector file with no overlapping of the laser (hatch
spacing, hs = 0.010 in). Triangle markers correspond to a doble x-y hatch vector
file (hs = 0.010 in). Circle markers correspond to a double x-y hatch vector file with
a default hatch spacing (hs = 0.004 in). ................................................................. 70
Figure 3.14. Optical micrographs of gels crosslinked with the three different vector files
(top and side views). A: Vector file with a single hatch with no overlapping of the
laser (hatch spacing, hs = 0.010 in). B: Vector file of x-y orthogonal hatch with hs =
0.010 in. C: Vector file of x-y orthogonal hatch, with default hatch spacing (hs =
0.004 in). NOTE: pictures were taken immediately after fabrication (original state).
Marker represents 1 mm. ....................................................................................... 70
Figure 3.15. Effect of energy dosage on gel thickness for a 20% (v/w) PEG-da 3.4K
solution with 0.5% (w/v) of I-2959 using three different vector files. Diamond
markers correspond to a single hatch vector file with no overlapping of the laser
(hatch spacing, hs = 0.010 in). Triangle markers correspond to a doble x-y hatch
vector file (hs = 0.010 in). Circle markers correspond to a double x-y hatch vector
file with a default hatch spacing (hs = 0.004 in). .................................................... 71
Figure 3.16. Stress-strain curves for the cure depth samples of the four different
solutions investigated. Gray and black lines correspond to a photopolymer
concentration of 20% (w/v) and 30% (w/v), respectively. Continuous and dashed
lines correspond to PEG-dma 1K and PEG-da 3.4K photopolymer. A, B, and C
correspond to samples crosslinked with an energy dosage of ~ 550, 1,250 and
2,500 mJ/cm2, respectively. ................................................................................... 72
Figure 3.17. Effect of energy dosage on mechanical properties of PEG-dma 1K
hydrogels (n = 6). A: Ultimate Stress and B: Compressive Modulus for a
photopolymer concentration of 20% (w/v). C: Ultimate Stress and D: Compressive
Modulus for a photopolymer concentration of 30% (w/v). ...................................... 75
Figure 3.18. Effect of energy dosage on mechanical properties of PEG-da 3.4K
hydrogels (n = 6). A: Ultimate Stress and B: Compressive Modulus for a
photopolymer concentration of 20% (w/v). C: Ultimate Stress and D: Compressive
Modulus for a photopolymer concentration of 30% (w/v). ...................................... 76
Figure 3.19. Effect of energy dosage on mechanical properties of 20% (w/v) PEG-da
3.4K hydrogels. A: Ultimate Stress and B: Compressive Modulus for samples
crosslinked with a single (x) hatch (hs = 0.010 in). C: Ultimate Stress and D:
xix

Compressive Modulus for samples crosslinked with a double x-y hatch (hs = 0.010
in). E: Ultimate Stress and F: Compressive Modulus for samples crosslinked with a
default hatch (double x-y, hs = 0.004 in). ............................................................... 78
Figure 3.20. Comparison between original thickness (solid bars) and swollen thickness
(downward diagonal) at different crosslinking energies. A and B, 20 and 30% (w/v)
concentration of PEG-dma 1K. C and D, 20 and 30% (w/v) concentration of PEGda 3.4K. E and F, 20% (w/v) PEG-da 3.4K samples crosslinked with a double x-y
hatch (hs = 0.010 in), and crosslinked with a default x-y hatch (hs = 0.004in),
respectively. # &: swollen dimension is statistically different to its corresponding
original dimension (p<0.05). ................................................................................... 79
Figure 3.21. Effect of energy dosage on gel thickness swelling for a 20% (v/w) PEG-da
3.4K solution with 0.5% (w/v) of I-2959 using three different vector files. Diamond
markers correspond to a single hatch vector file with no overlapping of the laser
(hatch spacing, hs = 0.010 in). Triangle markers correspond to a doble x-y hatch
vector file (hs = 0.010 in). Circle markers correspond to a double x-y hatch vector
file with a default hatch spacing (hs = 0.004 in). Solid markers correspond to the
original thickness. Hollow markers correspond to the swollen tickness. ............... 82
Figure 3.22. Optical micrographs of cure depth sample ............................................... 84
Figure 3.23. Characteristics of PEG-based hydrogels fabricated using SL at two
different energy dosages. A: Swelling ratio, B: Sol fraction (n = 6). ...................... 85
Figure 3.24. Dimensions of PEG-based hydrogels. A and B: PEG-dma 1K based
hydrogels, C and D: PEG-da 3.4K based hydrogels. A and C: gels fabricated at an
energy dosage of 180 mJ/cm2. B and D: gels fabricated at an energy dosage of
300 mJ/cm2 (n = 6). ................................................................................................ 89
Figure 3.25. Optical micrographs of ring samples at their equilibrium swollen state. ... 90
Figure 3.26. Complex 3D structures manufactured using SL, the chess rook on the right
in each picture was made with DSM Somos® WaterShed™ 11120 resin while the
rook on the left is PEG-based. A: PEG-based structure immediately after it was
built. B: deformation of elastic PEG-based structure. C: PEG-based structure after
drying. .................................................................................................................... 92
Figure 3.27. PEG-based scaffolds with embedded channels of different sizes and
orientations: A) isometric view, B) side view of a 1 x 1 x 1.6 cm block, and C) top
view of a 1 x 1 x 5 cm block. .................................................................................. 93
Figure 3.28. Multi-lumen PEG-based nerve regeneration conduits. A and B: isometric
and top view of NCG with OD = 5mm, ID = 3mm and twelve 500-μm lumens
fabricated with a 30% PEG-dma 1K solution. C and D: isometric and top view of
NCG with OD = 2.94mm, ID = 1.72mm and seven 400-μm lumens fabricated with a
xx

20% PEG-dma 1K solution. E and F: isometric and top view of NCG with OD =
3.7mm, ID = 2.09mm and seven 400-μm lumens fabricated with a 20% PEG-da
3.4K solution. Marker represents 1mm. ................................................................ 95
Figure 3.29. Brightfield images of 2D multi-material scaffolds. A – D Scaffolds
fabricated using fluorescently-labeled dextran: A nd B (10X) with PEG-dma 1K, C
and D (7.1X) with PEG-da 3.4K as the main material. E – H Scaffolds fabricated
using fluorescently-labeled RDGS: E and F (10X) with PEG-dma 1K, G and H
(7.1X) with PEG-da 3.4K as the main material. Arrows point to empty spaces
where the fluorescent component should be present. ............................................ 96
Figure 3.30. Confocal microscope images (25X) of the multi-material scaffolds
fabricated using fluorescently-labeled dextran. A-D: scaffolds fabricated with PEGdma 1K as the main material. E-H: scaffolds fabricated with PEG-da 3.4K as the
main material.......................................................................................................... 97
Figure 3.31. Fluorescent images of the multi-material scaffolds fabricated using
fluorescently-labeled PEG-RGDS. A-D: scaffolds fabricated with PEG-dma 1K as
the main material. E-H: scaffolds fabricated with PEG-da 3.4K as the main material.
............................................................................................................................... 99
Figure 3.32. Representative phase contrast image of HDFs attached to the regions
patterned with the photopolymer solution containing bioactive PEG-RGDS. A: 24
hours after cell seeding. B: One week after cell sedding. ...................................... 99
Figure 3.33. NGC fabricated using different colors of fluorescent particles in the PEGbased solution. A and B: isometric and top view of scaffold showing precise
placement of different materials between layers. C and D: isometric and side view
of scaffold showing precise placement of different materials across layers. Marker
represents 1mm. .................................................................................................. 100
Figure 3.34. Complex 3D structure manufactured in multi-material SL. PEG-dma 1K at
a 20% (w/v) concentration was used as the main material. The solution used to
create the staircase contained fluorescent microspheres. A: Structure during
fabrication, after rinsing and completing the second stage of using the second
material, the part is attached to the base of the mini-vat setup. B: Final structure.
Marker represents 5 mm. ..................................................................................... 101
Figure 4.1. Setup in the dynamic mechanical analyzer (DMA) for the compression test
of the NGC designs. ............................................................................................. 128
Figure 4.2. Schematic of the experiment to determine the static coefficient of friction
and free-body diagram. The static coefficient of friction is equal to the tangent of a.
(W is the weigth of the sample). ........................................................................... 128
xxi

Figure 4.3. Optical micrographs of the multi-lumen pattern crosslinked at different
speeds.................................................................................................................. 131
Figure 4.4. Interlayer bonding, A: appropriate interlayer bonding (overlapping ~280μm)
and B: inappropriate interlayer bonding as the structure will delaminate. Marker
represents 1 mm. ................................................................................................. 132
Figure 4.5. Top (A and C) and side (B and D) views of 2-layer multi-lumen structures
fabricated using different volumes for the second layer (section on the left of B and
D). A and B: structure fabricated using 280 μL (~300μm overlapping). C and D:
structure fabricated using 260 μL (~350μm overlapping). .................................... 133
Figure 4.6. Optical micrographs of the conduits at different stages of the fabrication
process: A: CAD drawing, B: after fabrication, C: after swelling, D: lyophilized, E:
sterilized, and F: reconstituted. ............................................................................ 134
Figure 4.7. Weight of nerve guidance conduits (NGCs) samples at different stages of
the manufacturing process. The swelling ratio for the samples swollen at
equilibrium after fabrication (QS) and swollen to equlibium after reconstitution (QR)
is included. ........................................................................................................... 136
Figure 4.8. Increase in weight of sterilized conduits as a function of time in PBS. A:
Data in terms of weight vs. time. B: Data in terms of percentage of PBS in the
samples vs. time. ................................................................................................. 137
Figure 4.9. Change in dimensions of NGCs at different stages of the fabrication
process (14 ≤ n ≤ 24). A: Outside diameter at the bottom end. B: Diameter of the
center lumen measured from the bottom end. C: Length of the conduit. D: Layer
thickness. E: Outside diameter at the top end (capped portion). F: Inside diameter
at the top end (capped portion). DSF = dimensional swelling factor. .................. 139
Figure 4.10. Optical micrographs of NGC samples at each stage of the manufacturing
process. Left column: top end (capped portion). Right column: bottom end....... 140
Figure 4.11. Optical micrographs of reconstituted NCG. A and B: side view. C: top
view. Please note the rough surface topography of the samples. ....................... 141
Figure 4.12. Optical micrographs of disk-shaped samples fabricated with SL after
lyophilization (A – D) and reconstituted to an equilibrium state (E, F). ................. 142
Figure 4.13. Optical micrographs of sutured conduits. A: lyophilized conduit with a
regular knot (right) and an air knot (left). B and C: air knot, and D and E: regular
knot, once the conduit is reconstituted. ................................................................ 144

xxii

Figure 4.14. Low magnification SEM images of lyophilized conduits. A and B: sample
cut longitudinally (A: free surface, B: internal structure). C and D: sample
transverse cross section (C: free surface, D: internal structure)........................... 145
Figure 4.15. Low magnification SEM images of sterilized conduits. A and B: sample cut
longitudinally (A: free surface, B: internal structure). C and D: sample transverse
cross section (C: free surface, D: internal structure). ........................................... 146
Figure 4.16. High magnification SEM images of sterilized conduits cut longitudinally. A,
C, and E: free surface. B, D, and F: internal structure. White particles are leftover
PBS salts.............................................................................................................. 147
Figure 4.17. High magnification SEM images of transverse cross sections of sterile
conduits showing the internal structure. A, C, E: periphery of the conduit. B, D,
and F: multi-lumen section in the center. ............................................................. 148
Figure 4.18. . High magnification SEM images of transverse cross sections of sterile
conduits showing the free-surface of the conduits. A, C, E: periphery of the conduit.
B, D, and F: multi-lumen section in the center...................................................... 149
Figure 4.19. High magnification SEM images of lyophilized conduits cut longitudinally.
A, C, and E: free surface. B, D, and F: internal structure. ................................... 150
Figure 4.20. High magnification SEM images of the interior of lyophilized conduits,
transverse cross sections between the lumens. Please note the distorted outline of
the lumens in A. The micro-porous structure of the material is observed in B, C, and
D micrographs. ..................................................................................................... 151
Figure 4.21. High magnification SEM images of the interior of lyophilized conduits,
transverse cross sections at the periphery of the conduit. The sheet-like folding
structure of the material is observed in these micrographs. ................................. 152
Figure 4.22. High magnification SEM images of the free-surface of lyophilized conduits,
transverse cross sections. Dimples and voids are noticeable in the material, and
sheet-like folding microstructure of the material outlining the lumens .................. 153
Figure 4.23. SEM images of sutured lyophilized NGCs.............................................. 154
Figure 4.24. Force versus displacement curves for the four types of conduits tested
under compression ............................................................................................... 155
Figure 4.25. Results of mechanical testing of four different types of conduit designs
under compression. A: Resistance to compression, B: Force required to collapse
the design, and C: Force required to break the conduit. ...................................... 156

xxiii

Figure 4.26. Compresion testing of NGCs designs: single lumen (left), multi-lumen
without post-processing (center), and post-processed multi-lumen (right), at
different stages. A: initially, B: partially compressed design, C: completely
collapsed design, D: compression of the material, and E: sample crushed. ........ 158
Figure 5.1. Layout of the 96-well plate for the UV irradiation and photoinitiator with UV
irradiation experiment. .......................................................................................... 175
Figure 5.2. Image preparation steps to threshold the desired objects in the image
analysis script....................................................................................................... 179
Figure 5.3. Image preparation steps for quantitative analysis. ................................... 180
Figure 5.4. Cytotoxicity of photoinitiators A) as a function of time for a given
photoinitiator concentration (0.05%), and B) as a function of photoinitiator
concentration for an exposure time of 48 hours. Survival is normalized to that
observed in non-DMSO controls. Solid bars and markers correspond to HMPP,
hollow bars and markers correspond to I-2959. Note that the symbols in B for
HMPP and I-2959 at concentrations of 0.125% and 0.0625 overlap. ................... 182
Figure 5.5. Survival of HDFs following exposure to UV energy (solid bars) and to the
photoinitiator I-2959 and irradiated with UV (downward diagonal bars), assessed
using a fluorescence plate reader. A: low cell concentration experiment (5,000
cells/cm2), B: high cell concentration experiment (50,000 cells/cm2). Note that no
detrimental effect is observed in the experiment using a high cell concentration,
although the data for the highest energies (12,000 and 20,000 mJ/cm2) has a high
variability. ............................................................................................................. 184
Figure 5.6. Live cells confluency of HDFs following exposure to UV energy (solid bars)
and to the photoinitiator I-2959 and irradiated with UV (downward diagonal bars),
assessed using image analysis. A: low cell concentration experiment (5,000
cells/cm2), B: high cell concentration experiment (50,000 mJ/cm2). Note that no
detrimental effect is observed in the experiment using a high cell concentration. 185
Figure 5.7. Fluorescent images for UV exposure experiment at a low (5,000 cells/cm2)
cell density. HDFs were stained with a LIVE/DEAD cell viability assay in which the
live cells fluoresce green and the dead cells fluoresce red. Right column: high
magnification images (100X). Left column: low magnification images (50X). ...... 187
Figure 5.8. Fluorescent images for photoinitiator and UV exposure experiment at a low
(5,000 cells/cm2) cell density. HDFs were stained with a LIVE/DEAD cell viability
assay in which the live cells fluoresce green and the dead cells fluoresce red. Right
column: high magnification images (100X). Left column: low magnification images
(50X). ................................................................................................................... 188
xxiv

Figure 5.9. Fluorescent images for UV exposure experiment at a high (50,000
cells/cm2) cell density. HDFs were stained with a LIVE/DEAD cell viability assay in
which the live cells fluoresce green and the dead cells fluoresce red. Right column:
high magnification images (100X). Left column: low magnification images (50X).
............................................................................................................................. 189
Figure 5.10. Fluorescent images for photoinitiator and UV exposure experiment at a
high (50,000 cells/cm2) cell density. HDFs were stained with a LIVE/DEAD cell
viability assay in which the live cells fluoresce green and the dead cells fluoresce
red. Right column: high magnification images (100X). Left column: low
magnification images (50X). ................................................................................. 190
Figure 5. 11. Viability of human dermal fibroblasts encapsulated in PEG hydrogels
photocrosslinked using SL at 2 and 24 hours following fabrication. Solid bars
correspond to PEG-dma 1K gels, downward diagonal bards correspond to PEG-da
3.4K gels. ............................................................................................................. 192
Figure 5.12. HDFs encapsulated in PEG hydrogels photocrosslinked using SL, stained
with a LIVE/DEAD cell viability assay in which the live cells fluoresce green and the
dead cells fluoresce red. A and B: at 2 hr following encapsulation, C and D: at 24
hr following encapsulation. E and F: low magnification image showing an even
distribution of cells throughout the gel (marker represents 1 mm)........................ 193

xxv

CHAPTER 1
INTRODUCTION
The focus of this research was on exploring the capabilities of stereolithography
to photocrosslink a well-known biopolymer, poly(ethylene glycol), and create threedimensional scaffolds with applications in tissue engineering. Specifically, the aim was
to produce a scaffold that could be used in peripheral nerve regeneration. The following
sections provide a review of the literature relevant for this project. Section one contains
a basic overview of the anatomy, physiology, and regenerative capacity of the
peripheral nervous system (PNS), the issues associated with its damage and the
current strategies for its repair necessary to understand the motivation for this research.
Section two reviews the current strategies for scaffold fabrication in tissue engineering.
The use of stereolithography, its fundamentals and justification for use in this project are
described in detail in section three. Section four describes the two main materials used
in this research, the biopolymer poly(ethylene glycol) and the photoinitiator Irgacure
2959, and the rationale for their use.

The final section describes the design of a

proposed scaffold for peripheral nerve regeneration.

1.1. RESEARCH MOTIVATION
In recent years, layered manufacturing (LM) or rapid prototyping (RP)
technologies, initially developed to create prototypes prior to production for the
automotive, aerospace, and other industries, have found applications in tissue
engineering (TE) and their use is growing rapidly. RP technologies are increasingly
1

demonstrating the potential for fabricating biocompatible 3D structures with precise
control of the micro- and macro-scale characteristics. Several comprehensive reviews
on the use of rapid prototyping technologies, also known as solid freeform fabrication,
have been published recently.1–4

The use of SL in TE has not been significantly

explored, perhaps because of the lack of commercially available implantable or
biocompatible materials from the SL industry. With the availability of photocrosslinkable
hydrogel materials, one important TE area to explore with SL is in soft tissue
engineering for the regeneration of peripheral nerves.
The large number of peripheral nerve injuries that occur annually in the United
States is still indeterminate. In 1995, there were more than 50,000 surgical procedures
performed to repair severed peripheral nerves.5,

6

The National Hospital Ambulatory

Medical Care Survey indicates 7.3 million injury-related visits during 2000 due to open
wounds, with many of the injuries including the peripheral nerve.7

Injuries in the

peripheral nerves can result in impaired sensation, reduced motor function, persistent
pain, and in the worst case scenario, complete loss of the injured limb.8, 9 Fortunately,
an injured peripheral nerve has the capacity to regenerate.10–17

1.1.1. THE PERIPHERAL NERVOUS SYSTEM
The nervous system (shown in Figure 1.1) is classified into the central nervous
system (CNS) and the peripheral nervous system (PNS). The CNS includes the brain
and spinal cord; its main functions are to conduct and interpret signals and to provide
excitatory stimuli to the PNS. The PNS consists of 43 pairs of nerves directly attached
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Figure 1.1. The nervous system: central nervous system (CNS) in light blue and peripheral
nervous system (PNS) in dark blue.18

to the cerebrospinal axis, and sensory nerve cell bodies, and their processes, attached
directly to a number of the spinal nerves. The PNS function is to receive information
from the external environment and carry signals to and from the brain and spinal cord.13,
19
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Two cell types compose the nervous system: neurons and neuroglia. Neurons
are the basic structural and functional unit of nervous tissue, and consist of two parts:
the cell body that contains the nucleus, associated organelles and cytoplasm, and the
nerve processes (axons and dendrites) that are projections from the cell body able to
conduct and transmit signals. Peripheral neurons (see schematic in Figure 1.2) consist
of a cell body and a long process, or axon which may reach one meter in length.17, 19, 20
Neuroglias (or glial cells) are support cells that aid the function of neurons and include
Schwann cells in the PNS and astrocytes and oligodentrites in the CNS.13, 17, 20
A peripheral nerve consists of a bundle of motor and sensory axons held
together by support tissue forming a defined trunk (see Figure 1.3). Each axon is
surrounded by sheaths of Schwann cells and myelin, the latter serves to increase the
propagation velocity of a nerve impulse, and is produced by the Schwann cells. There
are small gaps (~ 1µm) between the Schwann-myelin sheaths, called nodes of Ranvier.
The nodes of Ranvier allow saltatory conduction of a nerve impulse; that is, jumping of
impulses from node to node, which is faster and more energetically favorable than
continuous conduction.

Individual axons and their Schwann-myelin sheaths are

covered by thin layer of connective tissue, composed primarily of oriented collagen
fibers, called endoneurium.

Groups of axons are surrounded by many layers of

fibroblast cells and collagen, called perineurium, to form nerve fascicles. Finally, an
outer sheath of loose fibrocollagenous tissue, called epineurium, joins individual nerve
fascicles into a nerve. Peripheral nerves are well vascularized by a minute capillary
system within the support tissue of the nerve.13, 20, 22
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Figure 1.2. Schematic of a peripheral neuron.21

1.1.2. REGENERATION CAPACITY OF THE PERIPHERAL NERVOUS SYSTEM
Nerve injuries are a form of trauma with complicated rehabilitation outcomes
because mature neurons do not undergo cell division. The PNS, unlike the CNS, has
the capacity to regenerate. Peripheral nerve regeneration comprises the formation of
axonal sprouts, their outgrowths as regenerating axons and reinnervation of the original
target. A complete nerve transection is the most severe PNS injury. 10–13, 22, 23

Axon

Endoneurium
Basal
Lamina
Epineurium
Schwann Cell
Nucleous
Perineurium

Figure 1.3. Hierarchical schematic of the anatomy of a peripheral nerve. Axons surrounded by
sheaths of myelinating Schwann cells are enclosed by endoneurium. Next, the perineurium joins
individual axons to form nerve fascicles. Finally the support tissue called epineurium groups the
nerve fascicles forming the nerve.13
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Following transaction in the peripheral nerves, there is degeneration of the distal
nerve stump, followed by the generation of a microenvironment supportive of
regeneration. The distal nerve stump degenerates as a result of protease activity and
separation from the metabolic resources of the nerve cell bodies, the cytoskeleton
breaks down followed by the dissolution of the cell membrane. Schwann cells decrease
the synthesis of myelin and along with macrophages, clean myelin and axonal debris,
and produce cytokines to enhance axon growth.

Schwann cells differentiate to a

premyelinating mitotic Schwann cell phenotype and proliferate and align to create a
tubular structure referred to as band of Bunger that provides a physical guidance to
regenerating axons. New axonal sprouts usually emanate from the nodes of Ranvier.
Reinnervation is achieved when the axonal outgrowths reach their distal target, however
to achieve functional recovery the target must retain the ability to accept reinnervation
and recover from denervation atrophy.13, 17, 22, 23 Figure 1.4 shows a schematic of the
regeneration process in the PNS. Clinical treatment for PNS injuries is discussed in the
following section.

1.1.3. CLINICAL TREATMENT FOR PERIPHERAL NERVE INJURIES
Surgical reconnection is an effective clinical treatment for nerve transection if the
damaged nerves are directly adjacent and can be reconnected without causing
tension.13 Other strategies to repair small nerve injuries include using CO2 lasers to
“weld” the separated tissue and fibrin glue to reattach the injured nerves.14 When a
nerve transection occurs and the injury creates a large gap in the nerve (greater than
approximately 4mm), autologous nerve grafts sutured between the damaged nerve
6
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Figure 1.4. Responses to nerve transection in the PNS (adapted from [13]). Following axotomy
the distal nerve stump degenerates leaving cellular debris. Proliferating Schwann cells, along
with macrophages and monocytes work together to clean the cellular debris and generate a
microenvironment supportive of regeneration. Schwann cells align forming a column called band
of Bunger to guide axonal growth. Reinnervation is achieved when the axonal outgrowths reach
their distal target.

stumps are considered the standard of care.24 The use of autologous nerve grafts is the
most effective tubular technique that exists today for nerve regeneration, with clinical
functional recovery rates of approximately 80%.13,

17

Although functional recovery is

likely with autologous nerve grafts, the harvesting of the grafts results in an additional
surgery and loss of function at the donor site.6, 9–11, 13
Different materials have been used in the tubular repair of peripheral nerves.
Allo- or xenografts of arteries, veins, bone, and muscle among other natural materials
have been used, with the disadvantages of producing undesirable immune responses
and mismatching dimensions and mechanical properties, resulting in very poor success
7

rates.25 Silicone tubes have been one of the most frequently used synthetic materials
for nerve repair because of silicone’s inert and elastic properties. However, silicone
entubulation has long-term complications including fibrosis and chronic nerve
compression, requiring a complicated surgical removal of the tube once the nerve has
regenerated.16, 25 These natural and artificial tubes used in early years for nerve repair
function act as a tunnel that connects the damaged nerve stumps and accumulates
tissue fluid with important growth factors and extracellular matrix components for nerve
regeneration.12

Figure 1.5 shows the regeneration process through a guidance

channel, when the transection of the nerve is clean, and the nerve gap is smaller than
10mm.

Within the first hours after implantation, the tube fills with a clear, protein-

containing (clot-forming protein and fibrin) fluid released by the cut blood vessels in the
nerve ends. During the first week, a longitudinally oriented fibrin matrix is formed within
the tube creating a continuous bridge between the nerve ends, and this bridge is
invaded by cellular elements (fibroblasts, Schwann cells, macrophages, and endothelial
cells) from the proximal nerve stump trying to reach the distal nerve stump. By week
two, Schwann cells engulfe the axons advancing from the proximal stump. After four
weeks some axons reached the distal nerve stump, and many have become
myelinated.17 In recent years, plenty of research has been done to tissue engineer a
nerve guidance conduit (NGC) to replace simple tubes and improve peripheral nerve
repair by using bio-absorbable, bio-degradable materials, and incorporating important
growth factors, and cells into the conduit to promote faster healing over longer lengths.6,
11, 13–16, 25

Biodegradable NGCs, of collagen and the copolymer poly(DL-lactic-ε-

caprolactone), are now available for implantation in humans.26,

8

27

Recent studies in

nerve regeneration are also examining the conduit’s design, using multiple lumen in
order to better mimic the natural structure of a nerve and provide a greater surface area
for support cells and sprouting axons.28–34

Figure 1.5. Peripheral nerve regeneration process through a guidance channel.17
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1.2. SCAFFOLD FABRICATION STRATEGIES IN TISSUE ENGINEERING
Since the emergence of tissue engineering (TE), a wide variety of strategies for
the fabrication of three-dimensional (3D) scaffolds to restore damaged organ function
have been investigated. The design of a TE scaffold should mimic the structure of the
site where it will be implanted, as well as provide the biochemical cues to enhance
regeneration of the damaged organ.

The early strategies used to fabricate TE

scaffolds, many of which are still in practice today, include textile technologies, solvent
casting/particulate leaching techniques, and phase separation systems.

In general,

these strategies depend on the material used to fabricate the scaffold and its intended
application.35, 36
For the fabrication of tissue-engineered NGCs, different techniques have been
developed, including textile technologies, dipping of a substrate, deposition, solvent
casting/particulate leaching techniques, and phase separation systems. In a different
approach for the development of NGCs, novel decellularization treatments for allografts
have been explored in order to avoid undesirable immune responses.
Nerves, muscles and small intestinal submucosa have been investigated as
acellular allografts for nerve repair, these allografts have been pretreated with different
growth factors or seeded with Schwann cells (support cells in the peripheral nervous
system) prior to implantation in a rat model. Acellular allografts have shown promising
results. Nerve grafts retained the extracellular structure of peripheral nerve tissue, the
decellularization process yielded immunologically tolerated grafts, and ultimately, the
grafts with incorporated growth factors and cells supported regeneration.
10

5, 37–40

Still,

decellularized grafts have the disadvantage of not being readily available, as
decellularization protocols may take at least 48 hours, and storing of grafts
compromises their regenerative ability.6, 9
For the fabrication of NGCs using biomaterials, in textile technologies,
polyglycolic acid (PGA) and chitosan in fiber form have been used to fabricate NGC with
tubular braiding machines and electrospinning devices.

41, 42

Poly-L-lactic acid (PLLA),

copolymers of polylactide (PLA, both L-lactide and D-lactide) and polycaprolactone
(PCA), or blends of PLLA with the copolymer polylactide-glycolide acid (PLGA),
dissolved in either chloroform or methylene chloride have been used as the dipping
solution where cylindrical substrates (e.g. syringes, small polytef sheaths) are immersed
to create single tubes and tubes with multiple channels.28, 43, 44 PLGA has been used to
fabricate conduits combining injection molding and phase separation techniques, where
a highly concentrated solution of the polymer is injected into a cylindrical mold, and then
the solvent is removed by sublimation.29,

30, 32–34

PLLA, PLGA and urethane-based

polyglycolide-co-ε-caprolactone blends have been extruded into tubes with, and without
the use of salt particles in order to produce highly porous tubes via particle leaching.45–
48

Single and multichannel tubes of hydroxylethyl methacrylate (HEMA) have been

prepared using glass tubes as molds and polycaprolactone (PLC) fibers for templates.31,
49, 50

Simple tubes were prepared by injecting a HEMA precursor solution into a small

glass tubular mold, and placing the mold in a centrifuge until crosslinking of the HEMA.
The centrifugal forces cast the material to the walls of the tube creating a HEMA tube
with OD equal to the ID of the glass tube.49 For multichannel tubes, PLC fibers are
inserted into a glass tube that is filled with the HEMA precursor solution.
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After

crosslinking of the HEMA, the samples are removed from the glass mold and sonicated
to dissolve the PCL fibers, leaving the template of the fibers into the cylindrical shape of
HEMA.50

Chitin-based tubes have been prepared in a similar fashion using glass

molds.51 Suspension of alginate-chitosan and poly (D,L-lactic-co-ε-caprolactone) have
been deposited into spinning mandrels to produce simple tubes.52, 53 For the creation of
NGCs, it is proposed to use the rapid prototyping technology of stereolithography (SL)
with the biomaterial poly(ethylene glycol) modified with photocrosslinkable groups.

1.3. STEREOLITHOGRAPHY
Due to its accuracy and ease of use and control, SL has the potential to be a
unique process capable of fabricating 3D soft tissue scaffolds for mass production. The
use of RP technologies in tissue engineering is fairly recent with research activity rapidly
and continually increasing.
When stereolithography (SL), an RP or layered manufacturing (LM) process that
could automatically build detailed three-dimensional (3D) parts, became commercially
available in the mid-1980s, the manufacturing industry was profoundly impacted by
significantly improving the way in which prototypes were fabricated.54

Since the

introduction of SL, a number of new RP technologies have been developed and
commercialized with widely varying applications in engineering design, manufacturing,
medicine, and more.
Commercial line-scan SL solidifies thin layers of photo-reactive liquid polymer
using an ultraviolet (UV) laser that selectively crosslinks the liquid photopolymer by
rastering across the surface of the polymer contained in a vat. 3D shapes are built one
12

layer at a time by attaching the desired part to a build platform that begins at the surface
of the liquid photopolymer and traverses deeper into the liquid after each successive
layer is solidified.

Figure 1.6 shows a picture of a commercial SL system, the 3D

Systems 250/50, and a schematic that illustrates the SL process. The requisite for the
photopolymers used in SL is the ability to undergo photopolymerization by exposure to
UV radiation.

SL photopolymers are generally formulated from photoinitiators and

reactive liquid monomers.

Recent specialty photopolymers that resist high

temperatures or loads contain fillers (i.e. ceramic) and other chemical modifiers. The
photosensitivity of a photopolymer used in SL is determined with the “working curve” of
the photopolymer, which graphs in a log-linear fashion the cure depth (solidified
thickness of the liquid photopolymer) for a given exposure to the UV energy of the laser.
The primary photosensitivity parameters, EC (critical exposure) and DP (penetration
depth), are obtained from the X-intercept and slope of the working curve, respectively.
Figure 1.7 shows the working curve for the resin SL 5149 (Cibatool® 5148, Ciba Geigy
Corp., Tarrytown, NY). The EC value corresponds to the gel point of the photopolymer,
and the DP value denotes the depth of penetration of the laser beam into the
photopolymer solution.55
The use of SL in TE has not been significantly explored, perhaps because of the
lack of commercially available implantable or biocompatible materials from the SL
industry. Photocrosslinkable non-toxic formulations have been developed recently for
use in SL.56,

57

Mixtures of photocrosslinkable poly(propylene fumarate) (PPF) and

diethyl fumarate (DEF)58,

59

and mixtures of polyfunctional methacrylic oligomers and

hydroxyapatite60, 61 have been used in SL to create complex porous scaffolds for bone
13

regeneration. For soft tissue applications, Dhariwala et al. utilized SL to photocrosslink
a simple geometry using a mixture of poly(ethylene oxide) and poly(ethylene glycol)dimethacrylate (PEG-dma) to create hydrogels containing a high density (50 x 106
cells/mL) of Chinese hamster ovary cells (CHO-B2).62

Despite demonstrating the

viability of this cell line to the SL process, only simple geometries (rings with a 5-mm
diameter) were created.

In previous work by our group, the capabilities of SL to

fabricate PEG-hydrogel structures of high complexity were demonstrated using
solutions of a low molecular weight (MW 1K) photoreactive PEG, showing the potential
use of SL in soft TE applications.63–66
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Scanning
Mirrors
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Liquid
Photopolymer
Level
Built Part
(Solid Photopolymer)

Figure 1.6. Commercial SL system (3D Systems 250/50) (left) and schematic of the SL process
(right).

14

Figure 1.7. Working curve for SL 5149.55

1.4. MATERIALS USED
It has been shown previously the successful use of the polymer poly(ethylene
glycol) (PEG) and the photoinitiator Irgacure 2959 (I-2959) for the fabrication of complex
structures in SL.63–66 The following two sections describe these materials in more detail.
The chemical characteristics, physical properties, and applications of both materials are
discussed. Figure 1.8 shows the chemical structures of PEG and I-2959.

1.4.1. POLY(ETHYLENE GLYCOL)
PEG is one of the most widely used biocompatible polymers. PEG is considered
a biomaterial because it is generally non-toxic, non-immunogenic and can be easily
cleared from the body. Examples of the applications of PEG as biomaterial are the
PEG-protein conjugates used for the treatment of different illnesses, and the PEG
hydrogels used for cell encapsulation, drug delivery and wound healing. PEG’s lack of
15
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toxicity and immunogenicity is molecular weight (MW) dependant. Low molecular weight
PEG (< 1,000) can be oxidized in vivo into toxic diacid and hydroxyl acid metabolites via
sequential oxidations by alcohol dehydrogenase and aldehyde dehydrogenase. Higher
molecular weights of PEG are not metabolized via this route but rather excreted by
glomerular filtration, indicating that the PEG molecule is not reabsorbed by the renal
tubules.67 Photopolymerizable PEG with molecular weights of 3,400 (n ~ 77) and 6,000
(n ~ 136) are currently being used for soft TE applications.68–78
The following characteristics make PEG a strong candidate for creating
photocrosslinkable hydrogel tissue scaffolds. PEG is a hydrophilic polymer and can be
easily modified with photoreactive and crosslinkable groups like acrylates or
methacrylates.79 Crosslinked PEG becomes hydrogels, 3D polymer networks that can
swell large quantities of water without the dissolution of the polymer due to their
hydrophilic but crosslinked structure (see Figure 1.9). Moreover, hydrogels have high
permeability for oxygen, nutrients, and other water-soluble metabolites, thus giving them
physical characteristics similar to soft tissues.

PEG can be made bioactive by

covalently incorporating adhesion ligands, growth factors, and cytokines to the polymer
molecule, or by simply trapping the bioactive agents within the mesh of a PEG
hydrogel.68–72

While PEG hydrogels are normally non-degradable, they can be

rendered biodegradable by incorporating proteolytically degradable peptide sequences
into the PEG backbone.68 Another important characteristic of PEG hydrogels is the
capability to vary their mechanical properties, by varying their concentration, molecular
weight, degree of crosslinking, and degree of swelling, and all these terms are
interconnected.71,72, 80, 81
17
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1.4.2. IRGACURE 2959
Irgacure 2959 (I-2959) is a commercially available photoinitiator from Ciba
Specialty

Chemicals,

Inc.

I-2959

chemical

hydroxyethoxy)phenyl]-2-methyl-1-propanone.

name

I-2959

is
is

(2-hydroxy-1-[4-(2water-soluble

(at

concentrations lower than 1%) due to the hydroxyl functional group. Cytocompatibiblity
studies have shown that I-2959 is an advantageous radical-forming photoinitiator in cell
encapsulation applications since I-2959 does not have a significant detrimental effect on
18
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cell survival.

82–84

Also, I-2959 allows the photopolymerization of PEG-based solutions

as thin polymer networks that permit the fabrication of 3D PEG scaffolds using SL.63, 66

1.5. PROPOSED NERVE REGENERATION SCAFFOLD
It is proposed to use SL to fabricate bioactive multi-lumen and multi-material
PEG hydrogel NGCs and test these NGCs for functionality. It is believed that these
NGCs offer significant improvements in healing for peripheral nerve regeneration by
providing a greater surface area on which support cells can adhere, additional pathways
for sprouting axons, and the ability to optimize the biological communication through
precisely placed bioactive agents and cells. The design of this improved NGC has two
important characteristics: a capped portion at each end that allows effective suturing of
the proximal and distal stumps of the damaged nerve to the NGC, and a multi-lumen

19

middle portion that provides the advantages described above. Figure 1.11 illustrates a
cartoon depicting the desired elements of the proposed NGC.
The NGC is composed mainly of the biocompatible polymer PEG, but it contains
important bioactive agents such as adhesion ligands and growth factors to promote
faster healing. The end caps and the outermost ring of the multi-lumen section do not
contain bioactive factors, acting instead as a support material and helping ensure the
axons regenerate in the proper direction. The outermost sheath region will also aid in
preventing fibrosis around the NGC, as PEG hydrogels without adhesion ligands have
been shown to be cell non-adhesive.79 The multi-lumen section is composed of PEG
with mechanical properties similar to the mechanical properties of nerves and contains
bioactive factors to aid in the healing process. The tetrapeptide RGDS has a uniform
concentration all the way through the multi-lumen portion and its function is to provide
attachment sites for Schwann cells. RGD is a ubiquitous cell adhesion ligand that has
been extensively studied and has previously been used in PEG hydrogels for a variety
of applications, including neurite extension.68, 71, 72 A concentration gradient (from 5 to
100ng/mL) of neurotrophic factors such as nerve growth factor (NGF) is distributed
through the multi-lumen section in order to enhance regeneration.85, 86 Other bioactive
agents to aid in nerve regeneration process may be included in the design of the NGC.
For example, including a uniform concentration of the cytokine VEGF (vascular
endothelial growth factor) in the outermost ring of the NGC may enhance the
regeneration process, as VEGF has been shown to induce vascularization of the nerve
graft.86, 87
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Distal
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Figure 1.11. Cartoon of the proposed multi-lumen and multi-material bioactive PEG nerve
guidance conduit (NGC). The red spheres represent the gradient of NGF and the blue cubes
represent the tetrapeptide RGDS that has a uniform concentration throughout the multi-lumen
section of the conduit.
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CHAPTER 2
OBJECTIVES
Stereolithography (SL) is a unique technology that can be used with
photocrosslinkable biomaterials to create complex 3D tissue engineered scaffolds.
Much of the previous work exploring the capabilities of SL with photocrosslinkable
biomaterials has not investigated in-depth the characteristic behavior of the
photocrosslinkable material.

The aim of this work was to understand the

photocrosslinking behavior of a biopolymer widely used in tissue engineering, using SL
and create a tissue engineered scaffold that could be used in peripheral nerve
regeneration. Specifically, this work attempts to:
1. Experimentally characterize the SL curing profile of photocrosslinkable
poly(ethylene glycol) (PEG) aqueous solutions;
2. Evaluate the mechanical properties as well as the swelling behavior of PEGbased gels crosslinked in SL;
3. Develop the procedures to fabricate complex 3D PEG-based scaffolds in a layerby-layer fashion, including the use of multiple materials;
4. Develop, characterize, and evaluate the procedures to fabricate a scaffold to be
used in peripheral nerve regeneration; and
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5. Evaluate the conditions required to create 3D scaffolds in stereolithography, such
as photoinitiator concentrations and dosages of energy, in terms of their
cytocompatibility.
Together these objectives further the knowledge of developing 3D PEG-based
scaffolds using stereolithography for a variety of important tissue engineering
applications.

The first objective investigates the conditions that can render a

photocrosslinkable

PEG-based

biocompatible

solution

suitable

to

use

in

stereolithography for the layer-by-layer fabrication of complex 3D structures, and
evaluates the characteristic SL curing profile of the photocrosslinkable system.
Objective two examines the properties of the PEG-based gels crosslinked using
stereolithography. By understanding how the crosslinking influences different properties
of the material (e.g. equilibrium swelling behavior and elasticity), the procedures to
fabricate PEG-based scaffolds are developed (Objective three).

Furthermore,

understanding the influence of crosslinking on gel properties is important to design
better scaffolds with the necessary characteristics for a specific application.
With this foundation, the fourth objective focuses on developing scaffolds with a
specific application: the regeneration of peripheral nerves. The aim is to fabricate an
implantable, porous, biocompatible, multi-lumen nerve guidance conduit (NGC) with
improved suturability for the regeneration of peripheral nerves.
Finally, the fifth objective evaluates the conditions used to create 3D scaffolds in
stereolithography for cytocompatibility. The SL factors considered unfavorable for cell
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viability, such as exposure to photoinitiators, exposure to ultraviolet energy, and
exposure to free-radicals, were evaluated. Furthermore, the encapsulation of cells in
photocrosslinkable poly(ethylene glycol) (PEG) hydrogels using SL was investigated.
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CHAPTER 3
STEREOLITHOGRAPHY OF POLY(ETHYLENE GLYCOL)
Stereolithography (SL) was used to fabricate complex three-dimensional (3D)
structures of poly(ethylene glycol)

(PEG).

The use of SL to fabricate PEG-based

hydrogels, both complex structures and scaffolds containing different materials was
investigated. Photopolymerization experiments were performed to characterize different
PEG-based photopolymer solutions for use in SL, where the crosslinked depth (or gel
thickness) was measured at different laser energies.

The different photopolymer

solutions characterized consisted of two different types of photocrosslinkable PEG
(poly(ethylene glycol) dimethacrylate MW 1K, and poly(ethylene glycol) diacrylate MW
3.4K) at two different concentrations (20 and 30%), and a fixed concentration (0.5%) of
the photoinitiator Irgacure 2959. Gel thickness was a strong function of energy dosage,
PEG type and concentration. Results of mechanical testing showed that mechanical
properties were also a strong function of energy dosage, PEG type and concentration:
PEG-da 3.4K gels were stronger (had a higher ultimate stress value) than PEG-dma 1K
gels, gels prepared with a photopolymer concentration of 30% were stronger than the
ones prepared at a 20% concentration, and as more energy was used to crosslink the
gels, the stronger the gels. Equilibrium swelling behavior data of different PEG gels
crosslinked at different energies showed that the sol fraction and swelling ratio were
dependant on polymer type and concentration, but not on energy dosage for the two
energies investigated. Hydrogels fabricated with the PEG-da 3.4K photopolymer had a
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lower sol fraction and a higher swelling ratio than the ones fabricated with PEG-dma 1K,
and hydrogels fabricated with a 20% concentration had a higher swelling ratio and a
higher sol fraction than the ones fabricated with the 30% concentration. Furthermore,
the equilibrium swelling behavior in terms of dimensional changes of simple constructs
was investigated. The determined dimensional swelling factor exhibited a dependence
on energy dosage, PEG type, and concentration.

Overall, PEG-dma 1K gels at

equilibrium decreased in size, while PEG-da 3.4K gels increased in size, and as the
polymer concentration in solution prior to crosslinking decreased (from 30 to 20% (w/v)),
the size of the gels decreased. This work investigated what was necessary to fabricate
complex structures in a layer-by-layer fashion, using SL and photopolymerizable PEG,
with sufficient mechanical robustness and with specified final swollen feature sizes.
Furthermore, the use of SL to fabricate PEG-based hydrogels, both complex structures
and multi-material structures with specified spatially-controlled characteristics, was
demonstrated.

3.1. INTRODUCTION
In recent years, layered manufacturing (LM) or rapid prototyping (RP)
technologies, initially developed to create prototypes prior to production for the
automotive, aerospace, and other industries, have found applications in tissue
engineering (TE) and their use is growing rapidly. RP technologies are increasingly
demonstrating the potential for fabricating biocompatible 3D structures with precise
control of the micro- and macro-scale characteristics. Several comprehensive reviews
on the use of rapid prototyping technologies, also known as solid freeform fabrication,
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have been published recently.1–4 The 3D dispensing of liquids and pastes, known as
3D plotting, was one of the first RP technologies used in TE.

Agarose, chitosan,

hydroxyapatite, and poly(lactic-co-glycolic acid) (PLGA) are some of the materials used
in the creation of scaffolds with 3D plotters.5–7 Selective laser sintering (SLS) is another
RP technology explored in

TE, using materials in powder form such as

poly(caprolactone), polyetherketone, and hydroxyapatite.8–10

Fused deposition

modeling (FDM) has been used to fabricate scaffolds with controlled porosity for bone
regeneration using poly(caprolactone).

Pellets of poly(caprolactone) or blends of

poly(caprolactone) and hydroxyapatite are processed into filaments in order to be
extruded through the head of an FDM machine. 11–13
Researchers have developed 3D photopatterning techniques for the formation of
patterned scaffolds and substrates with patterned arrays of immobilized proteins and/or
cells using photopolymerizable poly(ethylene glycol)14–18 and photolithographic
projection-based processes for the fabrication of 3D scaffolds.19–21 Similar to the RP
technology of stereolithography (SL), these techniques use a photoreactive material, an
ultra-violet source, and 3D features are created in a layered fashion. However, contrary
to SL, these techniques are time consuming and require the use of multiple masks for
the patterning.

The use of SL in TE has not been significantly explored, perhaps

because of the lack of commercially available implantable or biocompatible materials
from the SL industry. Photocrosslinkable non-toxic formulations have been developed
recently for use in SL.22–27 For example, mixtures of photocrosslinkable poly(propylene
fumarate) (PPF) and diethyl fumarate (DEF)24,
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25

and mixtures of polyfunctional

methacrylic oligomers and hydroxyapatite26, 27 have been used in SL to create complex
porous scaffolds for bone regeneration. For soft tissue applications, Dhariwala et al.
utilized SL to photocrosslink a simple geometry using a mixture of poly(ethylene oxide)
and poly(ethylene glycol)-dimethacrylate (PEG-dma) to create hydrogels containing a
high density (50 x 106 cells/mL) of Chinese hamster ovary cells (CHO-B2).28 Despite
demonstrating the viability of this cell line to the SL process, only simple geometries
(rings with a 5-mm diameter) were created.

In previous work by our group, the

capabilities of SL to fabricate PEG-hydrogel structures of high complexity were
demonstrated using solutions of a low molecular weight (MW 1K) photoreactive PEG.29–
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In the work presented here, the characteristic photocrosslinking in SL of a high

molecular weight (MW 3.4K) photoreactive PEG, commonly used in TE, was
investigated. Furthermore, a 3D design of a nerve regeneration scaffold was fabricated
using SL and high molecular weight PEG to demonstrate the potential of this technology
in soft tissue engineering applications.
Commercial line-scan SL uses the actinic radiation of an ultraviolet laser (UV) to
selectively crosslink a liquid photopolymer contained in a vat. The setup in a typical SL
machine has a series of optics that focus the laser beam into a small spot (usually 75 or
250μm in diameter, where 75μm is considered high resolution and 250µm is the
traditional or more typical beam diameter) at the surface of the photopolymer. Complex
3D structures are created one layer at a time by fixing the structure to a movable
platform that begins at the surface of the liquid photopolymer. The UV laser scans a
thin cross-section of the 3D structure over the movable platform, crosslinking the liquid
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polymer. The platform submerges deeper into the liquid after each successive layer is
solidified, creating a 3D structure by stacking thin 2D cross-sections together one layer
at a time.33

The critical exposure (EC) and penetration depth (DP) are considered

fundamental properties of each photopolymer.33 EC represents the minimum energy
level required to transform the photopolymer from liquid to solid. DP is the penetration
depth of the UV energy into the photopolymer and represents the depth at which the
irradiance becomes 1/e times that at the surface.34 EC and DP can be evaluated easily
through experiments, by measuring the solidified depth of the photopolymer at different
energy levels.23, 32, 34–38 Commercial SL systems are designed to control the laser scan
speed across the surface of the photopolymer using equations for photospeed based on
the specific EC and DP parameters and other factors such as the laser power. Based on
the energy that the photopolymer receives, 3D parts can be solidified with layer
thicknesses as thin as 50 to 250μm, with overcures of approximately 200μm, in
commercial systems.
PEG is a highly biocompatible material with extensive biological applications.
PEG is a material suitable to use in SL because photoreactive and crosslinkable groups
like acrylates or methacrylates can be easily attached.39 These photoreactive groups, in
the presence of a photoinitiator and upon exposure to UV light, serve to crosslink the
PEG into a hydrogel. These hydrogels are permeable to oxygen, nutrients, and other
water-soluble metabolites and have a soft consistency that makes them similar to soft
tissues.40 Photopolymerizable PEG hydrogels have been investigated for a variety of
TE applications including cell encapsulation,41–44 creation of synthetic extracellular
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matrix (ECM) analogs,45–49 and for the formation of substrates with patterned arrays of
immobilized proteins and/or cells.14–17

Although PEG-based hydrogels are not

bioactive, cell-specific bioactivity can be achieved by covalently attaching adhesion
ligands, growth factors, and cytokines to the hydrogel, or by simply trapping the
bioactive agents within the hydrogel.43,

45–48

Additionally, while PEG hydrogels are

normally non-degradable, they can be rendered biodegradable by incorporating
proteolytically degradable peptide sequences into the PEG backbone or by creating a
copolymer with a degradable polymer such as poly(lactic acid).46, 49
This work investigates the use of high molecular weight photoreactive PEG in SL
for the creation of complex 3D structures with applications in TE. Rather than having a
liquid mixture of photoreactive monomers, as traditionally used with SL, a water-based
buffer solution of a photoreactive polymer (PEG-da) with a cytocompatible photoinitiator,
Irgacure 2959, was used here. Cure depth curves for the PEG-based photopolymer
solution at different concentrations as a function of energy exposure were determined
similar to previous experiments.29–32 The characteristic EC and DP values for the PEGbased photopolymer solutions were determined from these gel thickness curves. The
equilibrium swelling behavior and mechanical properties at different energies were also
investigated. Complex 3D PEG hydrogel structures were fabricated in a layer-by-layer
fashion.

Furthermore, the use of SL to fabricate multi-material 3D constructs with

specified spatially-controlled characteristics is described.
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3.2. MATERIALS AND METHODS
The following sections describe the experimental procedures in detail, from the
preparation of the photopolymer solutions used, to the procedures to measure and
determine the different parameters of interest to successfully fabricate complex 3D
structures with PEG using SL.

3.2.1. PHOTOPOLYMER SOLUTION
Two commercially available biocompatible photopolymers: poly(ethylene glycol)
dimethacrylate (PEG-dma MW 1000, Polysciences, Inc., Warrington, PA) and
poly(ethylene glycol) diacrylate (PEG-da, MW 3400, Laysan Bio Inc., Arab, AL) were the
primary material used to prepare the photoreactive solutions. The photopolymers were
dissolved in HEPES-buffered saline (HBS) at a concentration of 20% or 30% (w/v). The
photoinitiator Irgacure 2959 (I-2959, Ciba Speciality Chemicals Corp., Tarrytown, NY)
was added to the photopolymer solution at a concentration of 0.5% (w/v). It should be
noted that the photopolymer PEG-dma MW 1000 contained the polymerization inhibitors
monomethyl ether hydroquinone (MEHQ) and butylated hydroxytoluene (BHT), added
by the manufacturer.
To demonstrate the unique capabilities of SL for fabricating multi-material
spatially-controlled scaffolds, fluorescently labeled (490/520 nm) dextran (FITC-dextran,
Sigma-Aldrich, St. Louis, MO), bioactive PEG (PEG-RGDS), or fluorescently labeled
bioactive PEG (PEG-RGDS-FITC) were added to the photopolymer solution. A small
amount of each component was added to the photopolymer solution: 10mg/mL for PEG39

RGDS-FITC, 30mg/mL for FITC-dextran, and 115mg/mL for PEG-RGDS, these
solutions and plain PEG solutions were used for the fabrication of multi-material
scaffolds.
3.2.1.1. SYNTHESIS OF BIOACTIVE PEG (PEG-RGDS)
The bioactive PEG contained the tetrapeptide Arg-Gly-Asp-Ser (RGDS, Sigma,
Saint Louis, MO) and was prepared by reacting the peptide with acrylate–PEG–
succinimidyl carboxymethyl (ACRL–PEG–SCM, MW 3400, Laysan Bio Inc., Arab, AL) at
a 1:2M ratio in 50mM sodium bicarbonate buffer (pH 8.5) for 2 hours and subsequently
freeze-dried.47
3.2.1.2. SYNTHESIS OF FLUORESCENTLY LABELED BIOACTIVE PEG (PEG-RGDS-FITC)
Fluorescein isothiocyanate isomer (FITC, Sigma, St. Louis, MO) was used to
fluorescently label the bioactive PEG (PEG-RGDS). FITC was dissolved in anhydrous
DMSO (5mg/mL) and added to PEG-RGDS dissolved in 50mM sodium bicarbonate
buffer (pH 8.5) at a 1:10M ratio. The reaction mixture was allowed to react for 8hr in the
dark at 4ºC.50 The desired product (PEG-RGDS-FITC) was purified by dialysis and then
freeze-dried.16

3.2.2. APPARATUS AND SOFTWARE
A 3D Systems Model 250/50 SL machine (3D Systems, Valencia, CA) equipped
with a He-Cd laser (325nm, 40mW) was used for all experiments (see Figure 3.1). The
original setup of the SL machine was modified slightly to carry out the cure depth
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B

A

C
Figure 3.1. Stereolithography system. A: Commercial SL apparatus 250/50. B: Building envelope
of the commercial SL apparatus. C: Building envelop in the modified setup (insert shows the
sssembly of the self-aligning mini-vat setup.
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experiments and to fabricate complex 3D shapes.

The modifications consisted of

removing the original vat of material from the machine and using a self-aligning mini-vat
setup at the center of the platform to contain the photopolymer solution. The elevator
platform, originally used to support a part during its fabrication, was used to hold the
mini-vat. The height of the platform was set at a distance where the laser beam was
circular with a diameter of ~250µm. The beam diameter of this system is a limitation on
the micro-scale features that can be achieved.
It is important to briefly explain the specifics involved in the creation of a 3D part
in SL. Any computer-aided design (CAD) can be used to design the 3D parts to be
fabricated in SL. The CAD design must be in .stl format in order to be used with the
pre-processing software 3DLightyearTM (3D Systems, Valencia, CA).

3DLightyearTM

generates 2D slices of the 3D part, creating four different files, each one with different
information, necessary to build the part. The extensions of these build files are .v, .r, .l,
and .prm.
The largest and most important of these build files is the vector (.v) file, as it
contains the information of the vectors (start and end points defined by x, y and z
coordinates) that are traced by the laser to photocrosslink the polymer.51 There are
three different types of vectors that are used to define the surface boundaries and
internal structures in a layer using 3DLightyear™:

border, hatch, and fill vectors.

Border vectors define the object boundaries and are drawn first, while hatch and fill
vectors are used to fill in the space defined by the border vectors. The difference
between hatch and fill vectors is that fill vectors are used for upfacing and downfacing
42

surfaces that are not connected to additional part layers, while hatch vectors are used
when the region within a layer is sandwiched between additional part layers. The main
difference for the three different vectors is the speed at which they are drawn. Each
vector speed is defined by the overcure parameters in 3DLightyearTM. Only border and
hatch vectors are considered in the discussion below since it is not necessary to
differentiate between hatch and fill vectors.
Each commercial resin has its own build style conditions in 3DLightyearTM to
produce the build files. In general, the default build style conditions in 3DLightyearTM
produce a vector file that contains an extra border, and border and hatch vectors are
traced at different speeds (and thus different energies), with the speed of the hatch
vector generally being faster than the one for the border. In the default build operation,
the inner border vector that defines the boundaries of the layer is drawn first, then the
laser traces the hatch vectors (at a faster speed than the one for border vectors,
although the hatch pattern includes traces in x and y) that define the internal area.
Once finished with hatching, the second and outermost border vector is outlined. These
default conditions can be adjusted easily by changing the parameters in the built style.
Adjusting the speed of the vector files is done by changing the overcure
parameters for each vector type. Table 3.1 summarizes how the changes in overcure
affect the speed at which the vectors are drawn. Different overcure conditions were
evaluated by creating different build files for a cylindrical part.

The speeds of the

different vectors were obtained by simulating the fabrication of the cylindrical part. The
/showall command in the SL system displays the different vector speeds. Additionally,
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Table 3.1. Build style overcure parameters and the effect on vector speed. The 3rd and 4th
columns show the vector file generated by 3DLightyearTM and the vector file drawn on laser paper,
respectively. # No hatch is drawn because the hatch vector speed is too fast and does not mark
the laser paper. * No hatch is drawn as there is no hatch vector in the vector file.
Overcure Parameter

Vector Speeds

Hatch Overcure = -0.0010

Border Vector = 0.490
in/s

(Default Conditions)

Hatch Vector = 10.78 in/s

Hatch Overcure = 0.006
(maximum allowed)
Border Overcure = 0.002
(minimum allowed)
Hatch Overcure = 0.006
(maximum allowed)
Border Overcure = 0.02
(maximum allowed)
Hatch Overcure = -0.004
(minimum allowed)
Border Overcure = 0.002
(minimum allowed)

Border Vector = 0.490
in/s
Hatch Vector = 0.856 in/s

Border Vector = 3.850
in/s
Hatch Vector = 0.856 in/s
Border Vector = 0.005
in/s

Border Vector = 3.850
in/s
NO Hatch Vector

Border Overcure = 0.02
(maximum allowed)

Border Vector = 0.856
in/s

Hatch Overcure = 0.006
(maximum allowed)

Hatch Vector = 0.0005
in/s

Hatch Overcure = 0.006
(maximum allowed)

*

NO Hatch Vector in file

Hatch Overcure = -0.004
(minimum allowed)

Border Overcure = 0.006

Vector File Drawn
in Laser Paper
#

Border Overcure = 0.0075

Border Overcure = 0.0075
(default)

Vector File

Border Vector = 0.842
in/s
Hatch Vector =0.842 in/s
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*

laser paper (ZAP-48, Zap-it® Laser Alignment Products, Kentek Corporation, Pittsfield,
NH) was placed at the center of the elevator platform, and the laser was allowed to burn
the paper (the complete border, but only a portion of the harch) in order to detect speed
changes.
To improve the geometric accuracy of PEG-based parts built in SL, it was
recommended that the vector build files do not contain the extra border vector and that
the border and hatch vectors have equal speeds.32 As described above, equal speeds
of the border and hatch vectors are obtained by setting the overcure parameters at the
maximum allowed by the hatch overcure (0.006).

The extra border is removed by

changing the build style to have zero additional borders. Figure 3.2 shows the pattern
of a 5-mm disk containing twelve 500-μm circular openings within a 3-mm diameter
crosslinked with the default conditions (extra border and different border and hatch
speeds) and crosslinked with the modified conditions (no extra border and same border
and hatch speeds).

It can be seen that the pattern crosslinked with the default

conditions (Figure 3.2A) has a defined (and thicker) outline due to the extra border, and
it should be noted that the four inner openings are approximately 30 μm smaller than
the outer openings.

On the contrary, the pattern crosslinked with the modified

conditions appears flat and uniform and all the openings have the same dimensions
(Figure 3.2B).
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A

B
Extra Border

Border

C

D

Border

Extra Border

E

F

Figure 3.2. Top view of the patterns crosslinked used two different software conditions. A, C,
and E: default 3DLightyearTM parameters (extra border and different border and hatch speeds. B,
D, and F: modified parameters (no extra border and same border and hatch speeds. C and D:
inner openings. E and F: outer openings. Patterns crosslinked using a PEG-dma 1K 30%
solution. Marker in A and B represents 1mm. Marker in C – F represents 0.5 mm.
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3.2.3. CURE DEPTH / GEL THICKNESS ASSESSMENT
For the experiments, a flat-top cylindrical container was placed on the center of
the platform as depicted in Figure 3.3.A. The PEG-based photopolymer solution was
pipetted inside the container and filled up to the rim (Figure 3.3B). A glass slide was
placed on top of the container, in contact with the solution. The glass slide acted as
substrate that allowed the gel to adhere to the surface during fabrication thus facilitating
the measurement of the solidified gel. Samples were cured by drawing a hatch vector
pattern through the glass slide and into the PEG-based photopolymer solution at
different energy dosages (Figure 3.3C). This vector pattern formed a ~ 7.62mm by
7.62mm square from which the sample solidified depths were measured (see Figure
3.3D and E). The laser power for these experiments was ~23mW, and the energy
dosage was varied by changing the scan speed of the laser. The laser speed was
recorded, as well as the timing to crosslink the gels.
After polymerization, the glass slide was lifted off the container with the
polymerized gel adhered to the slide. The cured gels were quickly flushed with distilled
water to remove unreacted PEG solution, and the thickness (in z) of the gels was then
measured with calipers (Figure 3.3D). Five gels were cured per energy dosage, and
five different energies were used per PEG-based solution. The gels were placed in
distilled water and allowed to swell to equilibrium for more than 48hrs and the thickness
at the equilibrium swollen state was measured.
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He-Cd Laser
Optics
(focusing lens, mirrors)

B

Glass Slide

C

Movable
Platform

Flat-top Container
w/PEG-based

A
D
Glass Slide

E

Gel Thickness

Figure 3.3. Gel thickness experimental setup. A: schematic of SL apparatus, B: filling the
container with the PEG-based solution, C: drawing the vector pattern through the glass slide, D:
measuring the gel thickness with calipers, E: enlargement showing the gel attached to the glass
slide and illustrating the gel thickness.

It should be noted that the glass slide filtered ~18% of the laser power, and that
the commercial SL system automatically adjusts the speed of the laser according to the
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power readings in the system’s sensors. The adjustment is done to compensate for
power losses over the lifetime of the laser, in order to crosslink the resin with the
required energy. Glass slides were placed over the system’s sensors for the system to
detect the reduction in power and adjust the velocity accordingly. The energy dosage
was calculated from the measured laser power, the recorded time, and the area of the
samples, according to the following equation:

E=

PLt D
AS

(3.2 – 1)

where
E is the energy dosage in mJ/cm2,
PL is the laser power in mW,
tD is the total laser drawing time in seconds, and
AS is the sample area in cm2.
Cure depth assessments were done using three different vector patterns (see
Figure 3.4. All vector patterns formed a ~ 7.62mm by 7.62mm square. The vector
pattern, shown in Figure 3.4.A, consisted of a series of thirty parallel lines with each line
~250µm wide, or one laser beam width, and 7.62 mm long. The lines were parallel to
the y-axis of the machine and the distance between the centers of each line was
~250µm to avoid overlapping of the laser, therefore the vector file had one hatch,
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A

B

C
Figure 3.4. Different vector files used in the cure depth experiment (left: vector file according to
3DLightyearTM, right: vector file etched in laser paper). A: single (x) hatch with hatch spacing of
0.010 in, B: double x-y hatch with hatch spacing of 0.010 in, and C: default hatch, double x-y hatch
with hatch spacing of 0.004 in.

oriented in the same direction as the y-axis, with a hatch spacing of 0.010in (~250µm).
The vector pattern shown in Figure 3.4.B was the same as the one shown in Figure
3.4.A but included a second orthogonal hatch oriented in the same direction as the xaxis. The vector pattern shown in Figure 3.4.C. is the default hatch vector pattern of a
7.62mm by 7.62mm square produced in 3DLightyearTM. By default, two x-y hatches are
created with a hatch spacing of 0.004in (~102µm), therefore, each hatch consisted of
seventy two parallel lines.
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3.2.4. MECHANICAL TESTING
Samples from the cure depth assessments were placed in distilled water and
allowed to reach equilibrium for more than 48hrs.

The samples were tested in

unconfined compression (upper compression disk Ø = 6.3mm) using a dynamic
mechanical analyzer (DMA Q800, TA Instruments, New Castle, DE). The samples were
tested at room temperature in controlled force mode, using a pre-load of 0.01N and a
rate of 0.5N/min. The thickness of the samples at the equilibrium swollen state was
measured at the pre-load force of 0.01N.

The samples were wetted with enough

distilled water to cover the sample and prevent the sample from drying as the test took
several minutes (2 – 5 minutes, depending on the sample). Figure 3.5 shows images of
a sample from the cure depth assessment experiment during compression testing. It
should be noted that the samples’ area were larger than the compression disk.
Stress-strain curves were determined using Universal Analysis data analysis
software (Universal Analysis 2000 Version 4.3A, TA Instruments, New Castle, DE). The
ultimate strain (% strain value at sample failure), ultimate stress (stress value at sample
failure) and compressive modulus at 20-30% strain range were obtained from the
stress-strain curves. The material is considered to be strong if it has a high ultimate
stress value, as this means that a high force is required to break the material. A high
slope value (compressive modulus), i.e. steeper incline of the curve, represents a
material with low flexibility.

Figure 3.6 shows a representative strain-strain curve
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Upper Compression Disk
(Movable)
Applied Force
Cure Depth
Assesment
Sample

A

Lower Compression Base
(Fixed)

B

C

D

Figure 3.5. Compressioon testing of cure depth assessment samples. A: Prior to testing, the
sample is placed on compression base and the thickness is measured at a pre-load force of 0.01N.
B: Prior to testing, the sample is wetted with distilled water. C: Start of test, notice tht the whole
sample is covered in water to avoid drying of the sample during testing. D: End of test, notice that
the upper compression disk is in contact with the compression base.

obtained with Universal Analysis, indicating the ultimate stress, ultimate strain values,
and the compressive modulus slope.

3.2.5. GEL CHARACTERIZATION
Hydrogel samples of the four different photopolymer solutions were crosslinked
in SL. A simple ring pattern (ID = 2.5mm, OD = 8.0mm) was drawn by the laser at a
fixed laser speed to crosslink the samples under the same energy conditions. The
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Ultimate Strain
Ultimate Stress

Compressive Modulus
at 20 – 30% Strain Range

Figure 3.6. Stress-Strain curve from compression testing of cure depth assessment samples
indicating the ultimate stress, ultimate strain, and compressive modulus.

samples were weighed using an analytical balance (Sartorius CP124S, Sartorius AG,
Germany) and digital images of the samples were acquired using a stereomicroscope
(MZ16, Leica Microsystems, Germany) equipped with a CCD camera (Retiga 2000R
Fast 1394, QImaging Corp., Canada) to measure the samples’ dimensions. Weight and
dimensions of the samples were measured at different stages: 1) original (Wo, IDo, ODo)
or immediately after fabrication, 2) dried following fabrication, dried at room temperature
for > 48hrs (Wd, IDd, ODd), 3) swollen, after allowed to reach equilibrium in distilled
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water for > 48hrs (Ws, IDs, ODs), and 4) dried following swelling, dried at room
temperature for > 48hrs (Wrd, IDrd, ODrd).
The weights of the samples were used to calculate the sol fraction and swelling
ratio according to the following equations:

SolFraction =

(Wd − Wrd )
Wd

SwellingRatio =

(3.2 – 2)

Ws
Wrd

(3.2 – 3)

The dimensions of the scaffolds (OD, ID and thickness) were measured to
estimate the dimensional swelling factor (DSF) by comparing the swollen diameter with
the original diameter in the CAD drawing. The DSF was estimated from the following
equation:

DSF =

swollen dimension
design dimension

(3.2 – 4)

3.2.6. FABRICATION OF 3D STRUCTURES
In the new setup, the procedure to fabricate 3D structures in a layer-by-layer
fashion starts by adding a small amount of photopolymer solution to the mini-vat, and
the laser scan system draws the desired 2D pattern, crosslinking the liquid
photopolymer.

Next, additional photopolymer solution is added and the elevator
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platform is lowered a distance equal to the amount of solution added, in order to draw
the next 2D layer and maintain the laser beam diameter at the focusing spot.
Figure 3.7. shows a schematic of the mini-vat setup. The setup consisted of a
fixture and a mini-vat. The fixture incorporated a keyway design to secure the mini-vat
in a specific x-y orientation, and the fixture was affixed to the original elevator platform.
The mini-vat consisted of two pieces: base and cylinder. The base includes the same
keyway design to provide a press-fit into the fixture and maintain x-y registration of the
scaffold during fabrication. This feature provides an easy method for using multiple
hydrogel materials for scaffold fabrication.

The cylinder of the mini-vat can be

interchanged (from small to large) during the build as needed to hold more
photopolymer solution and thus manufacture longer scaffolds. An O-ring in the cylinder
seals the base-cylinder assembly for a water-tight closure.

Cylinder
Self-aligning
Mini-vat Setup

O-ring
Base
Keyed Fixture

Elevator Platform

Figure 3.7. Schematic of the self-aligning mini-vat setup.

55

Semi-automatic fabrication of PEG-based complex structures was achieved
using the following procedure. First, the CAD drawing of the structure is sliced in twodimensional layers using the 3DLightyearTM software and the layer thickness is set to
0.010inches.

Once the part was sliced, the build files are transferred to the SL

machine. To start the fabrication, a small amount of photopolymer solution is added to
the flat-bottom container, enough to create a “large” (~0.6-mm thickness) layer that
serves to attach the structure to the container during fabrication. The laser speed is
adjusted to crosslink this 0.6-mm layer.

Once the first layer is created, the semi-

automatic build in 0.010-in layers starts by manually adding photopolymer solution to
the container. Again, the laser speed is adjusted to create a 0.010-in layer, then the SL
machine was commanded to build the part: the laser draws the 2D patterns at the
necessary energy and the platform lowers automatically (by 0.010inches each time)
after each pattern is drawn. Every time a layer was crosslinked, the user adds more
photopolymer solution to the container, an amount of photopolymer solution equal to
0.010inches, using a micro-pipette, until the 3D structure is completed.

Once the

structure is completed, the part is rinsed with copious amounts of distilled water in order
to remove un-reacted polymer solution.
For multi-material fabrication, process planning plays an important role. There is
as many build files as materials used, and the process is time consuming as
intermediate steps for withdrawal and rinse of material are required. The self-aligning
mini-vat allows for x-y registration of the construct during fabrication so complex 3D
multi-material structures could be created. The photocrosslinkable PEG-based solution
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is added to and removed from the mini-vat using micro-pipettes in order to construct the
part in a layer-by-layer fashion.

During fabrication, the base-cylinder assembly is

removed so the part could be separately rinsed. Using the self-aligning feature, the
base-cylinder assembly is replaced and a multiple material build continued by adding a
different photocrosslinkable material to the assembly. The process is repeated until the
build is completed.
Figure 3.8 shows the designs to demonstrate the feasibility of multi-material SL
fabrication using either fluorescent or bioactive molecules in the PEG-based solution as
the second material. For the designs in Figure 3.8, the regions patterned with the
photopolymer solution containing FITC-dextran, PEG-RGDS, or PEG-RGDS-FITC were
crosslinked first (dark circles or squares with different dimensions) using the build files
shown in Figures 3.8C and D. A small amount of photopolymer solution (for a layer
thickness of ~ 1mm) containing FITC-dextran, or PEG-RGDS, or PEG-RGDS-FITC was
added to the mini-vat, and the individual build file to command the laser to crosslink the
specific pattern was used. Once the pattern was crosslinked, the photopolymer solution
was removed from the mini-vat to be reused. The mini-vat was removed from the
fixture to rinse the patterned scaffold with copious amounts of distilled water. Excess
water in the crosslinked pattern was carefully absorbed using a Kimwipe. The mini-vat
was then placed in the fixture, and a precise amount of photopolymer solution (without
FITC-dextran, PEG-RGDS, or PEG-RGDS-FITC) was added using a micro-pipette to
have a ~1-mm thick layer. Then, the corresponding build file was used to crosslink the
new desired pattern (see Figure 3.8E and F). Once the pattern was crosslinked, the
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photopolymer solution was removed to be reused and the scaffold was rinsed to remove
any unreacted photopolymer. The completed scaffold was then removed from the minivat.
1
0.75

∅ 0.70

0.50
7.20

7.20

∅1

∅ 0.50

A

B

C

D

E

F

Figure 3.8. Multi-material scaffold design. A and B: computer-aid design. C and D: vector file of
the regions patterned using the photopolymer solution containing fluorescently-labeled dextran
or bioactive PEG. E and F: vector file of the regions patterned using the primary photopolymer
solution. Units are in mm.
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The multi-material scaffolds fabricated with the photopolymer solution containing
FITC-dextran, or PEG-RGDS-FITC were placed in D-PBS, and fluorescent and
brightfield images were taken to examine the fluorescently patterned regions.

The

concentration of the fluorescently labeled component in the photopolymer solution was
30mg/mL for FITC-dextran and 10mg/mL for PEG-RGDS-FITC.

In the scaffolds

prepared using FITC-dextran, the fluorescent component was only physically trapped in
the hydrogel mesh, while for the scaffolds prepared with PEG-RGDS-FITC, the
fluorescent component was covalently attached into the hydrogel mesh. The scaffolds
fabricated with the photopolymer solution containing PEG-RGDS were allowed to swell
in serum-free media overnight. Cells were then seeded on top of the scaffolds and
observed using phase contrast microscopy.
Furthermore, a complex, multi-material 3D structure was fabricated using two
different photopolymer solutions of PEG-dma 1K (30% (w/v)), one plain and the other
containing fluorescent (580/605 nm) 10-μm microspheres (FluoSpheres®, Molecular
Probes, Inc., Eugene, OR). The complex 3D structure was a 23-mm detailed chess
rook, with a staircase contained within the walls, windows, and bricks in the façade.
The staircase was fabricated with the PEG-dma 1K solution containing fluorescent
microspheres.

The multi-material rook was manufactured in 0.010-in layers, semi-

automatically in three stages. In the first stage, the entire piece was fabricated except
for the staircase and the top part that includes the ceiling and the parapet using a plain
PEG-dma 1K solution. Then, the staircase was built using the photopolymer solution
containing fluorescent spheres.

Finally, the top of the rook and the parapet were
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fabricated using the same photopolymer solution used in the first stage. As described
above, the solutions were removed and the scaffold rinsed at each stage.

3.2.7. CELL MAINTENANCE
Cell culture reagents were obtained from Sigma-Aldrich (Saint Louis, MO) unless
otherwise specified. Human dermal fibroblasts (HDFs) were obtained from Cambrex
BioScience (Walkersville, MD) and maintained on Dulbecco’s Modified Eagle Medium
(DMEM) supplemented with 10% Fetal Bovine Serum (FBS; BioWhittaker, Walkersville,
MD), 200 mM L-glutamine, 10,000 units/mL of penicillin and 10 mg/mL of streptomycin.
Cells were maintained at 37 ºC in a 5% CO2 environment. Cell seeding experiments
were conducted using cultures at passage 12 or less.
The multi-material scaffolds used for the cell seeding experiments contained
regions patterned using the photopolymer solution containing 20mg/mL of PEG-RGDS.
The solutions used to prepare the multi-material scaffolds for the cell seeding
experiments were filter sterilized (0.22 μm filter; Cole-Parmer, Vernon Hills, IL) prior to
crosslinking. The scaffolds fabricated for the cell seeding experiments were made using
the PEG-da 3.4K (20% (w/v)) photopolymer solution.

Once the scaffolds were

fabricated, they were immediately rinsed with Dulbecco’s phosphate buffered saline (DPBS), and then placed in individual wells of a 24-well plate with serum-free media. The
plate was kept at 37ºC and 5% CO2 overnight for the scaffolds to swell to equilibrium
and for any unreacted material trapped within the gel to leach out. The media was
removed, and sterile silicone rings (Pharmed® BPT, Saint-Gobain Performance
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Plastics, Akron, OH) were used to secure the scaffolds at the bottom of the well,
preventing cells from going underneath the scaffold and attaching to the well’s surface.
A cell suspension containing 50,000 cells was added to each scaffold (two scaffolds for
each design), and then the scaffolds were incubated at 37ºC and 5% CO2. Cells plated
on wells without scaffolds served as controls. After 4 hours, the media was replaced to
remove any non-adherent cells. Cell adhesion was examined using phase contrast
microscopy (Leica DMIRB, Leica Microsystems, Germany) at 24 hours and after one
week.

3.2.8. STATISTICAL ANALYSIS
The mean and standard deviations of the data were calculated.

Data were

compared using two-tailed, unpaired, t-tests. P-values less than 0.05 were considered
to be significant.

3.3. RESULTS AND DISCUSSION
The desire to produce complex 3D scaffolds for TE has driven researchers to
explore a variety of fabrication technologies. Rapid prototyping techniques, such as
stereolithography (SL), are emerging as promising tools for scaffold fabrication. Despite
its promise, in-depth studies of SL using photopolymerizable biocompatible polymers
have been limited. The use of SL to fabricate PEG-based hydrogels, both complex
structures and scaffolds containing different materials was investigated. The following
sections present the findings from the experiments described in the material and
methods section.
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3.3.1. GEL THICKNESS
Initial investigations to understand the characteristic photopolymerization of PEGbased hydrogels fabricated using SL examined the effect of two different photoinitiators
(PIs), PI concentration, and polymer concentration on cure depth.

Poly(ethylene

glycol)-dimethacrylate MW 1K (PEG-dma 1K) was used as the photopolymer in the initial
investigations for being commercially available at a relatively accessible price (~
$9/gram), and was used as a proof-of-concept for creating complex scaffolds using
commercial stereolithography. The two different PIs investigated were Irgacure 2959 (I2959, Ciba Speciality Chemicals Corp., Tarrytown, NY) and 2-hydroxy-2-methyl-1phenyl-1-propanone (HMPP, Sartomer Co., Exton, PA).

Figure 3.9 shows the gel

thickness curves as a function of the different factors: PI type and concentration, and
PEG concentration. It can be seen in Figure 3.9 that the PI HMPP produced thicker
gels than I-2959 for a given concentration, indicating that the photopolymerization of
PEG-dma is dependent on PI type. The concentration of PI also affected gel thickness,
with thinner gels being created as the PI concentration increased (after a peak in
concentration below ~0.01% (w/v)). PEG-dma concentration also affected the thickness
of the crosslinked gels, with thicker gels obtained with a higher concentration of PEGdma (30% vs. 20%). Based on these results, the PI I-2959 is preferred over HMPP for
layered manufacturing using SL as I-2959 allows for photopolymerization of thinner
layers.
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Figure 3.9. Effect of photoinitiator type and concentration on gel thickness. Solid markers
correspond to HMPP and hollow markers correspond to I-2959: ■ 20% PEG-dma; ♦ 30% PEG-dma.
The energy dosage to obtain the gels was ~650 mJ/cm2 (power dosage ~65 mW/cm2).

To examine the relationship between gel thickness and energy dosage, a fixed PI
concentration (I-2959, 0.5% (w/v)) was used, and two different concentrations (20 and
30% w/v)) of two different photopolymers (PEG-dma 1K and PEG-da 3.4K) were
investigated. The vector file used for these investigations was the one shown in Figure
3.4A, in order to avoid overlapping of the laser. The measured hydrogel thickness was
graphed as a function of energy to obtain the cure depth curve specific for each the
PEG-based photopolymer solution. A plot of the hydrogel thickness, or cure depth,
versus the natural logarithm of the energy yields a straight line, with a slope equal to DP
and an intercept equal to EC (see Figures 3.10 and 3.11). This curve is known in SL as
the “working curve” of a photopolymer.33
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Figure 3.10. Effect of energy dosage on gel thickness for a PEG-dma 1K solution with 0.5% (w/v)
of I-2959. Solid markers correspond to 20% (w/v), and hollow markers correspond to 30% (w/v).

In Figures 3.10 and 3.11, the slope of the curves (each one representing a
different concentration of PEG in solution) is the same, yielding a DP value equal to
0.41mm. DP is the penetration depth of the UV energy into the photopolymer and
represents the depth at which the irradiance becomes 1/e times that at the surface.34
As the solutions are comprised primarily of water (~70 and 80% by volume for 30% and
20% (w/v) PEG-based solutions, respectively) and contain the same amount of PI, the
same slope on this curve (or depth of penetration) implies that the PI concentration is
the controlling factor for crosslinking in the range of irradiance explored. Since each PI
has a unique absorption spectrum depending on the wavelength of the light and PI
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concentration, the DP value would be different depending on the PI type, concentration,
and wavelength of the laser used.32
On the other hand, the EC value is different for each polymer type and
concentration. For 30% and 20% (w/v) PEG-dma 1K concentrations, the EC values are
36.25 and 64.05 mJ/cm2, respectively. The EC values for PEG-da 3.4K solutions are
53.07 mJ/cm2 for the 20% (w/v) concentration and 61.61 mJ/cm2 for the 30% (w/v). EC
represents the minimum energy required to transform the photopolymer from liquid to
solid.
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Figure 3.11. Effect of energy dosage on gel thickness for a PEG-da 3.4K solution with 0.5% (w/v)
of I-2959. Solid markers correspond to 20% (w/v), and hollow markers correspond to 30% (w/v).
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For PEG-dma 1K, the solution with a lower concentration of polymer has a higher
EC. A 50% increase in the concentration of the polymer leads to a significant decrease
in EC of almost 50%. With a lower concentration of PEG-dma 1K there is a smaller
number of possible crosslinking sites, and thus more energy is required to crosslink a
given cure depth. Opposite to the PEG-dma 1K solution, for PEG-da 3.4K the solution
with a lower concentration of polymer has a lower EC.
The difference in molecular weight between the two different photopolymers
makes PEG-dma 1K more reactive than PEG-da 3.4K at the same weight
concentration. At the same weight concentration, the molar concentration for a PEGdma 1K solution is 3.4 times larger than the one for a PEG-da 3.4K solution, therefore
there are more crosslinking sites present in a PEG-dma 1K solution. The different
photoreactive groups also influence the reactivity of the photopolymers. The first order
polymerization reaction rate constant (kP) for acrylated monomers is larger than the one
for methacrylated monomers.53 The acrylate group is considered more dormant than
the methacrylate group as its reactivity is lower.54
Figure 3.12 includes the gel thickness measurements for the four different
solutions. It can be seen in the graph that the thickness values (and x-intecept) for 20
and 30% PEG-da 3.4K, as well as for 20% PEG-dma 1K fall in the same region. It
could be possible that the amount of reactive sites present in these solutions do not play
a major role in the crosslinking, and the PI (at the concentration used) is the controlling
factor in the crosslinking. There are more reactive sites present in the 30% (w/v) PEGdma solution than in the other solutions, therefore the thickness values and x-intecept
66

for this solution fall apart from the rest. The amount of reactive sites is estimated using
the solution concentration and the molecular weight of the photopolymer as the molar
ratio between the two solutions being compared. It should be noted that although the
two photopolymers investigated here have different crosslinking groups (acrylate vs.
methacrylate) these groups have only one double bond at each end that can be
crosslinked (see Figure 1.9).
The reactive sites in a 30% (w/v) solution are ~1.72 times that of a 20% (w/v)
solution when the photopolymer in both solutions has the same molecular weight. For
example, for PEG-dma 1K the 30% to 20% (w/v) solution molar ratio is:

30%( w / v)
≈
20%( w / v)

gr 1mol
*
mL 1000 g 0.43
≈
≈ 1.72 ,
gr 1mol
0.25
0.25
*
ml 1000 g

0.43

and for PEG-da 3.4K:
gr 1mol
*
30%( w / v)
mL 1000 g 0.43
≈
≈
≈ 1.72
gr 1mol
20%( w / v)
0.25
0.25
*
ml 1000 g
0.43

Also, the reactive sites in a 30% (w/v) PEG-dma 1K solution are 3.4 times that of
a 30% (w/v) PEG-da 3.4K solution and 5.85 times that of a 20% (w/v) PEG-da 3.4K
solution. The molar ratio, at the same concentration, but different molecular weights is:
30%( w / v) PEG − dma1K
≈
30%( w / v) PEG − da3.4 K

gr 1mol
*
mL 1000 g 3400
≈
≈ 3.4 ,
gr 1mol
1000
0.43 *
ml 3400 g

0.43
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and the molar ratio at different concentration and different molecular weight is:
gr 1mol
*
30%( w / v) PEG − dma1K
mL 1000 g
≈
≈ 5.85
gr 1mol
20%( w / v) PEG − da3.4 K
0.25
*
ml 3400 g
0.43

Using a 20% (w/v) PEG-da 3.4K solution, the effect of successive energy dosage
on gel thickness was examined using the three different vector files shown in Figure 3.4.
Figure 3.13 shows the measured gel thickness versus laser scan speed for the three
different vector files. Figure 3.14 shows the top and side view of the gels crosslinked
with the three different vector files.
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Figure 3.12. Effect of energy dosage on gel thickness for PEG-dma 1K (square marker) and PEGda 3.4K (diamond markers) solutions with 0.5% (w/v) of I-2959. Solid markers correspond to 20%
(w/v), and hollow markers correspond to 30% (w/v).
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The data in Figure 3.13 shows that for a given laser speed, the crosslinked
thickness increases between 25–30% when an additional hatch is included in the vector
file (no overlapping of the laser) to crosslink the gel. The thickness increases between
56–65% using the default vector file (two orthogonal hatches with a hatch spacing of
0.004) to crosslink the gel.
The optical micrographs in Figure 3.14 show how the gel samples are
crosslinked with the different vector files. Figure 3.14A shows the gels crosslinked with
the vector file consisting of a single hatch with no overlapping of the laser (hs = 0.010
in), the well-defined vertical lines of the single hatch can be observed in the top view
image, and the crosslinked bullet-shape of the laser can be observed in the side view
(the surface shows a regular array of peaks and valleys). Figure 3.14B shows the gels
crosslinked with the vector file with two x-y hatches with no overlapping of the laser (hs
= 0.010 in), the two x-y patterned hatches can be observed in the top view image, while
the side view image shows a flat surface. Figure 3.14C shows the gels crosslinked with
the default vector file consisting of two x-y hatches with a hatch spacing of 0.004in, the
top and side views show a smooth and flat surface of the gels.
Figure 3.15 shows the gel thickness data versus energy dosage for the three
different vector files shown in Figure 3.4 using a PEG-da 3.4K 20% (w/v) solution.
Again, the data fits a straight line in a semi-logarithmic plot, with an EC value (intercept)
of 60 mJ/cm2 and a DP value (slope) equal to 0.41 mm.
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Figure 3.13. Gel thickness versus laser speed for a 20% (v/w) PEG-da 3.4K solution with 0.5%
(w/v) of I-2959 using three different vector files. Diamond markers correspond to a single hatch
vector file with no overlapping of the laser (hatch spacing, hs = 0.010 in). Triangle markers
correspond to a doble x-y hatch vector file (hs = 0.010 in). Circle markers correspond to a double
x-y hatch vector file with a default hatch spacing (hs = 0.004 in).
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Figure 3.14. Optical micrographs of gels crosslinked with the three different vector files (top and
side views). A: Vector file with a single hatch with no overlapping of the laser (hatch spacing, hs
= 0.010 in). B: Vector file of x-y orthogonal hatch with hs = 0.010 in. C: Vector file of x-y orthogonal
hatch, with default hatch spacing (hs = 0.004 in). NOTE: pictures were taken immediately after
fabrication (original state). Marker represents 1 mm.
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3.3.2. MECHANICAL TESTING
The mechanical properties of hydrogels are dependant on various parameters,
such as the main polymer type (e.g. PEG MW 1K vs. 3.4K) and concentration, the comonomer type and concentration, the polymerization conditions, the crosslinking
density, the degree of swelling, and the type of medium in which the hydrogel is
swollen.53,
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Figure 3.16 shows representative stress-strain curves for cure depth

samples of the four different photopolymer solutions investigated, crosslinked at
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Figure 3.15. Effect of energy dosage on gel thickness for a 20% (v/w) PEG-da 3.4K solution with
0.5% (w/v) of I-2959 using three different vector files. Diamond markers correspond to a single
hatch vector file with no overlapping of the laser (hatch spacing, hs = 0.010 in). Triangle markers
correspond to a doble x-y hatch vector file (hs = 0.010 in). Circle markers correspond to a double
x-y hatch vector file with a default hatch spacing (hs = 0.004 in).
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A

B

C
Figure 3.16. Stress-strain curves for the cure depth samples of the four different solutions
investigated. Gray and black lines correspond to a photopolymer concentration of 20% (w/v) and
30% (w/v), respectively. Continuous and dashed lines correspond to PEG-dma 1K and PEG-da
3.4K photopolymer. A, B, and C correspond to samples crosslinked with an energy dosage of ~
550, 1,250 and 2,500 mJ/cm2, respectively.
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different energy dosages. Charts A, B and C in Figure 3.16 correspond to samples
crosslinked with an energy dosage of ~ 550, 1,250 and 2,500 mJ/cm2, respectively.
Overall, in terms of the photopolymer type, it can be seen in the charts on Figure
3.16 that the PEG-da 3.4K hydrogels are stronger (higher ultimate stress value) than
the PEG-dma 1K hydrogels (dashed lines, corresponding to PEG-da 3.4K, are above
continuous lines, corresponding to PEG-dma 1K, in all three charts). For example, in
the data for Figure 3.16A, the ultimate stress is higher in PEG-da 3.4K hydrogels (59 ±
4 KPa and 18 ± 3 KPa, for 30 and 20% (w/v), respectively) than in PEG-dma 1K (35 ± 7
KPa and 5 ±3 KPa, for 30 and 20% (w/v), respectively).

Also, the PEG-da 3.4K

hydrogels are less flexible (curves have a steeper incline, and therefore compressive
modulus values are higher) than PEG-dma 1K hydrogels. For example, in the data for
Figure 3.16C, the compressive modulus is higher in PEG-da 3.4K hydrogels (335 ± 12
KPa and 149 ± 9 KPa, for 30 and 20% (w/v), respectively) than in PEG-dma 1K (122 ±
28 KPa and 66 ±24 KPa, for 30 and 20% (w/v), respectively).
A higher concentration of photopolymer results in stronger though less flexible
hydrogels. A 50% increase in concentration of the photopolymers leads to an increase
in the ultimate stress ranging from 40 to 700%, and an increase in the compressive
modulus ranging from 85 to 650%. For example, the PEG-da 3.4K samples crosslinked
with an energy dosage of ~2,500 mJ/cm2 have an ultimate stress of 104 ± 10 KPa and
75 ± 6 KPa, and a compressive modulus of 335 ± 12 KPa and 143 ± 9 KPa, for a 30
and 20% (w/v) photopolymer concentration, respectively.

PEG-dma 1K samples

crosslinked with an energy dosage of ~550 mJ/cm2 have an ultimate stress of 35 ± 7
73

KPa and 4.5 ± 3 KPa, and a compressive modulus of 82 ± 20 KPa and 12.6 ± 8 KPa, for
a 30 and 20% (w/v) photopolymer concentration, respectively.
Just as energy dosage has an effect on the cure depth of PEG-based solutions,
the mechanical properties at the equilibrium swollen state of the crosslinked gels are
also affected by the energy used to crosslink the gels. The energy dosage used to
crosslink the gels influences the crosslinking density directly and the degree of swelling
indirectly, this is described in detail next.
Figure 3.17 shows the effect of energy dosage on the mechanical properties of
PEG-dma 1K hydrogels for the two different concentrations investigated.

For a

concentration of 20% (w/v), as more energy is used to crosslink the gels, the ultimate
stress increases, and in consequence stronger gels are produced (Figure 3.17A).
Similarly, as more energy is used to crosslink the gels, the compressive modulus
increases, resulting in less flexible gels (Figure 3.17B).
For a concentration of 30% (w/v) of PEG-dma 1K, the ultimate stress increases
from ~250 mJ/cm2 to ~600 mJ/cm2, but it does not change significantly between ~600
mJ/cm2 to ~2,500 mJ/cm2 (Figure 3.13C). Regarding the compressive modulus, as
more energy is used to crosslink the gels, the compressive modulus increases, resulting
in less flexible gels (Figure 3.17D).
Figure 3.18 shows the effect of energy dosage on the mechanical properties of
PEG-da 3.4K hydrogels for the two different concentrations investigated.

For both

concentrations of the photopolymer (20 and 30% (w/v)) as more energy is used to
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Figure 3.17. Effect of energy dosage on mechanical properties of PEG-dma 1K hydrogels (n = 6).
A: Ultimate Stress and B: Compressive Modulus for a photopolymer concentration of 20% (w/v).
C: Ultimate Stress and D: Compressive Modulus for a photopolymer concentration of 30% (w/v).

crosslink the gels, the ultimate stress increases and in consequence stronger gels are
produced (Figures 3.18A and C).

Just as described before, an increase of the

photopolymer concentration increases the ultimate stress. The ultimate stress ranges
from 10 to 75 KPa, and from 42 to 104 KPa, for the 20% and 30% hydrogels,
respectively. As more energy is used to crosslink the gels, the compressive modulus
also increases for both concentrations of the photopolymer, resulting in less flexible gels
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(Figure 3.18B and C). The compressive modulus ranges from 22 to 143 KPa, and from
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Figure 3.18. Effect of energy dosage on mechanical properties of PEG-da 3.4K hydrogels (n = 6).
A: Ultimate Stress and B: Compressive Modulus for a photopolymer concentration of 20% (w/v).
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Figure 3.19 shows the effect of energy dosage on the mechanical properties of
PEG-da 3.4K hydrogels at a photopolymer concentration of 20% (w/v) crosslinked using
the three different vector files.

For the gels crosslinked with the single vector file

(hs=0.010 in), both the ultimate stress and compressive modulus increases with
increasing energy dosage. The ultimate stress ranges from 10 – 75 KPa, while the
compressive modulus ranges from 22 – 143 KPa. Likewise, for the gels crosslinked
with the double x-y vector file (hs=0.010 in), both the ultimate stress and compressive
modulus increases with increasing energy dosage. The ultimate stress ranges from 35
to 170 KPa, and the compressive modulus ranges from 60 to 190 KPa.
For the gels crosslinked with the default vector file consisting of a double x-y
hatch with a hatch spacing of 0.004 in, the ultimate stress data have a high variability,
and therefore there appears to be no correlation between ultimate stress and energy
dosage. However, similar to previous results, the compressive modulus increases with
increasing energy dosage. The compressive modulus ranges from 71 to 126 KPa.
Figure 3.20 compares the measured gel thickness, immediately after fabrication
and at their equilibrium swollen state (allowed to swell in distilled water for more than 48
hrs), for the different photopolymer solutions investigated (A – D), and for the PEG-da
3.4K solution at a concentration of 20% (w/v) crosslinked with the different vector files
(E and F).

It was mentioned that the energy dosage used to crosslink the gels

influences the crosslinking density directly as when more energy is applied to a given
volume of photopolymer the more the photopolymer crosslinks, until a point when no
more crosslinking sites are available. Also, it was mentioned that the energy dosage
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Figure 3.19. Effect of energy dosage on mechanical properties of 20% (w/v) PEG-da 3.4K
hydrogels. A: Ultimate Stress and B: Compressive Modulus for samples crosslinked with a single
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Figure 3.20. Comparison between original thickness (solid bars) and swollen thickness
(downward diagonal) at different crosslinking energies. A and B, 20 and 30% (w/v) concentration
of PEG-dma 1K. C and D, 20 and 30% (w/v) concentration of PEG-da 3.4K. E and F, 20% (w/v)
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corresponding original dimension (p<0.05).
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influences the degree of swelling indirectly, as more energy utilized represents a higher
crosslinked density, and the degree of swelling observed at equilibrium is influenced by
the degree of crosslinking.52, 53
For the 20% PEG-dma 1K samples, the data show that the thickness of the
samples at their equilibrium state is smaller than the original thickness independently of
the energy dosage used to crosslink the samples (Figure 3.20A). The samples shrink to
66% of the original thickness, for samples crosslinked with ~350 and ~600 mJ/cm2, and
to ~80% of the original thickness, for samples crosslinked with ~1,300 to 2,500 mJ/cm2.
As the solution used to crosslink the samples is primarily composed of water (80%), the
original crosslinked hydrogel samples (immediately after fabrication) contain this water
percentage (and some unreacted polymer). However, when the samples are allowed to
reach their equilibrium swollen state by placing them in distilled water for more than 48
hrs, the crosslinked hydrogels samples do not trap or hold more water and actually the
hydrogel structure contracts as it cannot retain the original water content. This may be
due to the low concentration of PEG-dma 1K and therefore the smaller number of
possible crosslinking sites that do not maintain the original structure (in terms of
thickness) in the equilibrium state.
For the 30% PEG-dma 1K samples, the data shows that the thickness of the
samples at their equilibrium swollen state do not change, except for the samples
crosslinked with the lowest energy (~250 mJ/cm2) where the samples shrink
significantly to a 90% of the original thickness (Figure 3.20B).

The crosslinked

hydrogels samples at their equilibrium swollen state do not trap or hold more water than
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the originally present, maintaining their structure (in terms of thickness). The reduction
in dimensions of the samples crosslinked with the lowest energy may be due to the fact
that the low energy loosely crosslinks the samples, and the samples cannot maintain
their structure in the equilibrium state.
In general, most the PEG-da 3.4K samples increased in dimensions in the
equilibrium swollen state (Figure 3.20C–F).

Two kinds of water can be found in

crosslinked hydrogel samples: the free or bulk water physically trapped in the hydrogel
mesh, and the bound water that is adsorbed in the PEG molecule.54 This can explain
why the PEG-da 3.4K samples do swell when allowed to reach their equilibrium swollen
state and PEG-dma 1K samples do not. There is a high difference (3-fold) in molecular
weight between the two types of PEG (1K vs. 3.4K). As a result, the crosslinked PEGda 3.4K samples are capable of retaining more water than the one already in solution,
by adsorbing it in the PEG molecule and by physically trapping it in the larger mesh.
The data in Figures 3.20C–F show that for PEG-da 3.4K samples (irrespective of
concentration, or crosslinking hatch) at higher energies (and therefore, higher
crosslinking) the higher the swelling of the samples. Moreover, an energy threshold can
be observed, where samples crosslinked at an energy below that threshold (600
mJ/cm2) are loosely crosslinked and do not retain more water than the one already in
solution (see Figure 3.21).
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Figure 3.21. Effect of energy dosage on gel thickness swelling for a 20% (v/w) PEG-da 3.4K
solution with 0.5% (w/v) of I-2959 using three different vector files. Diamond markers correspond
to a single hatch vector file with no overlapping of the laser (hatch spacing, hs = 0.010 in).
Triangle markers correspond to a doble x-y hatch vector file (hs = 0.010 in). Circle markers
correspond to a double x-y hatch vector file with a default hatch spacing (hs = 0.004 in). Solid
markers correspond to the original thickness. Hollow markers correspond to the swollen
tickness.

For 20% PEG-da 3.4K, the samples crosslinked at the lowest energy (~350
mJ/cm2) do not significantly swell at their equilibrium swollen state.

Samples

crosslinked at ~600 and ~950 mJ/cm2 swell to a final dimension ~10% larger than the
original. Samples crosslinked at ~1,400 mJ/cm2 and 2,500 mJ/cm2 swell to a final
dimension ~25% and ~30% larger than the original, respectively. For 30% PEG-da
3.4K, the samples crosslinked at the three lowest energies (~350, 650, and 950
mJ/cm2) do not significantly swell at their equilibrium swollen state.

Samples

crosslinked at ~1,500 and 2,500 mJ/cm2 swell to a final dimension ~26% and ~29%
larger than the original, respectively. This indicates that for a higher concentration of
the photopolymer, a higher energy is required to obtain a fully crosslinked sample. At
energies below ~600 mJ/cm2 for 20%, and below ~1,500 mJ/cm2 for 30% the resulting
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samples are loosely crosslinked and do not retain more water than the one already in
solution.
For the samples crosslinked with the double x-y hatch (hs=0.010 in), at energies
of ~500 mJ/cm2 the samples are loosely crosslinked and do not retain more water than
the one already in the original solution prior to crosslinking. Samples crosslinked at
~750, 1,150, 1,700 and 2,500 mJ/cm2 swell to a final dimension ~12, 22, 29 and 35%
larger than the original, respectively. For the samples crosslinked with the default hatch
(double x-y, hs=0.004 in), all the energies investigated produced fully crosslinked
samples. Samples crosslinked at ~800, 1,000, 1,200 and 1,600 mJ/cm2 swell to a final
dimension ~27 – 39% larger than the original, while samples crosslinked with the
highest energy (~2,750 mJ/cm2) swell to a final dimension ~47% larger than the original.
Figure 3.22 shows some representative optical micrographs of the samples at
their equilibrium swollen state. It can be seen that the PEG-dma 1K sample maintained
its structure, while the fully crosslinked PEG-da 3.4K samples deformed by buckling.
PEG-da 3.4K samples, both at 20 and 30%, as well as PEG-da 3.4K 20% samples
crosslinked using the single (x) and double x-y hatch (hs=0.010 in) crosslinked at the
lowest energy (loosely crosslinked) also maintained their structure. All the PEG-da 3.4K
20% crosslinked with the default hatch (double x-y hatch, hs=0.004) deformed by
buckling.

For the deformed samples, the higher the energy used to crosslink the

samples the larger the buckling observed.
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Figure 3.22. Optical micrographs of cure depth sample

3.2.3. GEL CHARACTERIZATION
PEG-based hydrogels fabricated using SL at the same energy dosage, for two
different energies, were examined to determine their sol fraction, swelling ratio, and
dimensional swelling factor.

Table 3.2 summarizes the measured weights for the

samples photocrosslinked in SL at each PEG-dma concentration. From these values,
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the swelling ratio and sol fraction of the gels were calculated. Figure 3.23 and Table 3.3
show the swelling ratio and sol fraction of the hydrogels fabricated at two different
energy dosages, for the four different PEG-based solutions investigated.
In general, hydrogels fabricated with PEG-dma 1K had a higher sol fraction (see
Eq. 3.2 – 2) and a lower swelling ratio (see Eq. 3.2 – 3) than hydrogels fabricated with
PEG-da 3.4K. In terms of photopolymer concentration, hydrogels fabricated with a 20%
concentration had a higher swelling ratio and a higher sol fraction than the ones
fabricated with the 30% concentration.

The sol fraction represents the amount of

unreacted photopolymer. A larger amount of unreacted photopolymer could lead to a
looser crosslinked structure, which in turn could lead to an increased uptake of water,
thus leading to a larger swelling ratio.
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Figure 3.23. Characteristics of PEG-based hydrogels fabricated using SL at two different energy
dosages. A: Swelling ratio, B: Sol fraction (n = 6).
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Table 3.2. Measured weights (in grams) of hydrogel samples fabricated using SL at two different
energy dosages for the four different PEG solutions investigated (n = 6). o: original weight,
weight of the sample immediately after fabrication. d: weight of the sample dried following
fabrication, dried at room temperature for > 48 hrs. s: swollen weight, after allowed to reach
equilibrium in distilled water. rd: weight of the sample dried following swelling, dried at room
temperature for > 48 hrs.
180 mJ/cm

2

PEG-dma 1K

PEG-da 3.4K

20%

30%

20%

30%

Wo

0.0369 ± 0.0034

0.0436 ± 0.0018

0.0435 ± 0.0046

0.0417 ± 0.0039

Wd

0.0085 ± 0.0006

0.0146 ± 0.0006

0.0109 ± 0.0012

0.0146 ± 0.0013

Ws

0.0400 ± 0.0023

0.0558 ± 0.0018

0.0844 ± 0.0034

0.0888 ± 0.0078

W rd

0.0036 ± 0.0001

0.0083 ± 0.0004

0.0059 ± 0.0002

0.0112 ± 0.0010

300 mJ/cm

2

PEG-dma 1K

PEG-da 3.4K

20%

30%

20%

30%

Wo

0.0319 ± 0.0015

0.0376 ± 0.0020

0.1158 ± 0.0040

0.1154 ± 0.0037

Wd

0.0072 ± 0.0003

0.0130 ± 0.0010

0.0107 ± 0.0107

0.0155 ± 0.0012

Ws

0.0400 ± 0.0023

0.0467 ± 0.0028

0.0998 ± 0.0043

0.0990 ± 0.0012

W rd

0.0037 ± 0.0002

0.0076 ± 0.0005

0.0063 ± 0.0005

0.0122 ± 0.0002

Table 3.3. Swelling ratio and sol fraction of hydrogels fabricated at two different energy dosages,
for the four different PEG-based solutions investigated (n = 6).
180 mJ/cm

2

PEG-dma 1K
20%
Sol Fraction
Swelling Ratio

PEG-da 3.4K
30%

1.40 ± 0.24
11.32 ± 0.90

20%

0.75 ± 0.10
6.72 ± 0.40

0.90 ± 0.14
14.25 ± 0.64

300 mJ/cm

Sol Fraction
Swelling Ratio

0.95 ± 0.12
10.88 ± 0.53

0.33 ± 0.09
8.23 ± 0.97

2

PEG-dma 1K
20%

30%

PEG-da 3.4K
30%

0.71 ± 0.17
6.15 ± 0.12
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20%
0.71 ± 0.27
15.86 ± 0.50

30%
0.27 ± 0.09
8.12 ± 0.08

The energy used to crosslink the gels does not have a significant effect on
swelling ratio or sol fraction. This is true, except for PEG-dma 1K 20% hydrogels that
have a lower sol fraction when crosslinked with a higher energy (1.40 ± 0.24 vs. 0.90 ±
0.12, for 180 and 300 mJ/cm2, respectively); and for PEG-da 3.4K 20% hydrogels that
have a higher swelling ratio when crosslinked with a higher energy (14.25 ± 0.64 vs.
15.86 ± 0.50 for 180 and 300 mJ/cm2, respectively). In the case of PEG-dma 1K 20%
hydrogels, a higher energy dosage represents more crosslinking, and as the sol fraction
represent the amount of unreacted polymer, the amount of unreacted polymer is
approximately 50% less in the gels crosslinked with the higher energy. In the case of
PEG-da 3.4K 20% hydrogels, again a higher energy dosage represents more
crosslinking, and as explained in the previous section, for PEG-da 3.4K hydrogels the
more crosslinking the more the swelling.
The equilibrium swelling behavior in terms of dimensional changes of simple
constructs was determined by measuring the dimensions of the constructs (OD and ID)
immediately after fabrication, and after allowed to reach equilibrium by placing them in
distilled water for more than 48 hours.

The calculated dimensional swelling factor

exhibited a dependence on energy dosage, PEG type, and concentration.

Overall,

PEG-dma 1K gels at equilibrium decreased in size, while PEG-da 3.4K gels increased
in size, and as the polymer concentration decreased, the size of the gels decreased.
Table 3.4 summarizes the dimensional swelling factor of hydrogels fabricated at two
different energy dosages, for the four different PEG-based solutions investigated.
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Table 3.4. Dimensional swelling factor (DSF) of hydrogels fabricated at two different energy
dosages, for the four different PEG-based solutions investigated (n = 6).
Outside Diameter
PEG-dma 1K

Energy

PEG-da 3.4K

20%

30%

20%

30%

180 mJ/cm

2

1.01 ± 0.01

1.03 ± 0.01

1.24 ± 0.01

1.28 ± 0.01

300 mJ/cm

2

0.99 ± 0.01

1.02 ± 0.01

1.29 ± 0.01

1.31 ± 0.01

Inside Diameter
PEG-dma 1K

Energy

PEG-da 3.4K

20%

30%

20%

30%

180 mJ/cm

2

1.12 ± 0.03

1.16 ± 0.04

1.34 ± 0.01

1.35 ± 0.02

300 mJ/cm

2

1.10 ± 0.02

1.09 ± 0.02

1.33 ± 0.01

1.36 ± 0.01

Wall Thickness
PEG-dma 1K

Energy

PEG-da 3.4K

20%

30%

20%

30%

180 mJ/cm

2

0.96 ± 0.02

0.97 ± 0.03

1.19 ± 0.02

1.25 ± 0.01

300 mJ/cm

2

0.94 ± 0.02

0.99 ± 0.01

1.26 ± 0.02

1.29 ± 0.01

For PEG-dma 1K gels, the original outside diameter is significantly smaller than
the outside diameter in the CAD design, while the inside diameter is significantly larger
than the one in the CAD design. The swollen dimensions, both ID and OD, are slightly
larger than the ones in the original CAD design. In general, the gels decreased in size,
as the wall thickness (actual crosslinked gel) decreased. The gels crosslinked at an
energy of 180 mJ/cm2 decreased by 4% and 3% for a photopolymer concentration of 20
and 30%, respectively. The gels crosslinked at an energy of 300 mJ/cm2 decreased by
6% and 1% for a photopolymer concentration of 20 and 30%, respectively (see Figure
3.24).
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Figure 3.24. Dimensions of PEG-based hydrogels. A and B: PEG-dma 1K based hydrogels, C and
D: PEG-da 3.4K based hydrogels. A and C: gels fabricated at an energy dosage of 180 mJ/cm2. B
and D: gels fabricated at an energy dosage of 300 mJ/cm2 (n = 6).

For PEG-da 3.4K gels, the original outside diameter is significantly smaller than
the outside diameter in the CAD design, while the inside diameter is almost the same as
the one in the CAD design. The swollen dimensions, both ID and OD, are considerably
larger than the ones in the original CAD design. In general, the gels increased in size
as the wall thickness (actual crosslinked gel) increased. The gels crosslinked at an
energy of 180 mJ/cm2 increased by 19% and 25% for a photopolymer concentration of
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20 and 30%, respectively. The gels crosslinked at an energy of 300 mJ/cm2 increased
by 26% and 29% for a photopolymer concentration of 20 and 30%, respectively. It
should be noted that these values are approximations, as the swollen PEG-da 3.4K
samples deformed forming a concave and not a flat ring. Inside diameters could be
measured more accurately than outside dimeters due to the deformation of the samples
(see Figure 3.25).

3.2.4. FABRICATION OF 3D STRUCTURES
Using the cure depth curves for 30% PEG-dma 1K presented previously, it was
possible to fabricate highly complex 3D structures in a layer-by-layer fashion. Figure
3.26 shows two chess rooks manufactured using SL. The rook on the right in each
picture was manufactured using the 3D Systems Viper™ Si2 SL apparatus using DSM

Side View

Top View
Outside Diameter

Top View
Inside Diameter

PEG-dma 1K

PEG-da 3.4K

Figure 3.25. Optical micrographs of ring samples at their equilibrium swollen state.
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Somos® WaterShed™ 11120 resin and standard SL build parameters for the resin.
The rook on the left in each picture was built semi-automatically in the modified SL
250/50 apparatus in 0.010-in layers. The PEG-based chess rook includes all the details
of the resin-based rook such as the staircase contained within the walls, the windows,
and the bricks in the façade and measures approximately 23mm. Figure 3.26B shows
that the PEG-based chess rook is elastic and can be easily deformed without breakage.
Figure 3.26C illustrates the shrinkage experienced by PEG when dry.
The procedure used to fabricate the PEG-based structure shown in Figure 3.26
is described here in detail and can be followed to fabricate any structure starting with its
computer-aid design (CAD) drawing. First, the CAD drawing of the structure was sliced
in two-dimensional layers using the 3DLightyearTM software and the layer thickness was
set to 0.010 inches. Once the part was sliced, the build files were transferred to the SL
machine. To start the fabrication, a small amount of photopolymer solution was added
to the flat-bottom container, enough to create a ~0.6-mm thickness layer. The structure
was fabricated at a laser power of ~10.40mW. The laser speed to produce a ~0.6-mm
layer was 0.16 in/s (EC = 12, DP = 2.5). The laser drew the first layer at a velocity of
0.16 in/s. Once the first layer was created, the semi-automatic build in 0.010-in layers
started by manually adding photopolymer solution to the container. The laser speed to
create a 0.010-in layer was 0.355 in/s (EC = 12, DP = 3.0). Using a pipette, an amount
of photopolymer solution equal to 0.010 inches was added to the container (68μL).
Then the SL machine was commanded to build the part: the laser draws the 2D patterns
at the necessary energy and the platform lowers automatically (by 0.010 inches each
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A

B

C

Figure 3.26. Complex 3D structures manufactured using SL, the chess rook on the right in each
picture was made with DSM Somos® WaterShed™ 11120 resin while the rook on the left is PEGbased. A: PEG-based structure immediately after it was built. B: deformation of elastic PEGbased structure. C: PEG-based structure after drying.

time) after each pattern is drawn. Every time a layer was crosslinked, the user added
more photopolymer solution to the container, until the 3D structure was completed.
Once the structure was completed, the part was rinsed with copious amounts of distilled
water in order to remove un-reacted polymer solution, and the structure was imaged.
The estimated SL fabrication time for the PEG-based chess piece shown in Figure 3.26
was approximately 30 – 40 minutes.
The use of photocrosslinkable PEG and SL has potential applications in TE for
the fabrication of complex 3D scaffolds with tailored properties and precisely placed
cells and growth factors. The pictures of the PEG-based structures in Figure 3.27 show
a block with a single embedded channel that bifurcates twice in different planes of the
gel (each bifurcation is oriented 90o from one another). This bifurcating geometry is
representative of the arterial system and a gel such as this one may potentially be used
as a tissue construct in angiogenesis studies (along with the appropriate bioactive
agents and cells). The dimensions of the PEG-based block in Figures 3.27A and B are
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A

B

C
Figure 3.27. PEG-based scaffolds with embedded channels of different sizes and orientations: A)
isometric view, B) side view of a 1 x 1 x 1.6 cm block, and C) top view of a 1 x 1 x 5 cm block.

1x1x1.6 cm, and the diameters of the embedded channels are 1 mm. Scaffolds of
virtually any length and geometry can be fabricated as demonstrated by the scaffold in
Figure 3.27C, which starts as a single channel and bifurcates twice with an overall
length of approximately 5 cm.
The images in Figure 3.28 show a 3D scaffold with promising use as a nerve
guidance conduit (NGC) in peripheral nerve regeneration. The design of the conduit
includes 3D features such as single lumen end caps for suture and a multi-lumen
middle section to enhance regeneration by providing a greater surface area for support
cells to adhere and additional pathways for sprouting axons to be guided for
regeneration. The conduit in Figure 3.28A and B (fabricated with a 30% PEG-dma 1K
solution) has an OD of 5 mm, an ID of 3 mm (these dimensions are within the
dimensions of a tubular sheath offered by SaluMedicaTM for peripheral nerve repair),
and twelve 500-μm lumens in the middle section. The CAD design of the conduit in
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Figure 3.28C–F has an OD of 2.94 mm, an ID of 1.72 mm, and seven 400-μm lumens in
the middle section. The images in Figure 3.28C and D were fabricated with a 20%
PEG-dma 1K solution, while the images in Figure 3.28E and F were fabricated with a
20% PEG-da 3.4K solution.

As PEG-da 3.4K swells, the final dimensions of the

conduits in Figure 3.28D and F were approximately 3.67 ± 0.191mm in OD, and 2.09 ±
0.176mm ID.
Simple 2D scaffolds with different materials were fabricated using SL. Brightfield
low magnification images of the multi-material scaffolds fabricated with both
photopolymer solutions containing either FITC-dextran (pictures A – D) or PEG-RGDSFITC (pictures E – H) are shown in Figure 3.29. Images A, B, E, and F correspond to
the scaffolds fabricated using PEG-dma 1K while C, D, G, and H correspond to the
scaffolds fabricated using PEG-da 3.4K. The fabrication of the multi-material scaffolds
shown in Figure 3.29 took approximately 10 minutes. During fabrication, the rinsing
(using a wash bottle with distilled water) and removal of excess water (using a Kimwipe)
were the most time consuming steps since care was required in order to avoid
damaging the scaffold. The scan times for the scaffolds were less than 5s for the
fluorescently labeled regions and approximately 20s for the plain PEG regions.
It can be seen in Figure 3.29 that the smallest features (∅ = 500 µm, L = 500 µm)
in the fluorescent pattern (images A and B, only when using FITC-dextran, arrows point
to empty spaces where the fluorescent component should be present) were not
crosslinked in the PEG-dma 1K scaffolds. This can be seen more clearly in images A,
C, and D in Figure 3.30 taken using a confocal laser scanning microscope. The empty
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A

B

D

C

E

F

Figure 3.28. Multi-lumen PEG-based nerve regeneration conduits. A and B: isometric and top
view of NCG with OD = 5mm, ID = 3mm and twelve 500-μm lumens fabricated with a 30% PEG-dma
1K solution. C and D: isometric and top view of NCG with OD = 2.94mm, ID = 1.72mm and seven
400-μm lumens fabricated with a 20% PEG-dma 1K solution. E and F: isometric and top view of
NCG with OD = 3.7mm, ID = 2.09mm and seven 400-μm lumens fabricated with a 20% PEG-da 3.4K
solution. Marker represents 1mm.

spaces in the PEG-dma 1K scaffolds where the smallest features should be located can
be seen easily, while the smallest features for the PEG-da 3.4K scaffolds do appear.
The absence of these features is due to the SL machine building only border vectors
(without hatching, see Figure 3.8 for the original CAD and build files) and so the solution
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A

B

C

E

F

G

D

H

Figure 3.29. Brightfield images of 2D multi-material scaffolds. A – D Scaffolds fabricated using
fluorescently-labeled dextran: A nd B (10X) with PEG-dma 1K, C and D (7.1X) with PEG-da 3.4K as
the main material. E – H Scaffolds fabricated using fluorescently-labeled RDGS: E and F (10X)
with PEG-dma 1K, G and H (7.1X) with PEG-da 3.4K as the main material. Arrows point to empty
spaces where the fluorescent component should be present.

is not receiving sufficient energy to crosslink a gel in these regions.

The energy

delivered by the laser to crosslink the medium and large features was ~1,700 mJ/cm2
while the energy delivered in the smallest features was ~780 mJ/cm2. This problem
was solved when creating the multi-material scaffolds using PEG-RGDS-FITC by
including an additional vector file of the smallest features only, and drawing the smallest
features three-times. In order to crosslink the smallest features, these have to be drawn
three times by the laser (energy delivered ~ 2,300 mJ/cm2).
Since the FITC-dextran was physically trapped within the crosslinked gel, it
leaches (diffuses) out of the hydrogel matrix once it is placed in PBS to reach
equilibrium, and it leaches out faster in the scaffolds prepared with PEG-da 3.4K. Since
96

the molecular weight of the PEG 3.4K is 3.4 times that of PEG 1K, the FITC-dextran
molecules leach out faster in the higher molecular weight PEGs. Fluorescent confocal
microscopy images of the scaffolds taken at higher magnification corroborate these
results. Brightfield and fluorescent images (Figure 3.30) were acquired using a confocal
laser scanning microscope (Zeiss LSM-5 Pascal, Carl Zeiss MicroImaging, Germany).
Figures 3.30A, C, and D show the empty spaces where the smallest features should be
located. Also, it can be seen in Figure 3.30H how the FITC-dextran leaches out from
the crosslinked PEG-da 3.4K gel. The images in Figures 3.29 and 3.30 were taken
quickly after fabrication (and not at equilibrium) in order to avoid the leaching effect.

A

B

C

D

E

F

G

H

Figure 3.30. Confocal microscope images (25X) of the multi-material scaffolds fabricated using
fluorescently-labeled dextran. A-D: scaffolds fabricated with PEG-dma 1K as the main material. EH: scaffolds fabricated with PEG-da 3.4K as the main material.
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The images in Figure 3.31 show the multi-material scaffolds fabricated with
fluorescently labeled PEG-RGDS.

The images were taken using an inverted

microscope (Leica DMIRB, Leica Microsystems, Germany) with fluorescent capabilities.
All the features of the scaffolds, even the smallest, are present. The difference in
`swelling between the two different hydrogel materials can also be noticed from these
images. A slight fluorescent smearing can be seen in the images in Figures 3.31, and it
is due to unreacted FITC that did not leach out during the dialysis purification step.
Figure 3.32 shows the specific localization of HDF cells in the regions patterned
with bioactive PEG containing the cell adhesion ligand RGDS. Procedures identical to
the ones described above were used to fabricate bioactive scaffolds. As expected,
PEG-RGDS provided a preferential attachment location for the cells. Phase contrast
microscopy images were taken at 24 hours and 1 week after cell seeding. Figure 3.32
shows representative images of the HDF cells attaching to regions where the PEGRGDS is located. Figure 3.32B (taken after one week) shows a higher density of wellspread cells.
Figure 3.33 shows an NGC fabricated with different materials. The outer portion
of the conduit contains 15-µm fluorescent green particles while the inner portion
contains 10-µm fluorescent blue particles (Figure 3.33A and B). The images in Figure
3.33C and D shows a NGC fabricated with different color of fluorescent particles in each
layer. These conduits illustrate the capability of SL to precisely place different agents
within the hydrogel construct, allowing multi-material fabrication, both within a single
layer and layer-to-layer.
98

A

B

C

D
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F

G

H

Figure 3.31. Fluorescent images of the multi-material scaffolds fabricated using fluorescentlylabeled PEG-RGDS. A-D: scaffolds fabricated with PEG-dma 1K as the main material. E-H:
scaffolds fabricated with PEG-da 3.4K as the main material.

A

B

Figure 3.32. Representative phase contrast image of HDFs attached to the regions patterned with
the photopolymer solution containing bioactive PEG-RGDS. A: 24 hours after cell seeding. B:
One week after cell sedding.
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B

A

C

D

Figure 3.33. NGC fabricated using different colors of fluorescent particles in the PEG-based
solution. A and B: isometric and top view of scaffold showing precise placement of different
materials between layers. C and D: isometric and side view of scaffold showing precise
placement of different materials across layers. Marker represents 1mm.

A complex, multi-material 3D structure (shown in Figure 3.34) was fabricated
using different solutions of PEG hydrogel as a demonstration of our fabrication
technique. The fabrication of the multi-material rook took approximately 3 hours using
the multi-material fabrication procedure described before. The same rook fabricated out
of plain PEG using this procedure requires less than 1 hour, and a single rook
fabricated out of commercial SL resin and using the automated commercial system
requires 2.5 hours (Figure 3.26). Thus, the build time for the multi-material fabrication
process shown here is comparable to the automated commercial system primarily
because sweeping is not required between layers (the viscosity of the solution is
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A

B

Figure 3.34. Complex 3D structure manufactured in multi-material SL. PEG-dma 1K at a 20% (w/v)
concentration was used as the main material. The solution used to create the staircase contained
fluorescent microspheres. A: Structure during fabrication, after rinsing and completing the
second stage of using the second material, the part is attached to the base of the mini-vat setup.
B: Final structure. Marker represents 5 mm.

essentially that of water), and the difference in the number of layers (~225 layers for the
automated commercial system with layer thicknesses of 0.004-in, and ~90 layers for the
developed fabrication procedures using PEG with layer thicknesses of 0.010-in). The
multi-material build times could be reduced by automating the material fill and removal
procedure, including developing an intermediate scaffold cleaning procedure.

3.4. CONCLUSIONS
In-depth studies of SL using photocrosslinkable PEG necessary to fabricate
complex structures in a layer-by-layer fashion, with sufficient mechanical robustness to
the 3D part during fabrication, and with specified final swollen size features were
performed.

The application of SL for the creation of complex scaffolds using a

photocrosslinkable biomaterial was demonstrated. Hydrogel scaffolds were created in
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SL using aqueous solutions of poly(ethylene glycol) and the cytocompatible
photoinitiator Irgacure 2959. Furthermore, the use of SL to fabricate PEG-based multimaterial structures with specified spatially-controlled characteristics was demonstrated
Fundamental SL photocrosslinking experiments were performed using the PEGbased solutions to obtain the hydrogel thickness as a function of energy. Cure depth, or
hydrogel thickness, curves as a function of energy provided two important parameters
of the PEG-based solutions: EC (critical energy) and DP (penetration depth). It should
be noted that commercial SL resins have EC values ranging from 8.3 – 16.3 mJ/cm2 (for
NanotoolTM and NanoformTM 15120, repectively) and DP values from 0.11 – 0.16 mm
(for NanotoolTM and WatershedTM 11120, respectively).55–57
The DP value (slope in the semi-logarithmic thickness vs. energy plot) was the
same for all the PEG-based solutions investigated (DP = 0.41mm or 16 mils). As the
investigated solutions are comprised primarily of water (~70 and 80% by volume for
30% and 20% (w/v) PEG-based solutions, respectively) and contain the same amount
of photoinitiator, the same slope (or the same depth of penetration) on the different
curves implies that the photoinitiator concentration is the controlling factor for
crosslinking in the range of irradiances explored. Since each photoinitiator has a unique
absorption spectrum depending on the wavelength of the light and photoinitiator
concentration, the DP value would be different depending on the PI type, concentration,
and wavelength of the laser used.
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EC values are different, depending on polymer type and concentration: 64mJ/cm2
and 36mJ/cm2 for PEG-dma 1K solution, and 53mJ/cm2 and 62mJ/cm2 for PEG-da
3.4K, at 20 and 30% concentration, respectively. The difference in molecular weight
between the two different polymers in each polymer makes the photopolymer PEG-dma
1K 3.4 times more reactive than PEG-da 3.4K. Thickness values for 30% PEG-dma 1K
solution are significantly larger than the thickness values for 20 and 30% PEG-da 3.4K,
as well as for 20% PEG-dma 1K. The amount of reactive sites present in the 20 and
30% PEG-da 3.4K, and in the 20% PEG-dma 1K solutions do not play a major role in
the crosslinking, and the photoinitiator (at the concentration used) is the controlling
factor in the crosslinking. The reactive sites in the 30% PEG-dma 1K solution are ~1.72
times that of the 20% PEG-dma 1K solution, and 3.4 and 5.84 times that of the 30 and
20% PEG-da 3.4K solutions, respectively.
Hydrogel samples created in SL were characterized in terms of mechanical
properties, sol fraction, mass swelling ratio (at equilibrium) and dimensional change (at
equilibrium). Mechanical properties of hydrogel samples created in SL were a strong
function of polymer type and concentration, as well as energy dosage used to crosslink
the samples. Overall, in terms of the photopolymer type, PEG-da 3.4K hydrogels are
stronger than the PEG-dma 1K hydrogels, in terms of photopolymer concentration, a
higher concentration results in stronger (though less flexible hydrogels), and in terms of
energy dosage, the higher the energy used to crosslink the samples the stronger the
produced samples.
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For example, in samples crosslinked at an energy of ~550 mJ/cm2 the ultimate
stress is higher in PEG-da 3.4K hydrogels (59 ± 4 KPa and 18 ± 3 KPa, for 30 and 20%,
respectively) than in PEG-dma 1K (35 ± 7 KPa and 5 ±3 KPa, for 30 and 20%,
respectively). Also, the PEG-da 3.4K hydrogels are less flexible (compressive modulus
values are higher) than PEG-dma 1K hydrogels. In samples crosslinked at an energy of
2,500 mJ/cm2 the compressive modulus is higher in PEG-da 3.4K hydrogels (335 ± 12
KPa and 149 ± 9 KPa, for 30 and 20%, respectively) than in PEG-dma 1K (122 ± 28
KPa and 66 ±24 KPa, for 30 and 20%, respectively).
Swelling ratio and sol fraction of samples fabricated using SL varied with respect
to polymer type and concentration. In general, hydrogels fabricated with PEG-dma 1K
had a higher sol fraction and a lower swelling ratio than hydrogels fabricated with PEGda 3.4K. In terms of photopolymer concentration, hydrogels fabricated with a 20%
concentration had a higher swelling ratio and a higher sol fraction than the ones
fabricated with the 30% concentration. The energy used to crosslink the samples did
not have a significant effect on swelling ratio or sol fraction, for the two energies
investigated.
The equilibrium swelling behavior in terms of dimensional changes of simple
constructs was investigated. The determined dimensional swelling factor exhibited a
dependence on PEG type and concentration. Overall, PEG-dma 1K gels at equilibrium
decreased in size (wall thickness of ring samples decreased), while PEG-da 3.4K gels
increased in size (wall thickness of ring samples increased).

As the polymer

concentration decreased, the size of the gels decreased. Energy dosage had an effect
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on the dimensional swelling factor only for PEG-da 3.4K based hydrogels, as more
energy was used to crosslink the samples, the more the samples increased in size at
the equilibrium swollen state.
A commercial SL system was modified in order to fabricate complex multimaterial structures, using small volumes of photocrosslinkable PEG. The SL system
modifications involved the removal of the original vat and replacement with a selfaligning mini-vat setup. The design of the mini-vat allowed for x-y registration of the
construct during fabrication so complex 3D multi-material structures could be created.
Photocrosslinkable solution was added to and removed from the mini-vat using micropipettes in order to construct the part in a layer-by-layer fashion, using the minimum of
photocrosslinkable solution. During multi-material fabrication, the fixture was removed
so the construct could be separately rinsed. Using the self-aligning feature, the fixture
was

replaced

and

a

multi-material

build

continued

by

adding

a

different

photocrosslinkable material to the build chamber. Highly complex hydrogel scaffold
structures were created in a layered fashion, including structures with internal channels
of various orientations and structures with more than one material, within and across
layers.

Thus, SL is a unique technology that can be used with photocrosslinkable

biomaterials to create complex 3D TE scaffolds, as the layered manufacturing nature of
SL allows control over the scaffold’s macro-scale design, as well as precise placement
of bioactive agents within the scaffold during construction.
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CHAPTER 4
FABRICATION OF MULTI-LUMEN PEG-BASED NERVE GUIDANCE CONDUITS USING
STEREOLITHOGRAPHY
The aim of this study was to explore the use of stereolithography (SL) on the
fabrication of nerve guidance conduits (NGC) for peripheral nerve regeneration. The
conduits were fabricated with photocrosslinkable poly(ethylene glycol) diacrylate (MW
3400) in an aqueous solution with the cytocompatible photoinitiator Irgacure 2959 (I2959).

The design of the conduit included a capped portion at each end to allow

suturing of the proximal and distal stumps of the damaged nerve to the NGC, and a
multi-lumen middle portion that mimics better the natural structure of a nerve and
provides a greater surface area for support cells and sprouting axons. A manufacturing
process for NGCs was developed. The manufacturing process involved the use of SL,
which permits a rapid fabrication strategy for complex 3D scaffolds, and post-processing
stages of lyophilization and sterilization, that preserve the scaffold, creating an
implantable, off-the-shelf product with improved suturability. The fabricated conduits
were characterized at each stage of the manufacturing process. Optical and scanning
electron microscopy showed that the conduits had a rough topography in the freesurface and that a micro-porous, sheet-like micro-structure of the material was created
by the lyophilization process. The weight degree of swelling and dimensional swelling
factors, showed that the final dimensions of the conduits are significantly larger than the
original dimensions, and that the samples return easily and rapidly to a swollen state
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when placed in an aqueous solution, maintaining the original overall structure.
Furthermore, resistance to deformation under compressive force, and static coefficient
of friction of the fabricated conduits with and without post-processing (lyophilization)
were evaluated. As implantable NGCs should resist compression from surrounding
tissue, it was determined that a multi-lumen design (with and without post-processing)
has a better resistance to compression than a single-lumen design with an equivalent
surface area. The calculated coefficient of friction for the conduits on glass was 1.10
and 0.56 for conduits with and without post-processing, respectively. The differences in
coefficient of friction indicate that the post-processed conduits at the swollen state are
less slippery and therefore easier to handle, a desirable characteristic of the ideal NGC.

4.1. INTRODUCTION
The large number of peripheral nerve injuries that occur annually in the United
States is still indeterminate. In 1995, there were more than 50,000 surgical procedures
performed to repair severed peripheral nerves.1,

2

The National Hospital Ambulatory

Medical Care Survey indicates 7.3 million injury-related visits during 2000 due to open
wounds, with many of the injuries including the peripheral nerve.3

Injuries in the

peripheral nerves can result in impaired sensation, reduced motor function, persistent
pain, and in the worst case scenario, complete loss of the injured limb.4,5 However, an
injured peripheral nerve has the capacity to regenerate and clinical treatment is
available.4–9
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Surgical reconnection is an effective clinical treatment for nerve transection if the
damaged nerves are directly adjacent and can be reconnected without causing
tension.9 Other strategies to repair small nerve injuries include using CO2 lasers to
“weld” the separated tissue and fibrin glue to reattach the injured nerves.10 When a
nerve transection occurs and the injury creates a large gap in the nerve (greater than
approximately 4mm), autologous nerve grafts sutured between the damaged nerve
stumps are considered the standard of care.13 The use of autologous nerve grafts is the
most effective tubular technique that exists today for nerve regeneration, with clinical
functional recovery rates of approximately 80%.9 Although functional recovery is likely
with autologous nerve grafts, the harvesting of the grafts results in an additional surgery
and loss of function at the donor site.2, 5–7, 9
Different materials have been used in the tubular repair of peripheral nerves.
Allo- or xenografts of arteries, veins, bone, and muscle among other natural materials
have been used, with the disadvantages of producing undesirable immune responses
and mismatching dimensions and mechanical properties, resulting in very poor success
rates.14 Silicone tubes have been one of the most frequently used synthetic materials
for nerve repair because of silicone’s inert and elastic properties. However, silicone
entubulation has long-term complications including fibrosis and chronic nerve
compression, requiring a complicated surgical removal of the tube once the nerve has
regenerated.12, 14 These natural and artificial tubes used in early years for nerve repair
function as a tunnel that connects the damaged nerve stumps and accumulates tissue
fluid with important growth factors and extracellular matrix components for nerve
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regeneration.8 In recent years, plenty of research has been done to tissue engineer a
nerve guidance conduit (NGC) to replace simple tubes and improve peripheral nerve
repair by using bio-absorbable, bio-degradable materials, and incorporating important
growth factors, and cells into the conduit to promote faster healing over longer lengths.2,
7,

9–12

Biodegradable NGCs, of collagen and the copolymer poly(DL-lactic-ε-

caprolactone), are now available for implantation in humans.15,

16

Recent studies in

nerve regeneration are also examining the conduit’s design, using multiple lumen in
order to better mimic the natural structure of a nerve and provide a greater surface area
for support cells and sprouting axons.17–23
Different techniques for the fabrication tissue-engineered NGCs have been
developed depending on the material used to fabricate the conduits, these include
textile technologies, dipping of a substrate, deposition, solvent casting/particulate
leaching techniques, and phase separation systems.

In textile technologies,

polyglycolic acid (PGA) and chitosan in fiber form have been used to fabricate NGC with
tubular braiding machines and electrospinning devices.

24, 25

Poly-L-lactic acid (PLLA),

copolymers of polylactide (PLA, both L-lactide and D-lactide) and polycaprolactone
(PCA), or blends of PLLA with the copolymer polylactide-glycolide acid (PLGA),
dissolved in either chloroform or methylene chloride have been used as the dipping
solution where cylindrical substrates (e.g. syringes, small polytef sheaths) are immersed
to create single tubes and tubes with multiple channels.17, 26, 27 PLGA has been used to
fabricate conduits combining injection molding and phase separation techniques, where
a highly concentrated solution of the polymer is injected into a cylindrical mold, and then
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the solvent is removed by sublimation.18,

19, 21–23

PLLA, PLGA and urethane-based

polyglycolide-co-ε-caprolactone blends have been extruded into tubes with, and without
the use of salt particles in order to produce highly porous tubes via particle leaching.28–
31

Single and multichannel tubes of hydroxylethyl methacrylate (HEMA) have been

prepared using glass tubes as molds and polycaprolactone (PLC) fibers for templates.20,
32, 33

Simple tubes were prepared by injecting a HEMA precursor solution into a small

glass mold, and placing the mold in a centrifuge until crosslinking of the HEMA,
centrifugal forces cast the material to the walls of the tube.32 For multichannel tubes,
PLC fibers are inserted into a glass tube that is filled with the HEMA precursor solution,
after crosslinking of the HEMA the samples are removed from the glass mold and
sonicated to dissolve the PCL fibers, leaving the template of the fibers into the
cylindrical shape of HEMA.33

Chitin-based tubes have been prepared in a similar

fashion using glass molds.34 Suspension of alginate-chitosan and poly (D,L-lactic-co-εcaprolactone) have been deposited into spinning mandrels to produce simple tubes.35, 36
In a different approach for the development of NGCs, novel decellularization
treatments for allografts have been explored in order to avoid undesirable immune
responses. Nerves, muscles and small intestinal submucosa have been investigated as
acellular allografts for nerve repair, these allografts have been pretreated with different
growth factors or seeded with Schwann cells (support cells in the peripheral nervous
system) prior to implantation in a rat model. Acellular allografts have shown promising
results, nerve grafts retained the extracellular structure of peripheral nerve tissue, the
decellularization process yielded immunologically tolerated grafts, and ultimately, the
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grafts with incorporated growth factors and cells supported regeneration.

1, 37–40

Still,

decellularized grafts have the disadvantage of not being easily available, as
decellularization protocols may take at least 48 hours, and storing of grafts
compromises their regenerative ability.2, 5
Several publications review the characteristics of an optimal nerve guidance
conduit. 2, 5–7, 9–12, 14 In summary, the characteristics of an ideal tissue engineered nerve
conduit are:
1. In general, the conduit must be easily available, or readily formed with the desired
dimensions, tear resistant, easy to handle, suturable, and sterilizable.
2. The material must be biodegradable, have low antigenicity, support electrical activity,
resist collapse during implantation and over the time of regeneration, be
porous for oxygen diffusion, be able to be readily vascularized, have the ability
to delivery bioactive factors and support cell growth.
3. Have a design with intraluminal channels, in order to better mimic the natural
structure of a nerve and provide a greater surface area for support cells and
sprouting axons.
In this work, the rapid prototyping technology of stereolithography (SL) is
explored for the fabrication of 3D NGCs. It has been shown previously that SL is a
unique technology with enormous potential in tissue engineering as it can be used with
photocrosslinkable biomaterials to create complex 3D tissue-engineered scaffolds. The
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layered manufacturing nature of SL allows control over the scaffold’s macro-scale
design, as well as precise placement of bioactive agents within the scaffold during
construction.41

The design of the NGC to be fabricated has two important

characteristics: a capped portion at each end that allows effective suturing of the
proximal and distal stumps of the damaged nerve to the NGC, and a multi-lumen middle
portion that provides a greater surface area for support cells and sprouting axons. The
dimensions of the design are the smallest permitted by the SL system used for the
fabrication, and were established based on data found in literature for peripheral nerve
regeneration in a rat model. The dimensions in the design are as follows: 2.94mm OD,
1.72mm ID, with seven 400-μm dimater lumens.
Photocrosslinkable poly(ethylene glycol) (PEG) was selected as the material to
fabricate the NGC as PEG is a highly biocompatible, FDA-approved material with
extensive biological applications.42

Crosslinked PEG forms hydrogels that are

permeable to oxygen, nutrients, and other water-soluble metabolites and have a soft
consistency that makes them similar to soft tissues.43 Although PEG-based hydrogels
are not bioactive, cell-specific bioactivity can be achieved by covalently attaching
adhesion ligands, growth factors, and cytokines to the hydrogel, or by simply trapping
the bioactive agents within the hydrogel.44–47 Additionally, while PEG hydrogels are
normally non-degradable, they can be rendered biodegradable by incorporating
proteolytically degradable peptide sequences into the PEG backbone or by creating a
copolymer with a degradable polymer such as poly(lactic acid).45, 48 In this work, high
molecular weight photopolymerizable PEG, already in use for a variety of TE
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applications including cell encapsulation,49–52 creation of synthetic extracellular matrix
(ECM) analogs,44–46

and for the formation of substrates with patterned arrays of

immobilized proteins and/or cells53–55 was used.
A manufacturing process for NGCs was developed. The manufacturing process
involved the use of SL, which permits a rapid fabrication strategy for complex 3D
scaffolds, and post-processing stages of lyophilization and sterilization, that preserve
the scaffold, creating an implantable, off-the-shelf product with improved suturability.
Characterization of the conduits was done at each stage of the manufacturing process.
The weight degree of swelling, dimensional swelling factors, and resistance to
deformation under compressive force were evaluated.

4.2. MATERIALS AND METHODS
4.2.1. PHOTOPOLYMER SOLUTION
Photocrosslinkable, commercially available poly(ethylene glycol) diacrylate
(PEG-da, MW 3400, Laysan Bio Inc., Arab, AL) was dissolved in HEPES-buffered saline
(HBS) at a concentration of 20% (w/v). The cytocompatible photoinitiator Irgacure 2959
(I-2959, Ciba Speciality Chemicals Corp., Tarrytown, NY) was added to the
photopolymer solution at a concentration of 0.5% (w/v). It has been demonstrated that
I-2959 causes minimal toxicity over a broad range of cell types and allows for
photopolymerization of thin layers.41, 56–59
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4.2.2. APPARATUS
A 3D Systems Model 250/50 SL machine (3D Systems, Valencia, CA) equipped
with a He-Cd laser (325 nm, 40 mW) was used for the fabrication of NGCs. The original
setup of the SL machine was modified slightly to fabricate complex 3D shapes. The
modifications consisted of removing the original vat of material from the machine and
using a self-aligning mini-vat setup at the center of the platform to contain the
photopolymer solution. The elevator platform, originally used to support a part during its
fabrication, is used to hold the mini-vat. The height of the platform was set at a distance
where the laser beam was circular with a diameter of ~250µm. The beam diameter of
this system is a limitation on the micro-scale features that can be achieved.

4.2.3. SCAFFOLD FABRICATION
4.2.3.1. STEREOLITHOGRAPHY
An NGC design with the following dimensions: 2.94mm OD, 1.72mm ID, and
seven 400-μm diameter lumens contained within the ID in the middle portion was
fabricated in a layer-by-layer fashion using SL.

Although cure depth, or hydrogel

thickness, curves as a function of energy for PEG-based solutions provided the
parameters EC (critical energy) and DP (penetration depth) used to build in SL, attempts
to use these parameters yielded no results. Laser scan speeds corresponding to the
determined EC (53.07 mJ/cm2) and DP (16 mils) parameters were 4 times faster than the
scan speeds normally used.

At the fast laser scan speeds (~4.15 in/s) the liquid
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photopolymer was not crosslinked. Therefore, in order to build a PEG-based structure
the appropriate laser scan velocity has to be determined first. The laser scan velocity is
determined by crosslinking the desired pattern at different scan speeds and inspecting
the patterns under a microscope. For the NGC design, the pattern of the multi-lumen
portion was crosslinked at different laser speed, and the size of the lumens was
measured from optical micrographs for each crosslinked pattern. The velocity at which
the multi-lumen pattern crosslinked forming a gel with sufficient mechanical strength to
be handled and imaged without severe deformation (i.e. it maintained its circular shape)
and all the lumens had were circular and closest to 400-μm in size was selected as the
velocity to fabricate the scaffold.
For layered fabrication, the thickness of the crosslinked gel at the specific
velocity should be determined. A large (> 500μL) amount of volume is added to the
container and the pattern is crosslinked. The crosslinked pattern should float in the
solution in order to measure its thickness using calipers or from optical micrographs.
Once the thickness of the gel is determined, a volume of solution corresponding to a
layer thickness smaller than the one crosslinked is added to the container so that the
first layer is well attached to the base.

For the consecutive layers, to have good

interlayer bonding the corresponding volume of solution that allows ~300μm of
overlapping between layers is added, and the platform is lowered a distance equal to
the amount of solution added, and the next pattern is crosslinked. The process is
repeated until the complete structure has been fabricated.
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The overlapping between layers of ~300μm was estimated by crosslinking a
second pattern using different volumes, and observing the samples under a
stereomicroscope. When a volume of 290 – 310μL was used, the second layer was
slightly attached to the first layer, or not attached (first layer attached to container, but
second layer was floating in the solution). The gel thickness of floating layers was
~1080μm. For a volume of 270 – 280μL, the layers were attached with a calculated
overlapping of 300 – 325μm. For volumes ≤ 260μL, the layers overlapped ~355μm, and
the lumen at the middle of the design was obstructed.
For example, at a laser power of ~23mW, it was determined that a laser speed of
~1.1 in/s crosslinked a gel with sufficient mechanical strength and matching dimensions.
For the size of the container used, in a volume of ~590μL the crosslinked pattern floated
and the gel had a thickness of ~1080μm. For the first layer, a volume of 400μL was
added, the crosslinked layer was well attached to the base of the container and had a
thickness of ~850μm. For the consecutive layers, a volume of 270μL was added, and
the following pattern was crosslinked. For the size of the container used, the layer
thickness corresponding to 270 μL was ~750 μm. The platform was then lowered a
distance equal to the layer thickness (~750μm), the corresponding a volume of solution
(270μL) was added, the consecutive layer was crosslinked, and the process was
repeated until the completion of the design.
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4.3.2.2. SWELLING
Fabricated NGCs were placed in phosphate buffered saline (PBS) for more than
48 hours to allow the samples to reach equilibrium. PBS was changed twice in order to
remove unreacted photoinitiator and polymer that leached out of the samples. The
samples swelled in PBS increasing in dimensions and absorbing PBS.
4.3.2.3. LYOPHILIZATION
Preliminary research was performed to lyophilize NGCs under the optimal
conditions to maintain their structure without deformation or damage. Freeze-drying (or
lyophilization) of the conduits can be performed in two ways, either freezing the conduits
in a slow manner by placing them in a -80ºC refrigerator for >12 hr, or by quick-freezing
them in liquid nitrogen, followed by drying under vacuum at -55ºC for >12 hr in a freezedry system (FreeZone 6, Labconco Corp., Kansas City, MO). Both freezing methods
yielded good results, although quick-freezing in liquid nitrogen is preferred as it is fast
and does not require packing of the NGCs in a substrate to maintain their structure
without deformation.
NGCs frozen in a -80ºC refrigerator required packing of the conduits prior to
freezing. In preliminary trials, aluminum foil and parafilm were used as substrates to
pack the conduits, with better results obtained when using parafilm (not stretched) as it
was sturdier than aluminum and the samples were not compressed during packing
(compressing the samples before freezing led to permanent deformation).
parafilm can be pre-rolled for easier packing.
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Also,

4.3.2.4. STERILIZATION
Once the conduits were lyophilized, they were placed individually in polystyrene
tubes, and sealed in Tyvek pouches for sterilization in a low-temperature hydrogen
peroxide plasma sterilizer (Sterrad 100S, Advanced Sterilization Products, Irvine, CA).
The sterilization cycle ran for 47 minutes.
4.3.2.5. SUTURE
Initial attempts to suture the NGCs in their capped portion were done at their
equilibrium swollen state after fabrication. Suturing of the conduits was not successful
due to the material tearing during suture.

However, suturing of the conduits after

lyophilization, both in the freeze-dry state and the reconstituted state, was possible.
Knots were stitched in the conduits using 10-0 sutures (10-0 Ethilon Black Nylon Suture,
Ethicon, Inc., Somerville, NJ) under a stereomicroscope by surgeons from William
Beaumont Army Medical Center (WBAMC).

4.2.4. CHARACTERIZATION
NGC samples, capped at one end only, were fabricated using SL to be
characterized at each stage of the fabrication process. The samples were weighed
using an analytical balance (Sartorius CP124S, Sartorius AG, Germany) and digital
images of the samples were acquired using a stereomicroscope (MZ16, Leica
Microsystems, Germany) equipped with a CCD camera (Retiga 2000R Fast 1394,
QImaging Corp., Canada) to measure the dimensions of the samples. The conduits
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were fabricated without the cap at one end to be able to measure the dimensions of the
lumens.
Features of the samples at the macro-scale such as surface topography were
examined using a stereomicrospcope. Low- and high-magnification optical micrographs
of the NGCs were taken at different stages: immediately after fabrication, after swelling
to equilibrium in PBS, after lyophilization, after sterilization in hydrogen peroxide, and
reconstituted to equilibrium.

Optical microscope images of disk-shaped samples

(D=8mm) fabricated with SL were taken after freeze-drying and after re-swelling to
equilibrium. Images of “dry” samples were taken using reflected light (illumination from
above), while “wet” samples were observed better using transmitted light (illumination
from the bottom).
Microstructural characterization of the samples was done using scanning
electron microscopy (SEM).

NGCs samples were imaged using a field emission

scanning electron microscope (S-4800 UHR FE-SEM, Hitachi, Pleasanton, CA). Only
samples in the dry state (after lyophilization and after sterilization) were imaged using
SEM as samples are observed under vacuum. Prior to SEM imaging, samples were
gold sputter-coated (SPI Sputter Coater, Structure Probe, Inc., West Chester, PA) for 60
seconds to avoid charging of the sample under the electron beam.
NGC samples were tested in compression (upper compression disk Ø = 6.3 mm)
using a dynamic mechanical analyzer (DMA Q800, TA Instruments, New Castle, DE).
The samples were glued to a rectangular piece of transparency using cyanoacrylate126

based glue (Brush-On™ Future Glue®) and held in place for 10-15 seconds to avoid
rolling of the sample during testing.

The samples were tested at room temperature in

controlled force mode, using a pre-load of 0.01 N and a rate of 0.5 N/min, applying the
force radially to the conduit design until the samples fractured (see Figure 4.1). Four
different types of conduit design were tested: 1) a single lumen design, with the
dimensions of the capped portion (OD = 2.94mm, ID = 1.72mm) at the equilibrium
swollen state, 2) a multi-lumen design (OD = 2.94mm, ID = 1.72mm, seven 400-μm
diameter lumens) at the equilibrium swollen state, 3) a multi-lumen design at the
reconstituted state after lyophilization, and 4) a single lumen design with an
approximate surface area equivalent to the multi-lumen design (OD = 2.94mm, ID =
1.27mm) at the equilibrium swollen state. Five samples per group were tested. The
diameter of the samples was measured at the beginning of the test at a pre-load force
of 0.01 N.

Curves of force versus displacement were determined using Universal

Analysis data analysis software (Universal Analysis 2000 Version 4.3A, TA Instruments,
New Castle, DE). The resistance to deformation (in N/mm) of the design, the force to
collapse the design, and the force to break the samples were obtained from these
curves.
The static coefficient of friction of NGCs at the equilibrium swollen state and
reconstituted to equilibrium after lyophilization and sterilization was determined with a
simple experiment (see Figure 4.2).59 Using a glass slide over a leveled surface, the
conduit was placed lying down at one end of the slide, and the other end of the slide
was fixed to the leveled surface. The glass slide was then slowly lifted from one end
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Upper Compression Disk
(Movable)
Applied Force

Single Lumen
NGC Design
Sample

Transparency

Lower Compression Base
(Fixed)
Figure 4.1. Setup in the dynamic mechanical analyzer (DMA) for the compression test of the NGC
designs.

(where the conduit was placed) until the conduit started to slide. The height at which
the conduit started to glide was then used to calculate the angle at where the force of
gravity is strong enough to overcome the static friction between the conduit and the
glass surface.

C
W sin(a)
A

W cos(a)
a
W

a
B

Figure 4.2. Schematic of the experiment to determine the static coefficient of friction and freebody diagram. The static coefficient of friction is equal to the tangent of a. (W is the weigth of the
sample).
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4.2.5. STATISTICAL ANALYSIS
The mean and standard deviations of the data were calculated.

Data were

compared using two-tailed, unpaired, t-tests. P-values less than 0.05 were considered
to be significant.

4.3. RESULTS AND DISCUSSION
4.3.1. SCAFFOLD FABRICATION
Using a modified SL system and the procedures described previously, NGCs
were fabricated with the appropriate dimensions to accommodate the sciatic nerve of
rats. Conduits can be individually fabricated or in batches of nine conduits at a time.60
The dimensions of the NGC design were modified by following the data found in
literature, taking into consideration the changes in dimensions due to swelling, and
working closely with surgeons at WBAMC. NGC samples with different dimensions
were fabricated and given to surgeons to test in vivo as described in the refinement
section of the approved IACUC protocol.61 The dimensions in the final NGC design are
as follow, 2.94mm OD, 1.72mm ID, and with seven 400-μm diameter lumens.
According to the feedback from surgeons at WBAMC, the sciatic nerve of 400-gr
Sprague-Dawley rats fit snugly into these NGCs. Another important suggestion by the
surgeons was to have a larger cap portion in the NGCs as this helps when invaginating
the damaged nerve into the cap to be sutured. Originally the cap portion was ~1mm in
length, new NGCs were fabricated with the cap portion larger than 1mm but smaller
than 2mm, and this size of cap was satisfactory for the surgeons.
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It should be

mentioned that the surgical technique for commercially available NGCs recommends
inserting the nerve stumps 3–5 mm into the tube ends.62
Figure 4.3 shows images of the multi-lumen portion crosslinked at different
speeds to determine the appropriate velocity to be used to fabricate the scaffolds. It
can be seen that at a high laser speed (low energy dosages ~ 205 mJ/cm2) a gel is
crosslinked, although it does not have sufficient mechanical strength and deforms
easily. Furthermore, the features (lumens) in the pattern are not preserved (see Figure
4.3A). On the contrary, when a low laser velocity is used (high energy dosage ~ 570
mJ/cm2) a gel with good mechanical strength is crosslinked (see Figure 4.3B). Although
the dimensions of the features (ranging from ~ 195 to 265 μm) at this high energy are
smaller that the dimension in the design (400 μm). Energies of ~ 300 mJ/cm2 crosslink
a “good” pattern with the dimensions of the features closest (ranging from ~ 310 to
340μm) to the ones in the design (400μm) (see Figures 4.3C and D).
Figure 4.4 shows images of 2-layer multi-lumen structures with appropriate
interlayer bonding (Figure 4.4A) and inappropriate interlayer bonding (Figure 4.4B).
The overlapping between the layers in Figure 4.4A is approximately 280μm. Adding a
large amount of volume (> 300μL) for the consecutive layers will produce a weak
structure that delaminates easily, or a cluster of 2D patterns floating in the solution.
Figure 4.5 also shows images of 2-layer multi-lumen structures crosslinked at the
same laser speed (1.123 in/s), but using different volumes for the second layer. Figure
4.5A and B show the top and side view of a 2-layer structure fabricated using 280μL for
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Laser Speed (in/s)
Corresponding Energy
(mJ/cm2)

A)

B)

C)

D)

Optical Micrograph of the
Crosslinked Pattern

Lumen Dimensions

1.633
205

0.592
570

1.147
295

1.123
300

Figure 4.3. Optical micrographs of the multi-lumen pattern crosslinked at different speeds.
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the second layer, and Figure 4.5C and D show the top and side view of a 2 layer
structure fabricated using 260μL for the second layer. The first layer was fabricated
using 400μL and it can be seen that the thickness of the first layer is < 850μm (section
on the left of Figure 4.5B and D). The structure in Figure 4.5A and B has a layer
overlapping of ~300μm, and the diameters of all the lumens are similar (from 349 to
422μm). As there is more overlapping (> 350μm) between the layers of the structure in
Figure 4.5C and D, the center lumen is smaller (~258μm) than the rest of the lumens
(339 – 396μm) due to overcuring. As the laser can penetrate ~1080μm (layer thickness
for the laser speed used) and the available volume (260μL) corresponds to a layer
thickness of ~725μm, the laser penetrates ~350μm into the already crosslinked layer,
and as crosslinked PEG transmits UV light, the center lumen is subjected to successive
exposure of UV and in consequence the center lumen is smaller than the rest of the
lumens.

A

B

Figure 4.4. Interlayer bonding, A: appropriate interlayer bonding (overlapping ~280μm) and B:
inappropriate interlayer bonding as the structure will delaminate. Marker represents 1 mm.
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A

B

C

D

Figure 4.5. Top (A and C) and side (B and D) views of 2-layer multi-lumen structures fabricated
using different volumes for the second layer (section on the left of B and D). A and B: structure
fabricated using 280 μL (~300μm overlapping). C and D: structure fabricated using 260 μL
(~350μm overlapping).

Figure 4.6 shows the computer-aided design (CAD) of the NGC, and images of
the fabricated conduits at different stages of the manufacturing process.

After

fabrication and after swelling (Figure 4.6B and C) the hydrogel based conduits were
transparent-clear and had a smooth surface. After post-processing (lyophilization and
sterilization, Figure 4.6D and E, respectively) the conduits became white and decreased
in size, decreasing slightly more after sterilization. The conduits reconstituted in PBS
(Figure 4.6F) returned quickly (see end of section 4.3.2.1) to the swollen state, became
cloudy, and had a rough topography.
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2.94 mm
1.97 mm

A

B

0.40 mm

C

D

E

F

Figure 4.6. Optical micrographs of the conduits at different stages of the fabrication process: A:
CAD drawing, B: after fabrication, C: after swelling, D: lyophilized, E: sterilized, and F:
reconstituted.
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4.3.2. CHARACTERIZATION
4.3.2.1. WEIGHT CHANGES
Samples were weighed at different stages of the manufacturing process:
immediately after fabrication, after allowed to reach equilibrium in PBS, after
lyophilization, after sterilization, and after reconstituted in PBS to equilibrium.

The

swelling ratio for the samples in equilibrium after fabrication, and after lyophilization was
calculated. The swelling ratio is defined as the ratio of the swollen weight by the dry
weight (the lyophilized weight was used as the dry weight).

Furthermore, the time

required for the samples to reach equilibrium when reconstituted was determined by
weighing the samples at different time intervals.
Figure 4.7 shows the weight of the samples at the different stages of the
manufacturing process and the corresponding swelling ratio for the samples after
fabrication and after lyophilization. It can be seen that the samples swelled, significantly
increasing in weight when allowed to reach equilibrium in PBS after fabrication. It can
be seen easily in Figure 4.6 that the samples’ dimensions decreased even more after
sterilization, but when comparing the weight of the samples after lyophilization with the
weight after sterilization, the samples increased slightly in weight after sterilization. This
may be due to some absorption of hydrogen peroxide used in the sterilization stage
(0.0077 ± 0.004 gr vs. 0.0080 ± 0.004 gr, for lyophilized vs. sterilized samples). Also,
the calculated swelling ratio indicates that the samples at equilibrium after fabrication
retain more water than the samples reconstituted to equilibrium after lyophilization and
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0.09
QS = 10.93 ± 0.51

0.08
QR = 9.12 ± 0.52

0.07

Weight (gr)

0.06
0.05
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0.03
0.02
0.01
0
After Fabrication

Swollen

Lyophilized

Sterilized

Reconstituted

Figure 4.7. Weight of nerve guidance conduits (NGCs) samples at different stages of the
manufacturing process. The swelling ratio for the samples swollen at equilibrium after fabrication
(QS) and swollen to equlibium after reconstitution (QR) is included.

sterilization.

Both the swollen and reconstituted samples were blot dried using a

kimwipe before being weighed. For the swollen samples, only the excess water in the
surface and inside the lumens is absorbed when the sample is dried with the kimwipe.
However, for the reconstituted samples, some of the water trapped in the micropores
created during the lyophilization stage is absorbed by the kimwipe when the sample is
blot dried. This may be the reason why the reconstituted samples weighed less than
the swollen samples. Micropores are created by the removal of the water trapped in the
hydrogel from the frozen structure during lyophilization.
Figure 4.8A shows the weight gained by the samples when placed in PBS as a
function of time. Figure 4.8B shows that when placed for less than 10 minutes, the
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samples already absorbed 70% of the total PBS that will be taken up. By 30 minutes,
the samples have already reached the equilibrium swollen state as the percentage of
PBS absorbed is 93 ± 5%.
4.3.2.2. DIMENSIONAL CHANGES
NGC samples were imaged at different stages of the manufacturing process and
different dimensions of the samples were measured.

The NGC samples were

fabricated without the cap portion at one end (bottom) to be able to measure the
diameter of the lumens. The dimensional swelling factor, expressed as the ratio of the
swollen dimension by the dimension immediately after fabrication was calculated.
Figure 4.9 shows the different dimensions measured, and the corresponding
dimensional swelling factor for each dimension is included in each graph.
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Figure 4.8. Increase in weight of sterilized conduits as a function of time in PBS. A: Data in terms
of weight vs. time. B: Data in terms of percentage of PBS in the samples vs. time.
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It can be seen in Figure 4.9 that all the dimensions changed at the different
stages of the manufacturing process. All the dimensions increased significantly (except
for the inside diameter Figure 4.9F) when the samples were allowed to reach
equilibrium after fabrication.

Then, with the lyophilization stage, the dimensions

significantly decreased, and decreased even more with sterilization. Yet, the samples
returned to their swollen dimensions once reconstituted, as there is no statistically
significant difference between the swollen dimensions after fabrication, and the
reconstituted swollen dimensions (except for the inside diameter in the capped portion,
Figure 4.9F).
Dimensional swelling factor data showed that the final swollen volume of the
samples depends on the features of the sample. For example, the sample expanded
along its major axis (longitudinally) to a final dimension 25% larger than the original (the
calculated DSF for both the overall length of the sample and an individual layer in the
sample was 1.25). The radial expansion however behaved in a peculiar manner and
depended on the type of feature. For example, the outside diameter (as measured on
both ends) expanded to a final dimension 22% larger than the original, while inside
diameters expanded to a final dimension 15% larger than the original (as in the case of
the center lumen). Figure 4.10 shows the optical micrographs of the samples at the
different stages of the manufacturing process.
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Figure 4.9. Change in dimensions of NGCs at different stages of the fabrication process (14 ≤ n ≤
24). A: Outside diameter at the bottom end. B: Diameter of the center lumen measured from the
bottom end. C: Length of the conduit. D: Layer thickness. E: Outside diameter at the top end
(capped portion). F: Inside diameter at the top end (capped portion). DSF = dimensional swelling
factor.
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After fabrication

Swollen to equilibrium

Lyophilized

After sterilization

Reconstituted to equilibrium

Figure 4.10. Optical micrographs of NGC samples at each stage of the manufacturing process.
Left column: top end (capped portion). Right column: bottom end.
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4.3.2.3. OPTICAL MICROSCOPY
Figure 4.11 shows optical micrographs of NGC samples reconstituted to
equilibrium. A rough surface topography can be observed from these micrographs.
Optical micrographs of disk-shaped samples fabricated with SL taken after lyophilization
and reconstituted to an equilibrium state are shown in Figure 4.12. Macro- and micropores and a rough topography created during lyophilization where water crystals were
present and then removed can be observed from these optical micrographs.

B

A

C
Figure 4.11. Optical micrographs of reconstituted NCG. A and B: side view. C: top view. Please
note the rough surface topography of the samples.
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A

B

C

D

E

F

Figure 4.12. Optical micrographs of disk-shaped samples fabricated with SL after lyophilization (A
– D) and reconstituted to an equilibrium state (E, F).
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Figure 4.13 shows the optical micrographs of a conduit sutured by Dr. John
Horton from WBAMC. Figure 4.13A shows two types of knots sutured in a lyophilized
conduit: a regular (tight) knot (on the right of the conduit) and an air (loose) knot (on the
left of the conduit). When the sutured conduit was reconstituted to equilibrium, the
conduit expanded. The originally regular knot in the lyophilized conduit resulted being
too tense (in consequence, the conduit material is compressed by the suture) in the
reconstituted swollen conduit. On the other hand, sutured air knots in the lyophilized
conduit resulted in regular knots (with adecuate tension as the suture is not
compressing the conduit) in the reconstituted swollen conduit.

Conduits at the

reconstituted swollen state were also successfully sutured.
4.3.2.4. SCANNING ELECTRON MICROSCOPY
Lyophilized and sterilized NGCs samples were cut longitudinally into halves, and
transversely to observe the free surface and internal structure of the conduits using a
scanning electron microscope (SEM). Figures 4.14 – 4.15 show low magnification SEM
images of lyophilized and sterilized conduits, respectively.

It can be seen that the

conduits decreased in dimensions in the sterilization stage, although their pattern was
preserved. Images of the transverse cross section of lyophilized conduits (Figure 4.14C
and D) show a slightly distorted pattern.
High magnification images of sterilized conduits are shown in Figures 4.16 – 18.
Figure 4.16 shows the free surface (A, C, E) and internal microstructure (B, D, F) of
conduits cut along the major axis.

Free surface images show the presence of
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A

B

C

D

E

Figure 4.13. Optical micrographs of sutured conduits. A: lyophilized conduit with a regular knot
(right) and an air knot (left). B and C: air knot, and D and E: regular knot, once the conduit is
reconstituted.

dimples and pits in the exterior of the conduits, creating a rough surface. Images of the
interior of the conduits show the presence of micro-pores, and a sheet-like
microstructure with folds of the material. White particles in the images are leftover salts
from the PBS solution where the samples were allowed to swell. Figure 4.17 shows the
internal microstructure and Figure 4.18 shows the free-surface of transverse cross
sections of sterile conduits. The micro-porous, sheet-like structure is observed better at
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the periphery of the conduit, while the material between the lumens is flattened, with
almost no topography. Not much difference is observed between the free-surface and
the interior of the sterile conduits.

A

B

C

D

Figure 4.14. Low magnification SEM images of lyophilized conduits. A and B: sample cut
longitudinally (A: free surface, B: internal structure). C and D: sample transverse cross section
(C: free surface, D: internal structure).
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A

B

C

D

Figure 4.15. Low magnification SEM images of sterilized conduits. A and B: sample cut
longitudinally (A: free surface, B: internal structure). C and D: sample transverse cross section
(C: free surface, D: internal structure).

High magnification images of lyophilized conduits are shown in Figures 4.19 –
4.22. Figure 4.19 shows the free-surface (A, C, E) and internal microstructure (B, D, F)
of conduits cut along the major axis. A well-defined line can be observed in Figure
4.19A, this line is the overcuring between layers. The rough free-surface of the exterior
of the conduits, containing voids and pits, can be observed in images A, C and E of
Figure 4.19. Images of the interior of the conduit depict the porosity of the conduits
(Figure

4.19B

and

D)

and

the

folding
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of

the

material

forming

a

A

B

C

D

E

F

Figure 4.16. High magnification SEM images of sterilized conduits cut longitudinally. A, C, and E:
free surface. B, D, and F: internal structure. White particles are leftover PBS salts.
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A

B

C

D

E

F

Figure 4.17. High magnification SEM images of transverse cross sections of sterile conduits
showing the internal structure. A, C, E: periphery of the conduit. B, D, and F: multi-lumen section
in the center.
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A

B

C

D

E

F

Figure 4.18. . High magnification SEM images of transverse cross sections of sterile conduits
showing the free-surface of the conduits. A, C, E: periphery of the conduit. B, D, and F: multilumen section in the center.
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A

B

C

D

E

F

Figure 4.19. High magnification SEM images of lyophilized conduits cut longitudinally. A, C, and
E: free surface. B, D, and F: internal structure.
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sheet-like microstructure (Figure 4.19E). Figure 4.20 show the interior of transverse
cross sections of the multi-lumen portion of lyophilized conduits.

A micro-porous

structure is observed, however, contrary to sterilized conduits, the outline between
lumens (Figure 4.20A) is not well-defined. Figure 4.21 shows interior of transverse
cross sections at the periphery, the sheet-like structure of the material can be easily
appreciated from these images. Figure 4.22 shows the free-surface of transverse cross
sections of multi-lumen conduits. The outline of the lumens is well-defined at the free
surface (Figure 4.22A), dimples are observed in the material between the lumens
(Figure 4.22B and C) and folding of the material is observed at the periphery (Figure
4.22D).

A

B

C

D

Figure 4.20. High magnification SEM images of the interior of lyophilized conduits, transverse
cross sections between the lumens. Please note the distorted outline of the lumens in A. The
micro-porous structure of the material is observed in B, C, and D micrographs.
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A

B

C

D

Figure 4.21. High magnification SEM images of the interior of lyophilized conduits, transverse
cross sections at the periphery of the conduit. The sheet-like folding structure of the material is
observed in these micrographs.
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A

B

C

D

Figure 4.22. High magnification SEM images of the free-surface of lyophilized conduits,
transverse cross sections. Dimples and voids are noticeable in the material, and sheet-like
folding microstructure of the material outlining the lumens
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Figure 4.23 shows the SEM images of conduits sutured at their lyophilized state.
The material did not tear during suture, and faults or splitting of the material were not
observed in these micrographs.
4.3.2.5. MECHANICAL TESTING
Force versus displacement curves of the four different types of conduits tested
under compression are shown in Figure 4.24. From these curves, the resistance to
deformation (in N/mm) of the design, the force to collapse the design, and the force to

Figure 4.23. SEM images of sutured lyophilized NGCs.
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Figure 4.24. Force versus displacement curves for the four types of conduits tested under
compression

break the samples were obtained (results shown in Figure 4.25).

Figure 4.26 shows

images of the different NGC designs during compression testing. Results show that the
single-lumen design with the dimensions of the cap portion is the most flexible, the
multi-lumen design at the equilibrium swollen state is the most resistant to deformation,
and both the single lumen design with a surface area equivalent to the multi-lumen
design and the multi-lumen design at the reconstituted swollen state, fall in between
them.
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Figure 4.25. Results of mechanical testing of four different types of conduit designs under
compression. A: Resistance to compression, B: Force required to collapse the design, and C:
Force required to break the conduit.

Comparison of the resistance to deformation and force to collapse for the four
different designs was useful in characterizing the fabricated conduits. It was expected
that the single lumen design with the dimensions of the cap portion would be the easiest
to deform. As the resistance to deformation is an extensive property, dependent on the
material and the structural design, the single lumen design with the dimensions of the
cap portion has the smallest amount of material. The resistance to deformation for the
single lumen cap portion design was 0.05 ± 0.005 N/mm, and less force (0.13 ± 0.025
N) compared with the other designs was required to collapse it. The multi-lumen design
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(with no post processing) was better able to resist deformation than the other designs.
The resistance to deformation of the multi-lumen design (with no post processing) was
0.40 ± 0.063 N/mm, with more force (0.45 ± 0.055 N) required to collapse the design,
compared to the other designs. The reconstituted multi-lumen design (post-processed
by lyophilization and sterilization) had a resistance to deformation of 0.25 ± 0.087
N/mm, and a force required to collapse the design of 0.36 ± 0.049 N. As the postprocessing of the conduits introduced micro-pores into the design, the properties of the
design changed, resulting in a more flexible, but less strong design. The single-lumen
design with a surface area equivalent to the multi-lumen design (equal amount of
material) had a resistance to deformation of 0.17 ± 0.022 N/mm and the force required
to collapse the design was 0.28 ± 0.033 N, which are significantly smaller than the multilumen design, both with and without post-processing. It should be noted that none of
the samples failed when the design was collapsed.
The force to failure results indicate that the point of failure is determined by the
material properties and not the structural design. There is no statistically significant
difference in the force required to completely break the four different conduits. Also, it
can be seen in Figure 4.24, that once the structural design of the conduit has been
collapsed, the deformation experienced is that of the material, as the slope of the curves
is the same.
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A

B

C

D

E
Figure 4.26. Compresion testing of NGCs designs: single lumen (left), multi-lumen without postprocessing (center), and post-processed multi-lumen (right), at different stages. A: initially, B:
partially compressed design, C: completely collapsed design, D: compression of the material, and
E: sample crushed.
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4.3.2.6. COEFFICIENT OF FRICTION
Experimental results of a simple experiment to determine the static coefficient of
friction of NGCs at the equilibrium swollen state and reconstituted to equilibrium after
lyophilization and sterilization, showed that the angle at which the conduits started to
glide was ~30º for not post-processed conduits and ~48º for post-processed conduits.
The calculated coefficient of friction of the conduits on glass was 1.10 and 0.56 for
conduits with and without post-processing, respectively.

As observed before in the

optical micrographs in Figures 4.10 to 4.13, post-processing of the conduits resulted in
a rough surface topography, and as a consequence, less slippery conduits. Therefore,
the post-processed conduits at the swollen state are easier to handle, a desirable
characteristic of the ideal NGC.

4.4. CONCLUSIONS
The fabrication of a three-dimensional nerve guidance conduit (NGC) design with
the rapid prototyping technology of stereolithography (SL) was demonstrated using
photocrosslinkable poly(ethylene glycol) (PEG).

The design of the NGC has two

important characteristics: a capped portion at each end that allows effective suturing of
the proximal and distal stumps of the damaged nerve to the NGC, and a multi-lumen
middle portion that provides a greater surface area for support cells and sprouting
axons. The dimensions of the design were the smallest permitted by the SL system
used for the fabrication: 2.94mm OD, 1.72mm ID and with seven 400-μm diameter
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lumens. Due to swelling of the material the dimensions in the final, swollen state were
approximately: 3.38mm OD, 2.43mm ID, and lumen diameter of 585μm.
A complete manufacturing process of NGCs consisted of three different stages:
1) photocrosslinking using stereolithography, which permits a rapid fabrication strategy
for complex 3D scaffolds, 2) swelling to equilibrium, to allow the scaffold to reach the
final dimensions while removing unreacted photopolymer, 3) lyophilization, that
preserves the scaffold, making it an off-the-shelf product with improved suturability and,
4) sterilization with hydrogen peroxide, to be able to implant in vivo.
The fabricated conduits were characterized at each stage of the manufacturing
process. Optical and scanning electron microscopy showed that the conduits had a
rough topography in the free-surface and that a micro-porous, sheet-like micro-structure
of the material was created by the lyophilization process. The weight degree of swelling
and dimensional swelling factors, showed that the final dimensions of the conduits are
significantly larger than the original dimensions, and that the samples return easily and
rapidly to a swollen state when placed in an aqueous solution, maintaining the original
overall structure.
Furthermore, resistance to deformation under compressive force, and static
coefficient of friction of the fabricated conduits with and without post-processing
(lyophilization) were evaluated. As implantable NGCs should resist compression from
surrounding tissue, it was determined that a multi-lumen design (with and without postprocessing) has a better resistance to compression than a single-lumen design with an
equivalent surface area. The calculated coefficient of friction for the conduits on glass
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was 1.10 and 0.56 for conduits with and without post-processing, respectively. The
differences in coefficient of friction indicate that the post-processed conduits at the
swollen state are less slippery and therefore easier to handle, a desirable characteristic
of the ideal NGC.

Furthermore, post-processing (lyophilization) of the conduits

improved the suturability. The suturability of the conduits after post-processing and
after reconstitution to a swollen state was demonstrated
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CHAPTER 5
CELL VIABILITY OF HUMAN DERMAL FIBROBLASTS TO STEREOLITHOGRAPHY
PARAMETERS AND CELL ENCAPSULATION USING STEREOLITHOGRAPHY
Stereolithography (SL) is a unique rapid prototyping technology with enormous
potential in tissue engineering as it can be used with photocrosslinkable biomaterials to
create complex 3D tissue-engineered scaffolds. The layered manufacturing nature of
SL allows control over the scaffold’s macro-scale design, as well as precise placement
of bioactive agents within the scaffold during construction. Some tissue engineering
applications rely on the availability of cells for the success of the application (e.g. the
reduction of invasiveness in cartilage or bone repair using systems with encapsulated
chondrogenic or osteoblast cells). Stereolithography parameters related to unfavorable
cell growth and survival, including photoinitiator exposure, ultraviolet exposure, and
radical formation of the photoinitiator upon exposure to ultraviolet energy were
assessed in vitro using human dermal fibroblast (HDFs) cells to explore the capabilities
of SL to create scaffolds with encapsulated cells.

Furthermore, HDFs were

encapsulated in photocrosslinkable poly(ethylene glycol) (PEG) hydrogels using SL and
the viability of the cells was evaluated at 2 and 24 hours following encapsulation. Two
different types of PEG were used to encapsulate the cells. Results showed that SL
threshold levels for unfavorable cell survival were considerably away from the ones
used to create PEG-based scaffolds in SL. Hydrogel scaffolds with encapsulated cells
showed a uniform distribution of cells throughout the scaffolds, and a high percentage of
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viable cells at both 2 and 24 hours (at least 87%). No significant differences in the
viability of cells were observed for the two PEG types, or for the the two time points.
The results presented here indicate that the use of SL and photocrosslinkable
biomaterials, such as photocrosslinkable PEG, appears feasible for fabricating scaffolds
with living cells for a variety of important tissue engineering applications.

5.1. INTRODUCTION
The field of tissue engineering (TE) began in the 1980’s to overcome the
shortage of transplant tissue lost to cancer, trauma, or for the repair of birth defects.
The objective of TE is the creation of an artificial tissue with the ability to repair or
replace damaged tissue, and restore tissue function. Most tissue-engineered constructs
have two key components: cells and scaffold material, on which the cells can grow and
generate new tissue.

Cells are usually extracted from a small piece of tissue and

expanded in vitro to be incorporated into a scaffold for later implantation.

In the

simplest strategy for cell incorporation into a scaffold, cells are seeded into the scaffold
at a high cell density to increase the chances of survival and differentiation of the cells
into new tissue, usually immediately before implantation. Another approach is to in vitro
create an efficient construct with the use of bioreactors where cells are provided with
certain stimuli (chemical and/or electro/mechanically) to elicit specific responses to the
cells.1–4
The creation of photocrosslinkable biomaterials has increased the number of
applications of photopolymerization in the biomedical field, from the creation of contact
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lenses, dental fillers and biomimetic coatings, to drug delivery and cell encapsulation.5
In TE, the use of photocrosslinkable biomaterials has permitted the incorporation of
cells during the fabrication of the scaffold under cytocompatible conditions.

The

availability of cytocompatible photoinitiators and the fast crosslinking times of
biomaterials have allowed the creation of scaffolds with cells uniformly incorporated.
Different cell types have been successfully incorporated into photocrosslinkable
hydrogels with promising results for different TE applications.

Researchers have

encapsulated chondrocytes in poly(ethylene glycol) (PEG) hydrogels for tissue
engineering cartilage, as the encapsulated chondrocytes remained viable in in vitro
culture for 6 weeks and produced cartilaginous tissue throughout the construct.6–9
Mesenchymal stem cells have been encapsulated in PEG matrices with transforming
growth factor β1 (TGF) physically trapped within the hydrogel mesh, the cells formed
cartilage-like tissue.10

Osteoblasts and mesenchymal stem cells have been

incorporated into PEG hydrogels with covalently attached cell-adhesive peptide
sequences, with promising results in bone tissue engineering as the encapsulated cells
formed a mineralized matrix.11,

12

These cell-polymer systems can be useful for

minimally invasive implantation in cartilage and bone defect sites.

In another

application, photocrosslinkable hyaluronic acid (modified with methacrylate groups) has
been used to encapsulate valvular interstitial cells (VICs). The system showed potential
for the creation of tissue-engineered heart valves.13

Photopolymerizable PEG with

adhesive and proteolytically degradable domains have been investigated as synthetic
extracellular matrix analogs for tissue engineering, by encapsulating smooth muscle
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cells and assessing viability, migration, proliferation and matrix protein production of the
cells within the hydrogels.14 In addition, the encapsulation of cells has other promising
applications such as the therapeutic treatment of different diseases like diabetes,
hemophilia, cancer and renal failure.15
As the photopolymerization of biomaterials involves the use of an ultraviolet (UV)
light sensitive system for the photoinitiation and formation of free-radicals that drive the
polymerization reaction, various studies have investigated the toxicity of different
photoinitiating systems commonly used in cell encapsulation. It has been shown that
the commercially available photoinitiator Irgacure 2959 (I-2959) (chemical name: 2hydroxy-1-[4-(2-hydroxyethoxy)phenyl]-2-methyl-1-propanone) causes minimal toxicity
over a broad range of cell types, and each cell line tolerates a different maximum
concentration of the photoinitiator.16–18
In the photopolymerization process, upon exposure to UV energy, the
photoinitiator

produces

free-radicals,

and

the

free-radicals

then

induce

the

polymerization of the monomer or the crosslinking of the photoreactive macromer. The
creation of free-radical species during photopolymerization generates a potential
degenerative environment for cells, as free-radicals are involved in the metabolism of
carcinogens.19 Moreover, it is well known that UV energy adversely affects cell viability
due to DNA damage, where the toxic response to UV exposure is both dose-dependent
and wavelength-dependent. UV radiation is classified into three types: UV-A (320 to
400 nm), UV-B (290 to 320 nm), and UV-C (100 to 290 nm), where the latter is
considered the most damaging.19, 20 Few studies have examined the effects of plain UV
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energy, or the effects of the free-radicals from the photoinitiator under exposure to
UV.16, 21
Recently, researchers have explored the use of photocrosslinkable biomaterials
and developed three-dimensional photopatterning systems for the fabrication of tissue
engineering scaffolds.22–29 The wavelength most often used in these systems or in the
crosslinking of biomaterials is 365 nm.6–14,

22–29

Also in recent years, the rapid

prototyping technology of stereolithography is being used to produce highly complex
three-dimensional scaffolds with applications in tissue engineering. The wavelengths
available in SL are 325 and 355 nm.30–33

In this work, SL parameters related to

unfavorable cell growth and survival, including photoinitiator exposure, ultraviolet
exposure, and radical formation of the photoinitiator upon exposure to ultraviolet energy
were assessed in vitro using human dermal fibroblast (HDFs) cells to explore the
capabilities of SL to create scaffolds with encapsulated cells. Furthermore, HDFs were
encapsulated in photocrosslinkable poly(ethylene glycol) (PEG) hydrogels using SL and
the viability of the encapsulated cells was evaluated.

5.2. MATERIALS AND METHODS
5.2.1. CELL MAINTENANCE
Cell culture reagents were obtained from Sigma-Aldrich (Saint Louis, MO) unless
otherwise specified. Human dermal fibroblasts (HDFs) were obtained from Cambrex
BioScience (Walkersville, MD) and maintained on Dulbecco’s Modified Eagle Medium
(DMEM) supplemented with 10% Fetal Bovine Serum (FBS; BioWhittaker, Walkersville,
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MD), 200 mM L-glutamine, 10,000 units/ml of penicillin and 10 mg/ml of streptomycin.
Cells were maintained at 37 ºC in a 5% CO2 environment. All cell culture experiments
were conducted using cultures at passage 10 or less. For routine subculturing, the HDF
cells were split at a 1:12 ratio once per week and medium replaced every 2-3 days.

5.2.2. PHOTOINITIATOR TOXICITY
Cell viability of HDFs exposed to different concentrations of two different
photoinitiators (PI) was assessed using a MTT cytotoxicity assay (Sigma-Aldrich, St.
Louis, MO).

The two PIs used were: Irgacure 2959, or I-2959, (2-hydroxy-1-[4-(2-

hydroxyethoxy)phenyl]-2-methyl-1-propanone)

(Ciba

Speciality

Chemicals

Corp.,

Tarrytown, NY) and HMPP (2-hydroxy-2-methyl-1-phenyl-1-propanone) (Sartomer Co.,
Exton, PA). HDFs were cultured in 96-well flat-bottom plates (50,000 cells/well) in the
presence of decreasing concentrations of the PI, starting at 0.5% with 5 doubling
dilutions thereafter. A concentration of 20 µl/ml of DMSO in distilled water was used as
the vehicle solution to dissolve the PI. Although I-2959 is considered water-soluble at
low concentrations, the high concentrations of I-2959 used in this study were not readily
water-soluble.

Thus, DMSO was chosen to dissolve the PIs due to both the high

concentrations of I-2959 and hydrophobicity of HMPP. DMSO is a general solvent for
hydrophobic compounds that is widely used in the preservation of numerous cell lines.
Controls were incubated with equivalent dilutions of vehicle (DMSO) and with neither
vehicle nor compound. Cells were incubated for different time periods (1, 4, or 24
hours) and cytotoxicity was assessed using a MTT colorimetric assay.
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5.2.3. UV IRRADIATION TOXICITY
HDF cells were seeded in tissue culture treated polystyrene multi-well plates at
two different concentrations: 5,000 and 50,000 cells/cm2 and exposed to UV energy at
12 hours from seeding. It should be noted that cells were seeded in the wells only in
every other column, and every other row, being each cell-containing well surrounded by
empty wells (see Figure 5.1). Therefore, when irradiating the cells with UV energy, any
scattered light irradiates mainly the empty wells, minimizing extra UV exposure to the
other cell-containing wells. HDFs were exposed to increasing energy levels of UV light
by rastering a circular pattern with the laser of a SLA 250/50 at different laser speeds.
For the experiments, the elevator platform of the SL machine was set at a height
at which the laser beam was circular with a diameter of ~250µm, laser paper was fixed
to the platform and a circular pattern with area equal to the well area (0.32 cm2) was
burnt in the laser paper. The pattern burnt in the paper marked the location to place the
cell-containing well to be exposed to UV. The circular pattern drawn by the laser when
exposing the cells to the UV energy was smaller than the well area (approximately two
laser beams smaller in diameter, A = 0.27cm2) in order to have a clearance and prevent
the laser from hitting the rim of the well and scattering the beam.
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Empty well
Cell-containing well

Figure 5.1. Layout of the 96-well plate for the UV irradiation and photoinitiator with UV irradiation
experiment.

Before UV exposure, the media was removed from the cells and washed once
with PBS to minimize absorption of the radiation by the phenol red in the media. The
plate was set in place to irradiate the well with the UV energy of the laser. Following UV
exposure, media was added to the cells and then the plate was incubated for 4 – 6
hours to assess cell viability using a LIVE/DEAD® Viability/Cytotoxicity kit (Molecular
Probes, Eugene, OR).

5.2.4. UV IRRADIATION + PHOTOINITIATOR TOXICITY
In the photopolymerization process, upon absorption of UV the photoinitiator
forms free-radicals that initiate the reaction. Free-radicals are considered toxic species
involved in the metabolism of carcinogens. In order to evaluate the effect of the freeradicals formed by the photoinitiator, cells were exposed to the photoinitiator and
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irradiated with UV. Similar to the procedure above, the media was removed from the
cells and washed once with PBS, and a buffer solution containing 0.5% (w/v) of the
photoinitiator I-2959 was added to the well. The volume of photoinitiator solution added
to the well corresponded to a height of approximately 3 mm. The plate was set in place,
and the well irradiated UV laser. Following the UV irradiation, the photoinitiator solution
was removed from the cells, the well was washed once with PBS, and fresh media was
added. The plate was then incubated for 4 – 6 hours to assess cell viability using a
LIVE/DEAD® Viability/Cytotoxicity kit.

5.2.5. CELL ENCAPSULATION
Two commercially available biocompatible photopolymers: poly(ethylene glycol)
dimethacrylate (PEG-dma MW 1000, Polysciences, Inc., Warrington, PA) and
poly(ethylene glycol) diacrylate (PEG-da MW 3400, Laysan Bio Inc., Arab, AL) were
used to encapsulate the HDFs in SL. PEG-dma 1K or PEG-da 3.4K were dissolved in
10 mM HEPES buffered saline (HBS, pH 7.4), followed by addition of I-2959. AcryloylPEG-RGDS was then added to the photopolymer solution, to provide the cells with
attachment sites as PEG is a cell non-adhesive material and HDFs are an adherent cell
line. The solution was then filter sterilized (0.22 μm filter; Cole-Parmer, Vernon Hills,
IL). A cell suspension in complete media was mixed in equivolume amount with the
PEG solution to form a cell-polymer solution with the following concentrations: 106
cells/ml, 30% (w/v) PEG-dma 1K or 20% (w/v) PEG-da 3.4K, 0.5% (w/v) I-2959, and 5
mg/ml acryloyl-PEG-RGDS.

The cell-polymer solution was then pipetted inside the
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mini-vat setup of the SL machine, and a simple ring pattern (ID = 3 mm, OD = 5mm)
was drawn by the laser. Four patterns were fabricated at a time and the fabrication of
each pattern took less than 10 seconds. Fresh cell-polymer solutions were mixed each
time a batch of four patterns was created.

Once the cell-containing scaffold was

fabricated, it was placed with media in an incubator at 37ºC and 5% CO2. Cell viability
of the encapsulated cells was assessed using a LIVE/DEAD® Viability/Cytotoxicity kit
(Molecular Probes, Eugene, OR) at 2 and 24 hours following fabrication

5.2.6. CELL VIABILITY AND TOXICITY EVALUATION
For the evaluation of photoinitiator toxicity, following the incubation period (1, 4,
or 24 hours), 10 µl of MTT solution were added to each well and the plates were
incubated for an additional 4-6 hours at 37 ºC. Isopropanol was then added to each
well to dissolve the formazan crystals that were formed. The relative absorbance at 560
nm was determined using a microplate reader (Spectra MAX 190, Molecular Devices
Corporation, Union City, CA).
For the evaluation of the effects of UV exposure and photoinitiator together with
UV, the LIVE/DEAD viability/cytotoxicity kit was used to fluorescently examine the cells.
The concentrations of the fluorescent dyes used were 1 μM calcein AM and 4 μM
ethidium homodimer-1, incubation with the dye occurred for approximately 10-15
minutes at 37ºC before fluorescent evaluation.

The relative fluorescence was

determined using a fluorescent plate reader (Fluoroskan Ascent, Labsystems, Finland)
with excitation / emission optics set at 485 / 518 (± 12) nm respectively. Furthermore,
177

fluorescent images were acquired using an inverted microscope with fluorescence
capabilities (Leica Microsystems, Leica DM IRB, Germany).
Fluorescent images were analyzed to quantify the change in cell density. The
acquired fluorescent images with both the LIVE (green) and DEAD (red) stains were
analyzed using image analysis software from National Instruments TM (Vision Assistant,
Version 8.0.0). In order to quantify the density of live cells, a script was programmed to
analyze the images and obtain the cell density data from the image as confluence (area
occupied by the cells divided by the image area).

Figures 5.2 and 5.3 show the

sequence of steps in the script to analyze the images. The steps to analyze the image
can be separated in two sections: image preparation steps for threshold (shown in
Figure 5.2) and image preparation steps for quantitative analysis (shown in Figure 5.3).
First the image is prepared to define a threshold for the desired objects in the
image to be analyzed, and the steps for this are as follows: 1) input image, 2) adjust
brightness, contrast and gamma to bring up the fluorescence of the image, 3) extract
the green plane of the image, 4) re-adjust brightness, contrast and gamma, 5) transform
grayscale values of the image, and 6) apply a threshold to segment the desired pixels of
the image. Then, a series of morphological operations are made to prepare the image
for quantitative analysis, and these operations are: 7) open objects, 8) apply a
Danielsson operation, 9) remove small objects, 10) filter particles, and 11) analyze
particles. Different measurements can be selected in the analysis step to export to
Excel, to report the confluence of the image, the percentage area of the particle by
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image area was selected. Once the data were exported to Excel, the percentages for
each particle were summed and the sum is the corresponding image confluence.

1) Input original image.

2) Adjust brightness, contrast and gamma.

3) Extract green plane.

4) Re-adjust brightness contrast and gamma.

5) Transform grayscale values.

6) Apply threshold.

Figure 5.2. Image preparation steps to threshold the desired objects in the image analysis script.
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7) Basic morphology: open objects.

8) Advanced morphology: Danielsson.

9) Remove small objects.

10) Particle filter.

11) Particle analysis.
Figure 5.3. Image preparation steps for quantitative analysis.

180

Cell viability of the encapsulated cells was assessed using a LIVE/DEAD®
Viability/Cytotoxicity kit (Molecular Probes, Eugene, OR) at 2 and 24 hours following
fabrication. Briefly, following incubation, the media was removed and the gels were
rinsed twice with Dulbecco’s phosphate buffered saline (D-PBS). The gels were then
incubated for 15 minutes with a solution containing 0.4 µM calcein AM and 0.8 µM
ethidium homodimer-1. The gels were then rinsed with D-PBS and observed using an
inverted microscope with fluorescence capabilities (Leica Microsystems, Leica DM IRB,
Germany). Three samples were fabricated for each timepoint and fluorescent images
were taken at three different locations on each sample. The number of live and dead
cells in each image was then determined.

5.2.7. STATISTICAL ANALYSIS
The mean and standard deviations of the data were calculated.

Data were

compared using two-tailed, unpaired, t-tests. P-values less than 0.05 were considered
to be significant.

5.3. RESULTS AND DISCUSSION
5.3.1. PHOTOINITIATOR TOXICITY
Cell viability of HDFs exposed to different concentrations of the two types of PIs
used here was assessed with a MTT-based cytotoxicity assay. Cytotoxicity increased
with increasing PI concentrations, and increased exposure time, as expected (see
Figure 5.4). For a given PI concentration (0.5%), the detrimental effect of the PIs on cell
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survival is evident after 4 hours of exposure (see Figure 5.4A).

For prolonged

exposures (24 hours), cell viability was similar to the non-DMSO control (complete
media) for HDFs treated with I-2959 only at concentrations up to 0.05% (see Figure
5.4B). These results agree with previous studies on the effect of I-2959 on cytotoxicity
of cells.16–18 It should be noted, however, that the longer exposure times used here are
greater than any exposure the cells would actually experience during the SL process.
Once constructs are made (30-40 minutes, even for complex 3D structures), the
constructs would be placed in media and excess PI would begin leaching out. Thus,
0.5% I-2959 could realistically be used in conjunction with SL without severe
cytotoxicity.
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Figure 5.4. Cytotoxicity of photoinitiators A) as a function of time for a given photoinitiator
concentration (0.05%), and B) as a function of photoinitiator concentration for an exposure time of
48 hours. Survival is normalized to that observed in non-DMSO controls. Solid bars and markers
correspond to HMPP, hollow bars and markers correspond to I-2959. Note that the symbols in B
for HMPP and I-2959 at concentrations of 0.125% and 0.0625 overlap.
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5.3.2. CYTOTOXICITY

OF

UV IRRADIATION

AND

PHOTOTINITIATOR-UV

IRRADIATION
To assess the toxic effect of UV irradiation, and the effect of photoinitiator under
UV irradiation on cultured HDFs exposed to a range of UV irradiation from 0 – 20,000
mJ/cm2 from the 325 nm laser of the SL system a LIVE/DEAD viability/cytotoxicity kit
was used.

Cells viability was determined using fluorescence readings and image

analysis for two different cell concentrations (5,000 and 50,000 cells/cm2).

No

detrimental effect of UV irradiation, nor of photoinitiator under UV irradiation, was
observed in the experiment using a high concentration of cells (50,000 cells/cm2). For a
low concentration of cells (5,000 cells/cm2), cell viability decreased with increasing the
UV energy dosage at which the cells were exposed. Viability of cells exposed to a
concentration of 0.5% (w/v) of the photoinitiator I-2959 and irradiated with different
dosages of UV also decreased with increasing energy dosages.
Figure 5.5 shows the results of cell viability determined from fluorescent readings
for the two cell concentrations. For the experiment of UV irradiation using a low cell
concentration (Figure 5.5A, solid bars), a significant decrease (63%) in cell survival is
observed at the highest energy exposure of 20,000 mJ/cm2, while the cell survival for
the other energies are comparable to the control. For the experiment of photoinitiator
exposure and UV irradiation using a low cell concentration (Figure 5.5A, downward
diagonal bars), the cell survival for the lowest energy (1,500 mJ/cm2) is comparable to
the control (cells not exposed to UV).

A decrease in cell survival (not statistically
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Figure 5.5. Survival of HDFs following exposure to UV energy (solid bars) and to the
photoinitiator I-2959 and irradiated with UV (downward diagonal bars), assessed using a
fluorescence plate reader. A: low cell concentration experiment (5,000 cells/cm2), B: high cell
concentration experiment (50,000 cells/cm2). Note that no detrimental effect is observed in the
experiment using a high cell concentration, although the data for the highest energies (12,000 and
20,000 mJ/cm2) has a high variability.

significant) is observed at energies of 2,500 and 6,000 mJ/cm2 (77% and 82%,
respectively). For the two highest energy exposures, a statistically significant decrease
in cell survival is observed (52% and 63%, for 12,000 and 20,000 mJ/cm2, respectively).
No detrimental effect is observed in the experiments using a high cell concentration
(Figure 5.5B), although the data for the highest energies (12,000 and 20,000 mJ/cm2)
have a high variability (approximately from ±14 to ±23%).
Figure 5.6 shows the results of cell viability determined from cell confluency data
obtained from image analysis for the two cell concentrations. Similar to the results from
fluorescence readings, UV irradiation using a low cell concentration (Figure 5.6A, solid
bars) shows a statistically significant decrease in cell survival at the highest energy
exposure. The confluency of the control (cells not exposed to UV) is 27.7 ± 5.4%, while
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Figure 5.6. Live cells confluency of HDFs following exposure to UV energy (solid bars) and to the
photoinitiator I-2959 and irradiated with UV (downward diagonal bars), assessed using image
analysis. A: low cell concentration experiment (5,000 cells/cm2), B: high cell concentration
experiment (50,000 mJ/cm2). Note that no detrimental effect is observed in the experiment using a
high cell concentration.

the confluency of the cells exposed to an energy of 20,000 mJ/cm2 decreased to 7.2 ±
6.8%. The cell confluency for the rest of the energies is comparable to the control.
For the experiment of photoinitiator exposure and UV irradiation using a low cell
concentration (Figure 5.6A, downward diagonal bars), a statistically significant decrease
in cell confluency is observed at the three highest energy exposures (fluorescence
readings data, showed a significant decrease for the two highest energies only). Again,
confluency of the control is 27.2 ± 6.6%, and the confluency for an energy of 1,500
mJ/cm2 is comparable to the control (27 ± 8%). A slight decrease in cell confluency is
observed for an energy of 2,500 mJ/cm2, as the determined confluency is 22.4 ± 3.9%.
At the three highest energies (6,000, 12,000 and 20,000 mJ/cm2), the confluency
decreased to 19.2 ± 3.4, 12.2 ± 4.0 and 7.1 ± 3.1%, respectively.
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Similar to

fluorescence reading data, no detrimental effect is observed in the experiments for both
UV and photoinitiator and UV using a high cell concentration (Figure 5.6B).
Figures 5.7 – 5.10 show the fluorescent images of the cells exposed to UV
irradiation and to the combined effect of photoinitiator under UV irradiation for the two
cell concentrations. The differences in cell density for the different experiments can be
observed in the pictures on these figures. In the high cell concentration experiments,
the cell confluency is high, ~50%, according to the image analysis. In these images, the
cells are close to each other and even overlap.

In the low cell concentration

experiments, a confluency of ~27% was calculated. The cells in these images are
relatively close to each other, but empty (black) spaces between cells can be observed.
The reduction in cell density can be observed for the low cell concentration
experiments for both the UV exposure experiment and the photoinitiator under UV
irradiation experiment. For the UV irradiation experiment, a few live (green) cells are
present in the 10x image (Figure 5.7, left column) for 20,000 mJ/cm2 of energy, and a
high number of dead (red) cells can be observed in the 5x image (Figure 5.7, right
column). For the photoinitiator under UV irradiation experiment, the reduction in cell
density is more gradual and can be observed from the energy dosage of 6,000 mJ/cm2
up. Contrary to the UV irradiation experiment, dead (red) cells are not observed in the
low magnification images. This can be due to both the smaller number of cells present,
and the fact that the cells in the photoinitiator under UV experiment are rinsed more
times, and as dead cells are poorly attached, the dead cells are lost during rinsing.
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Control

1,500 mJ/cm2

2,500 mJ/cm2

6,000 mJ/cm2

12,000 mJ/cm2

20,000 mJ/cm2
Figure 5.7. Fluorescent images for UV exposure experiment at a low (5,000 cells/cm2) cell density.
HDFs were stained with a LIVE/DEAD cell viability assay in which the live cells fluoresce green
and the dead cells fluoresce red. Right column: high magnification images (100X). Left column:
low magnification images (50X).
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Control

1,500 mJ/cm2

2,500 mJ/cm2

6,000 mJ/cm2

12,000 mJ/cm2

20,000 mJ/cm2
Figure 5.8. Fluorescent images for photoinitiator and UV exposure experiment at a low (5,000
cells/cm2) cell density. HDFs were stained with a LIVE/DEAD cell viability assay in which the live
cells fluoresce green and the dead cells fluoresce red. Right column: high magnification images
(100X). Left column: low magnification images (50X).
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Control

1,500 mJ/cm2

2,500 mJ/cm2

6,000 mJ/cm2

12,000 mJ/cm2

20,000 mJ/cm2
Figure 5.9. Fluorescent images for UV exposure experiment at a high (50,000 cells/cm2) cell
density. HDFs were stained with a LIVE/DEAD cell viability assay in which the live cells fluoresce
green and the dead cells fluoresce red. Right column: high magnification images (100X). Left
column: low magnification images (50X).
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Control

1,500 mJ/cm2

2,500 mJ/cm2

6,000 mJ/cm2

12,000 mJ/cm2

20,000 mJ/cm2
Figure 5.10. Fluorescent images for photoinitiator and UV exposure experiment at a high (50,000
cells/cm2) cell density. HDFs were stained with a LIVE/DEAD cell viability assay in which the live
cells fluoresce green and the dead cells fluoresce red. Right column: high magnification images
(100X). Left column: low magnification images (50X).
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5.3.3. CELL ENCAPSULATION
Human dermal fibroblasts were seeded within PEG hydrogel constructs by
combining a cell suspension with the photopolymer solution, which was then used in the
SL fabrication process.

Two types of photocrosslinkable PEG were used to

encapsulate the cells: PEG-dma 1K and PEG-da 3.4K. Additionally, the cell-adhesive
ligand RGDS was covalently incorporated within the hydrogel matrix to provide
attachment sites for the cells. The laser energy required to crosslink these gels was
~350 mJ/cm2, and the power radiated per unit area was ~78 mW/cm2 taking ~5 seconds
to crosslink each gel. The percentage of live cells encapsulated in PEG hydrogels
fabricated using SL was determined at 2 and 24 hours following fabrication using a
LIVE/DEAD® viability/cytotoxicity kit. There was a high percentage of viable cells at
both 2 and 24 hours for both PEG-types (at least 87%) with no significant difference in
the viability of cells at the two time points (see Figure 5.11), indicating that the cells can
survive the SL process. Figure 5.12 shows representative fluorescent images of the
gels demonstrating high viability of encapsulated cells after 2 and 24 hours of
fabrication with a uniform distribution of cells throughout the gel.
Photopolymerization experiments in the presence of cells are generally carried
out using handheld UV lamps with a peak wavelength at 365nm (UV-A long wavelength
range) rated at a power range of 2-10 mW/cm2.

In these experiments the cell-

containing photopolymer solution is placed in a mold, and then exposed to UV energy
for a certain amount of time until the solution crosslinks.6–14 In the work presented here,
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a UV laser beam is scanned over the photopolymer solution at a given speed
crosslinking the scanned area. Although the power irradiated per unit area used in the
work presented here is higher (~78 mW/cm2) than the one used by other groups for the
photopolymerization of gels in the presence of cells (2-10 mW/cm2), the actual energy
dosage to crosslink the gels is generally lower. As a comparison, Williams et al.10,
encapsulated mesenchymal stem cells in PEG hydrogels using a 365 nm UV lamp rated
at 4 mW/cm2 taking ~5 minutes to crosslink the gels, exposing the cells to an energy
dosage of ~1200 mJ/cm2, while the energy dosage used here in the presence of cells is
~350 mJ/cm2 at a wavelength of 325 nm.
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Time following encapsulation (hours)
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Figure 5. 11. Viability of human dermal fibroblasts encapsulated in PEG hydrogels
photocrosslinked using SL at 2 and 24 hours following fabrication. Solid bars correspond to PEGdma 1K gels, downward diagonal bards correspond to PEG-da 3.4K gels.
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Figure 5.12. HDFs encapsulated in PEG hydrogels photocrosslinked using SL, stained with a
LIVE/DEAD cell viability assay in which the live cells fluoresce green and the dead cells fluoresce
red. A and B: at 2 hr following encapsulation, C and D: at 24 hr following encapsulation. E and F:
low magnification image showing an even distribution of cells throughout the gel (marker
represents 1 mm).
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5.4. CONCLUSIONS
Stereolithography parameters related to unfavorable cell growth and survival,
including photoinitiator exposure, ultraviolet exposure, and radical formation of the
photoinitiator upon exposure to ultraviolet energy were assessed in vitro using human
dermal fibroblast (HDFs) cells. These experiments were used to explore the capabilities
of SL to create scaffolds with encapsulated cells. Cell viability of HDFs exposed to
increasing concentrations of two types of PIs and to a fixed concentration of PI for
different exposure times was investigated. Cytotoxicity increased with increasing PI
concentration and increased exposure time. For a given PI concentration (0.5%), the
detrimental effect of the PIs on cell survival is evident after 4 hours of exposure. For
prolonged exposures (24 hours), cell viability was similar to the non-DMSO control
(complete media) for HDFs treated with I-2959 only at concentrations up to 0.05%.
These results agree with previous studies on the effect of I-2959 on cytotoxicity of
cells.16–18 It should be noted, however, that the longer exposure times used here are
greater than any exposure the cells would actually experience during the SL process.
Once constructs are made (30-40 minutes, even for complex 3D structures), the
constructs would be placed in media and excess PI would begin leaching out. Thus,
0.5% I-2959 could realistically be used in conjunction with SL without severe
cytotoxicity.
The toxic effect of UV irradiation and the effect of photoinitiator (at a given
concentration of 0.5%) under UV irradiation on cultured HDFs exposed to a range of UV
irradiation from 0 – 20,000 mJ/cm2 from the 325 nm laser of the SL system was
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assessed using HDFs cultured on tissue culture plates at two different cell
concentrations: 5,000 and 50,000 cells/cm2.

Cell viability was determined using

fluorescence readings and image analysis. No detrimental effect of UV irradiation nor of
photoinitiator under UV irradiation was observed in the experiment using a high
concentration of cells (50,000 cells/cm2).

For a low concentration of cells (5,000

cells/cm2), cell viability decreased with increasing the UV energy dosage. Cell viability
for cells exposed to a concentration of 0.5% (w/v) of the photoinitiator I-2959 and
irradiated with different dosages of UV also decreased with increasing energy dosages.
In the high cell concentration experiments, the cells were close to each other and even
overlapped, while in the low cell concentration experiments, cells were still relatively
close to each other but empty (black) spaces between cells could be observed. Cell-tocell contacts have been found to protect from apoptosis in vascular smooth muscle cells
(VSMC), an adherent cell type, promoting cell survival as N-cadherin mediated cell-tocell contacts increase Akt and Bad phosphorylation initiating anti-apoptotic signaling.34
This may explain why no detrimental effect of UV irradiation nor of photoinitiator under
UV irradiation was observed in the experiment using a high concentration of cells.
Results from image analysis were comparable to fluorescence readings, but for
the experiment using a low cell concentration exposed to the photoinitiator under UV
irradiation, image analysis was better able to detect the significant differences in cell
viability.

In summary, results showed that SL threshold levels for unfavorable cell

survival were considerably away from the ones used to create PEG-based scaffolds in
SL.
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Furthermore, HDFs were encapsulated in photocrosslinkable poly(ethylene
glycol) (PEG) hydrogels using SL and the viability of the cells was evaluated at 2 and 24
hours following encapsulation. Two different types of PEG were used to encapsulate
the cells: PEG-dma 1K, and PEG-da 3.4K. Hydrogel scaffolds with encapsulated cells
showed a uniform distribution of cells throughout the scaffolds, and a high percentage of
viable cells at both 2 and 24 hours (at least 87%), with no significant difference in the
viability of cells at the two time points or for the two PEG types. The results presented
here indicate that the use of SL and photocrosslinkable biomaterials, such as
photocrosslinkable PEG, appears feasible for fabricating scaffolds with living cells for a
variety of important tissue engineering applications.
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CHAPTER 6
CONCLUSIONS AND RECOMMENDATIONS
This

research

focused

on

using

the

rapid

prototyping

technology,

stereolithography (SL), and a photocrosslinkable biomaterial, poly(ethylene glycol)
(PEG), to create 3D scaffolds with applications in tissue engineering (TE). The main
objective was to create an implantable multi-lumen nerve guidance conduit (NGC) for
the regeneration of peripheral nerves. The capabilities of SL to create scaffolds with
encapsulated cells for a variety of TE applications were also explored.
The appropriate conditions that allowed the photopolymerization of PEG in thin
layers to successfully fabricate complex structures in a layer-by-layer fashion were
investigated.

Two different types of photocrosslinkable PEG were used for this

research: poly(ethylene glycol) dimethacrylate, molecular weight 1K (PEG-dma 1K) and
poly(ethylene glycol) diacrylate, molecular weight 3.4K (PEG-da 3.4K).

The

photopolymers were used in aqueous solutions at two different concentrations: 20 and
30% (w/v). Photopolymerization experiments were performed to characterize different
PEG-based photopolymer solutions for use in SL where the crosslinked depth (or gel
thickness) was measured at different laser energies.
Prior to investigating the characteristic photocrosslinking of PEG-based solutions,
photoinitiating conditions were determined by examining two different photoinitiators at
different concentrations.

Photopolymerization of thin layers, preferred for layered
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manufacturing as the layer thickness controls the resolution of the fabricated parts, was
identified for a 0.5% (w/v) concentration of the cytocompatible photoinitiator Irgacure
2959 (I-2959).

Therefore, the PEG-based photopolymer solutions investigated

contained a 0.5% (w/v) concentration of I-2959.
In the photopolymerization experiments for the different photoreactive PEG
solutions, gel thickness versus energy dosage data in a semi-logarithmic plot (known in
SL as the working curve for a given resin formulation) conformed closely to a straight
line, just as the data for commercial SL resins. The parameters known in SL as EC
(critical exposure) and DP (penetration depth), considered fundamental properties of
each photoreactive formulation, are determined from the working curve of the
photoreactive formulation and are used to automatically build structures in SL. While
the research presented in Chapter 3 determined the EC and DP for the PEG-based
solutions investigated, these values could not be used in the SL system to automatically
build PEG-based scaffolds. Future work should investigate the different SL parameters
involved in the automatic fabrication of structures, such as the parameters given by the
pre-processing software 3DLightyearTM and the parameters of the resin file in the SL
system, as these contain the information to build a part.
The information given by 3DLightyearTM and the information in the resin file are
specific to commercial resins. Commercial resins are a mixture of reactive monomers,
unlike the photoreactive solutions used here that are mainly composed of water where
the reactive species are polymers with reactive end groups.

The appropriate

modifications or adjustments to the build files in 3DLightyearTM and in the resin file
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should be investigated to take into account the characteristic photocrosslinking of PEGbased solutions and be able to automatically build PEG-based structures.
A significant part of this research focused on characterizing PEG-based hydrogel
samples created in SL in terms of mechanical properties, sol fraction, swelling ratio and
dimensional changes.

Hydrogel samples were created using four different

photopolymer solutions (two different photopolymers at two different concentrations).
Mechanical properties of hydrogel samples created in SL were a strong function of
polymer type and concentration, as well as energy dosage used to crosslink the
samples. Swelling ratio and sol fraction of samples fabricated using SL (at a given
energy dosage for two different energy dosages) varied with respect to polymer type
and concentration. The sol fraction represents the amount of unreacted photopolymer
contained in the gel after fabrication. A larger amount of unreacted photopolymer could
lead to a looser crosslinked structure, which in turn could lead to an increased uptake of
water and a larger swelling ratio. In general, hydrogels fabricated with PEG-dma 1K
had a higher sol fraction and a lower swelling ratio than hydrogels fabricated with PEGda 3.4K. In terms of photopolymer concentration, hydrogels fabricated with a 20%
concentration had a higher swelling ratio and a higher sol fraction than the ones
fabricated with the 30% concentration. The energy used to crosslink the samples did
not have a significant effect on swelling ratio or sol fraction for the two energies
investigated.
The equilibrium swelling behavior of PEG samples created in SL determined as
change in dimensions of simple constructs was investigated.
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The determined

dimensional swelling factor (DSF), representing the ratio of the swollen dimension by
the dimension in the original design, exhibited a dependence on PEG type and
concentration. Overall, PEG-dma 1K gels at equilibrium decreased in size, while PEGda 3.4K gels increased in size. As the polymer concentration decreased, the size of the
gels at equilibrium decreased when compared to the equilibrium sizes of the gels
fabricated at higher polymer concentrations. For the two energy dosages investigated,
energy dosage had an effect on the dimensional swelling factor only for PEG-da 3.4K
based hydrogels where when more energy was used to crosslink the samples, the more
the samples increased in size at the equilibrium swollen state.
In summary, as each photopolymer formulation produced hydrogels with unique
characteristics (swelling, mechanical strength, photosensitivity, etc), the PEG-based
solution to be used during SL fabrication must be selected or designed for the specific
application. One advantage of using the photopolymer PEG-dma 1K, for example, is
that because of its photosensitivity, complex hydrogel structures can be fabricated with
a layer resolution of ~0.010-in.

Hydrogels of PEG-da 3.4K are already being

investigated for tissue engineering applications due to their resemblance to soft tissue in
terms of elasticity and water content. From a cost perspective, a concentration of 20%
(w/v) of PEG-da 3.4K is preferred over 30% (w/v), because both concentrations
produced similar hydrogel structures and therefore, the lower concentration of PEG
reduced the overall material cost. As a result, the NGCs with application in tissue
engineering developed in the current research used PEG-da 3.4K at a concentration of
20% (w/v).
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The aim of the research presented in Chapter 4 was to demonstrate the use of
SL to fabricate NGCs, and develop a complete manufacturing process for NGC
fabrication that provided an off-the-shelf implantable product.

The fabrication of an

NGC design with two important characteristics was demonstrated where the design
included a capped portion at each end that allows effective suturing of the proximal and
distal stumps of the damaged nerve to the NGC, and a multi-lumen middle portion that
provides a greater surface area for support cells and sprouting axons. The dimensions
of the design were the smallest permitted by the SL system used for the fabrication:
2.94mm OD, 1.72mm ID, with seven 400-μm diameter lumens. Due to swelling of the
material the dimensions in the final swollen state were approximately: 3.38mm OD,
2.43mm ID with lumen diameters of 585μm.

The use of SL in the manufacturing

process provides a rapid fabrication technology for complex 3D scaffolds. With the
addition of lyophilization and sterilization, the resulting manufacturing process rapidly
creates implantable, off-the-shelf products with improved suturability.

With the

lyophilization stage, the dimensions of NGCs significantly decreased, and decreased
even more with sterilization, yet the samples returned quickly (less than 30 minutes) to
their swollen dimensions and original structure once reconstituted. Suturability of the
conduits was demonstrated at both the post-processed and reconstituted state.
Future research on NGCs should focus on three main issues. First, as cells
cannot be incorporated into the NGC during fabrication as they would not survive the
post-processing stages, cell studies (including attachment, differentiation, and secretion
of growth factors) using support cells (Schwann cells) should follow.
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Secondly,

incorporation of growth factors (such as nerve growth factor (NGF) or vascular
endothelial growth factor (VEGF)) into NGCs should be explored in detail for
subsequent in vivo studies as the incorporation of these growth factors into NGCs
enhances the regeneration process. Studies incorporating these factors into NGCs,
either physically trapped within the hydrogel mesh or covalently attached to the PEG
chain, and testing the release and bioactivity of the factors may be important and
necessary for the creation of bioactive NGCs.

Finally, in vivo studies that test the

regeneration capabilities of NGCs fabricated with SL using a rat model should be
performed.
Stereolithography parameters related to unfavorable cell growth and survival,
including photoinitiator (PI) exposure, ultraviolet exposure, and radical formation of the
photoinitiator upon exposure to ultraviolet energy were assessed in vitro using human
dermal fibroblast (HDFs) cells. Furthermore, the capabilities of SL to create scaffolds
with encapsulated cells were explored. In-vitro studies showed that SL threshold levels
for unfavorable cell survival were well above the levels used to create PEG-based
scaffolds in SL, and cell encapsulation studies indicated that the use of SL and
photocrosslinkable PEG appears feasible for fabricating scaffolds with living cells for a
variety of TE applications. Potential mutations and damage to DNA as a result of UV
and free-radicals exposure should be explored in greater detail in future research.
In summary, this research demonstrated that SL represents a unique additive
fabrication technology that can create complex 3D TE scaffolds, allowing for control
over the scaffold’s macro-scale design as well as precise placement of viable cells and
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bioactive agents within the scaffold during construction. A detailed characterization of
PEG-based scaffolds created in SL was presented.

A manufacturing process for

implantable multi-lumen off-the-shelf NGCs with improved suturability for the
regeneration of peripheral nerves was developed.

The research presented here

provides the foundation for continued research on the development of tissueengineered scaffolds to enhance the regeneration of peripheral nerves and on the use
of hydrogels in SL for a variety of TE applications.
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